ML20116E607

Rev 0 to Offsite Dose Calculation Manual

ML20116E607
Person / Time
Site:	Hope Creek
Issue date:	04/09/1985
From:	SOURCE TECHNOLOGIES, INC.
To:
Shared Package
ML20116E604	List: ML20116E599 ML20116E607
References
PROC-850409, NUDOCS 8504300345
Download: ML20116E607 (121)

Text

- - -

OFFSITE DOSE CALCULATION MANUAL FOR ,

PUBLIC SERVICE ELECTRIC AND GAS COMPANY HOPE CREEK GENERATING STATION Revision O APRIL 9, 1985 Prepared by SOURCE TECHNOLOGIES, INC.

Quantum Technology Division 830 Franklin Court Ma rie t ta , Georgia 30067 B504300345 850426 PDR ADOCK05000g4 A

l-

)

TABLE OF CONTENTS Page List of Tables iii List of Figures iv References v

1.0 INTRODUCTION

1.0-1 2.0 LIQUID EFFLUENTS 2.0-1 2.1 Liquid Effluent Monitor Setpoint Calculations 2.0-1 2.1.1 Liquid Radwaste Discharge Line Monitor 2.0-2 2.1.1.1 Releases of Single Liquid Radwaste Streams . 2.0-3 2.1.1.2 Simultaneous Releases of Liquid Radwaste Streams 2.0-11 2.1.2 Cooling Tower Blowdown Line Effluent Monitor 2.0-12 2.2 Liquid Effluent Dose Calculations 2.0-15 2.3 Definitions of Liquid Effluent Terms 2.0-24 3.0 GASEOUS EFFLUENTS 3.0-1 3.1 Gaseous Effluent Monitor Setpoint Calculations 3.0-1 3.1.1 Normal Setpoint Method 3.0-2 3.1.2 Startup Setpoint Method 3.0-5 3.2 Gaseous Effluent Dose Calculations 3.0-8 3.2.1 Site Boundary Dose 3.0-8 3.2.2 Air Dose 3.0-10 3.2.3 Dose to a Member of the Public 3.0-11 3.3 Meteorological Model 3.0-51 3.4 Definitions of Gaseous Effluents Terms 3.0-52 SOURCE PSEGODCM i Rev. O, 85/4/2

TABLE OF CONTENTS (continued)

Page 4.0 SPECIAL DOSE CALCULATIONS 4.0-1 4.1 Necessity of Operating Effluent- Treatment Systems 4.0-1 4.1.1 Liquid Radwaste Treatment System 4.0-1 4.1.2 Ventilation Exhaust Treatment System 4.0-3 4.1.3 Gaseous Radwaste Treatment System 4.0-4 4.2 Total Fuel Cycle Dose 4.0-8 4.3 Initial Evaluation of Unplanned Gaseous Releases , 4.0-9 4.4 Dose to a tiember of the Public Due to Activities Inside the Site Boundary 4.0-17 4.5 Integrated Population Dose 4.0-18 5.0 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 5.0-1 5.1 Sampling Program 5.0-1 5.2 Interlaboratory Comparison Program 5.0-13 l

l l

l SOURCE:PSEGODCM ii Rev. O, 85/4/2 L

LIST OF TABLES Number Title Page 2.1-1 Maximum Permissible Concentration of Dissolved or Entrained Noble Gases Released from the Site to Unrestricted Areas in Liquid Waste 2.0-13 2.1-2 Maximum Discharge Capacity of Liquid Radwaste Streams for the Hope Creek Generating Station 2.0-14 2.2-1 Site Related Ingestion Dose Commitment Factor, A 2.0-19 it 2.2-2 Bioaccumulation Factors 2.0-21 2.2-3 Adult Ingestion Dose Factors 2.0-22

~

3.1-1 Dose Factors for Exposure to a Semi-Infinite Cloud of Noble Gases 3.0-7 3.2-1 Pathway Dose Factors for Section 3.2.1.b (Pio) 3.0-14 3.2-2 Pathway Dose Factors for Section 3.2.3 3.0-22 (Ri$o) 3.2-3 Controlling Receptors, Locations, and Pathways 3.0-44 3.2-4 Atmospheric Dispersion Parameters for Controlling Receptor Locations 3.0-46 3.2-5 Parameters Used in Dose Factor Calculations 3.0-47 4.3-1 Infant Pathway Dose Factors for Section 4.3 (R i ) 4.0-10 4.3-2 Child Pathway Dose Factors for Section 4.3 4.0-13 (Ri3) 5.0-1 Radiological Environmental Monitoring Program 5.0-2 i

SOURCE:PSEGODCM iii Rev. O, 85/4/2

LIST OF FIGURES Number Title Page 4.1-1 Liquid Radwaste Treatment System 4.0-5 4.1-2 Ventilation Exhaust Treatment System 4.0-6 4.1-3 Gaseous Radwaste Treatment System 4.0-7 5.1-1 Onsite Sampling Locations, Artificial Island 5.0-11 5.1-2 Offsite Sampling Locations, Artificial Island 5.0-12 SOURCE:PSEGODCM iv Rev. O, 85/4/2

REFERENCES The following documents are referred to by number in the text of this Manual.

1. Radiological Effluent Technical Specifications, Hope Creek Generating Station, Draft, March 1985.

2. Final Safety Analysis Report, Hope Creek Generating Station, updated through Amendment 9.

3. Applicant's Environmental Report - Operating License Stage, Hope Creek Generating Station, updated through Amendment 4.

4. U. S. Nuclear Regulatory Commission, " Calculation of Annual Doses to Man from Routine Releases of Reac' tor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Regulatory Guide 1.109, Revision 1, 1977.

5. U. S. Nuclear Regulatory Commission, " Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors,"

Regulatory Guide 1.111, Revision 1, 1977.

6. U. S. Nuclear Regulatory Commission, " Preparation of Radio-logical Effluent Technical Specifications for Nuclear Power Plants," USNRC Rept. NUREG-0133, 1978.

7. " Artificial Island Radiological Environmental Monitoring Program - 1983 Radiological Report," Public Service Electric and Gas Company, March 1984.

l l

l SOURCE:PSEGODCM v Rev. O, 85/4/2

Section

1.0 INTRODUCTION

The OFFSITE DOSE CALCULATION MANUAL is a supporting document of the RADIOLOGICAL EFFLUENT TECHNICAL SPECIFICATIONS. As such the ODCM describes the methodology and parameters to be used in the calculation of offsite doses due to radioactive liquid and gaseous effluents, and in the ::alculation of liquid and gaseous effluent monitoring instrumentation alarm / trip setpoints.

The ODCM contains a list and graphical description of the specific sample locations for the radiological environmental monitoring program. Schematic configurations of liquid and gaseous radwaste effluent systems are also included.

The ODCM will be maintained at the plant for use as a reference

. guide and training document of accepted methodologies and calcu-lations. Changes in the calculational methods or parameters will be incorporated into the ODCM in order to assure that the ODCM represents the present methodology in all applicable areas.

Computer software to perform the described calculations will be maintained current with the ODCM.

SOURCE:PSEGODCM 1.0-1 Rev. O, 85/4/2

Section 2.0 LIQUID EFFLUENTS The Hope Creek Generating Station is located on the Delaware River which supplies service make-up water to the Cooling Tower Basin and receives water from the Cooling Tower Blowdown Line.

All releases from the liquid waste manageme at system are made to the Liquid Radwaste Discharge Line which releases into the.

Cooling Tower Blowdown Line for dilution prior to discharge to the Delaware River.

2.1 LIQUID EFFLUENT MONITOR SETPOINT CALCULATIONS Technical Specification 3.3.7.10 states, in part:

The radioactive liquid effluent monitoring instrumentation channels shown in Table 3.3.7.10-1 shall be OPERABLE with their alarm / trip'setpoints set to ensure that the limits of Specification 3.11.1.1 are not exceeded.

The limits for radioactive liquid effluents presented below are as stated in Specification.3.ll.l.1:

The concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS shall be limited to the concentrations specified in 10CFR20, Appendix B, Table II, Column 2 for radionuclides other than dissolved'or entrained noble gases. For dissolved or entrained noble gases, the concentration shall be limited as shown in Table 3.11-1 (of RETS). [RETS Table 3.11-1 is included as Table 2.1-1-of the ODCM.]

The two liquid effluent monitors listed in Technical Specifi-cation Table 3.3.7.10-1 are the following:

RE4861 - Liquid Radwaste Discharge Line Monitor l RE8817 - Cooling Tower Blowdown Effluent Line Monitor

?

!' SOURCE:PSEGODCM 2.0-1 Rev. O, 85/4/2 l

The methodology of this section applies to setpoints for these two montiors. The setpoints calculated according to this section are regarded as upper bounds for the actual monitor setpoints. That is, setpoint adjustments are not required to be performed if the existing setpoint level corresponds to a lower count rate than the calculated value.

The actual monitor setpoint, which corresponds to the calculated concentration plus background for the specific monitor, is determined from calibration data or from operational data associated with liquid sample analysis data.

For the purpose of satisfying Technical Specification 3.3.7.10, the setpoints of each of the two station liquid effluent line monitors shall be established according to' the methodology presented for each monitor below.

2.1.1 Liquid Radwaste Discharge Line Monitor - RE4861 The liquid radwaste discharge lin, monitor provides alarm and automatic termination of release functions prior to exceeding the concentration limits specified in 10CFR20, Appendix B, Table II, Column 2 at the release point to the unrestricted area. To meet this specification, the alarm / trip setpoints for the liquid radwaste discharge monitor and flow measurement devices are set to assure that the following equation is satisfied:

cf < C MPC (2-1)

F+f where:

CMPC = the effluent concentration limit (Specification 3.11.1.1) implementing 10CFR20 for the site, corresponding to the specific mix of radio-nuclides in the effluent stream being considered for discharge [uci/ml].

SOURCE:PSEGODCM 2.0-2 Rev. O, 85/4/2

i l

1 s

\

l l

c = the setpoint [uci/ml] of the radioactivity monitor measuring the radioactivity concen-tration in the effluent line prior to dilution and subsequent release; the setpoint represents a value which, if exceeded, would result in concentrations exceeding the limits of 10CFR20 in the unrestricted area.

f = the flow setpoint as determined at the radiation monitor location, in volume per unit time, but in the same units as F, below.

F = the dilution water flow setpoint as determined prior to the release point, in volume per unit time.

2.1.1.1 Releases of Single Liquid Radwaste Streams At the Hope Creek Generating Station, the Liquid Waste Sample Tanks, the Floor Drain Sample Tanks, the Detergent Drain Tanks, and the Condensate Storage Tanks all discharge to the Liquid Radwaste Discharge Line.

The effluent in the Liquid Radwaste Discharge Line is monitored prior to discharge into the Cooling Tower Blowdown Line to the Delaware River. The Cooling Tower Blowdown Line furnishes the dilution flow (F). The waste effluent flow (f) and the monitor setpoint (c) for the Liquid Radwaste Discharge Line Monitor are determined and' set to meet the conditions of equation (2-1) for a.given effluent concentration, C. The method by SOURCE:PSEGODCM 2.0-3 Rev. O, 85/4/2

which this is accomplished is as follows:

Step 1) The potential liquid radwaste streams at the Hope Creek Generating Station are the following:

a) Waste Sample Tanks b) Floor Drain Sample Tanks c) Detergent Drain Tanks d) Condensate Storage Tank A sample is obtained from the tank (s) planned for discharge into the Liquid Radwaste Discharge Line.

Step 2) The radionuclide concentration for a liquid waste tank to be released is obtained from the sum of measured concentrations as determined by the analyses required in RETS Table 4.11-1:

C y= C + (C, + C, + Cg+C )

i g where:

C

= the concentration of each measured 9

gamma emitter observed by gamma-ray spectroscopy of each waste sample

[uci/ml].

Ca

= the concentration of alpha emitters in liquid waste as measured in the most recent QUARTERLY composite sample for the tank under consideration

[uCi/ml]. (NOTE: Sample is analyzed for gross alpha.)

SOURCE:PSEGODCM 2.0-4 Rev. O, 85/4/2

g = the measured concentrations of Sr-89 and Sr-90 in liquid waste as observed in the most recent QUARTERLY composite sample for the tank under consideration

[uCi/ml].

C = the measured concentration o f' f

Fe-55 in liquid waste as observed in the most recent OUARTERLY composite sanple for the tank under consideration

[uci/ml].

Ct H-3 in liquid waste as determined from analysis of the most recent QUARTERLY composite sample for the tank under consideration [uci/ml].

A new Cg term will be included in the analysis of each batch. Results from the most current QUARTERLY composite will comprise values used in the terms for alpha, strontiums, iron, and tritium.

Step 3) The measured radionuclide concentrations are used to calculate a Dilution Factor, DF, which is the ratio of total dilution flow rate to tank flow rate required to assure that the limiting concentrations of 10CFR20, Appendix B, Table II, Column 2 are met at the point of discharge to the Delaware River.

SOURCE:PSEGODCM 2.0-5 Rev. O, 85/4/2

I DF =

[Cg\ )

{i '*

MPC.

i C Ca Cs Cg Ct

= g

+ + + + + SF

{ MPC g 1 MPC a MPC 3 MPC g MPC t 1

9 where:

Ci =

the measured concen tra tion of Cg,Ca' C 3, as defined in Step 2.

Cf and Ct MPC= MPC , MPC a, MPC 3, MPC g, and MPC t are limiting concentrations of the appropria te radionuclides from 10CFR20, Appendix B, Table II, Column 2. For dissolved or entrained noble gases, the concentra-tion shall be limited to the' specific MPC values presented in Table 2.1-1.

SF = the safety factor; a conservative facv:r used to compe nsa te for s ta ti s ti ca l fluctua tions and errors of measurements.

The a c tua l value to be used for the sa f e ty factor will be determined in implementing procedures.(For example, SF = 0.5 corresponds to a 100 percent va ria tion . )

Step 4) The dilution flow ra te setpoint for minimum dilution flow rate, Pd, is es ta blis he d at ninety percent of the e x pe c te d dilution flow ra te:

Ed =(0.9) X (Expected Cooling Tower Blowdown SOURCE:PSEGODCM 2.0-6 Rev. O, 85/4/2

NOTE: If. radioactivity from plant operations accumulates in the Cooling Tower Blowdown Basin such that measurable quantities of radionuclides are detected in the ,

Cooling Tower Blowdown Basin, calculations of Fd must include a term to account for radioactivity present in the dilution stream prior to the introduction of s the liquid waste tank effluent:

Fd' =(Fd) X (1 - MPC fraction of the Cooling Tower Blowdown).

Step 5) For the case DF<l, the liquid waste tank effluent concentration meets the limits of 10CFR20 without dilution, and effluent discharge flow rate may be assigned any desired value. For DF>1, the setpoint for the maximum permissible effluent discharge flow rate, fe, must be calculated:

=F + " #

f, d 't d d" t DF E where:

fe = maximum permissible effluent discharge flow rate (i.e., for effluent discharging through the Liquid Radwaste Discharge Line into the Cooling Tower Blowdown Line).

SOURCE:PSEGODCM 2.0-7 Rev. O, 85/4/2

Fd = the dilution flow rate setpoint from Step 4.

f = the expected flow rate of liquid waste t

tank discharge. (This value will have an upper limit of the maximum discharge capacity of the particular liquid waste tank pump (s).) The maximum discharge capacities for the liquid waste tanks at HCGS are presented in Table 2.1-2.

DF = Dilution Factor from Step 3.

Step 6) The liquid radwaste effluent radiation monitor setpoint may now be determined based on the values of E i C i, f, and Fd which were specified to provide compliance with the limits of 10 CFR20, Appendix B, Table II, Column 2. The monitor response is primairly to gamma radiation; therefore, the actual setpoint is based on C g. The monitor setpoint which corresponds to the particular setpoint concentration, c, is determined based on monitor calibration data or on operational data which correlates monitor response to sample analyses associated with actual effluent releases.

The setpoint concentration, c [uci/ml], is determined as follows:

c=A C g [uci/ml]

l 9 i

i l SOURCE:PSEGODCM 2.0-8 Rev. O, 85/4/2 l

i

where:

[C 9

g = the sum of the concentrations of all measured gamma emitters as determined in Step 2.

A = Adjustment factor which will allow the setpoint to be established in a practical manner for conve-nience and to prevent spurious alarms. So as to alarm should an inadvertent release occur, A is not to exceed 20.

f A = e (See Note 2 below.) i f

where:

f e = maximum permissible effluent discharge flow rate determined according to Step 5 above.

ft = the expected flow rate of liquid waste tank discharge from Step 5 above.

If A > 1, Calculate c and determine the maximum value for the actual monitor setpoint.

If A < 1, Release may not be made as planned. Re-evaluate Steps 3,4, and 5.

NOTE 1: The calculated setpoint concentration, c, establishes the base value for the monitor setpoint. However, in establishing the actual monitor setpoint for a particular monitor, background radiation levels must be considered. Normally, the actual monitor setpoint includes the calculated setpoint value plus background. Background levels l SOURCE:PSEGODCM 2.0-9 Rev. O, 85/4/2 i

L

must be controlled such that radioactivity levels in the effluent stream being monitored can be accurately assessed at or below the calculated setpoint value.

NOTE 2: If DF<l, then A = (1/DF), not to exceed A = 20.

If calculated setpoint values are near actual concen-trations planned for release, it may be impractical to set the monitor alarm based on this value. In this case a new setpoint may be calculated by decreasing the effluent flow, increasing the dilution flow, or by decreasing bi Ci by further processing of the liquid radwaste planned for release, and by following the methodology presented in Steps 3, 4, and 5.

If no discharge is planned for this pathwa~y, the monitor setpoint should be established as close to background as practical to prevent spurious alarms and yet alarm should an inadvertent release occur.

SOURCE:PSEGODCM 2.0-10 Rev. O, 85/4/2

2.1.1.2 Simultaneous Releases of Liquid Radwaste Streams If two or more liquid waste tanks (or liquid waste streams) are to be released simultaneously, then the Liquid Radwaste Discharge Line Radiation Monitor setpoint is determined as follows:

Step A) Perform Step 3 from Section 2.1.1.1 separately for each liquid waste tank, solving the equation for DF using the values in the concentration term from the sample analyses of each liquid waste stream to be discharged simultaneously. (DF 1) = Db' for Tank 1, (DF2) = DF for Tank 2, ...

Step B) Determine DF', which is the greatest value for DF selected from DP ,1 DF ,2 DF .3 . . determined in Step A above. Use DF' in the determination of f, in Step E below.

Step C) Determine f 3, which is the sum of the expected flow rates for all waste tanks releasing simultaneously. Use f, in the determination of f, in Step E below.

f s

ft1 + ft2 + ft3 Step D) Perform Step 4 of Section 2.1.1.1.

Step E) Perform Step 5 of Section 2.1.1.1, where ft = fs as determined in Step C above; DF = DF' as determined in Step B above; and where all other terms in Step 5 are as previously defined.

SOURCE *PSEGODCM 2.0-11 Rev. O, 85/4/2

NOTE: If f e

• f s, Simultaneous releases may not be made as planned; Re-eva lua te Steps A, B, C and D.

If t e > f 3, Then individual tanks may be released at expected flow ra te s ;

proceed to S te p F to determine the actual monitor setpoint.

Stop F) Perf orm Step 6 of Section 2.1.1.1 to determine the monitor setpoint, where ft"I ass determined in Step C above; and where the value for g Cg is the highest value for any of the tanks releasing simultaneouslyg 2.1.2 Cooling Tower Blowdown Line Effluent Monitor (RE8817)

The Cooling Tower Blowdown Line is the blowdown line to the Delaware River, and it provides dilution for the liquid ra dwa s te discharges. The radia ticn monitor has no control function, but serves as support (backup) for the Liquid Radwaste Discharge Line Monitor. The Cooling Tower Blowdown Line Ef fluent Monitor setpoint is established as follows:

c = + DF [uCi/ml]

([9 CU) where C g and DF have values as determined in Section g

2.1.1 S te p 2 and Step 3 respectively for the liquid radwaste sample tank (s) planned for release.

(For p ra c t i ca li ty , for this monitor only, if DF is determined to be < 1, DF may be set equal to 1 for the purpose of calcula ting the monitor setpoint.)

SOURCE:PSEGODCM 2.0-12 Rev. O, 85/4/2

a Table 2.1-1 (Reprint of Table 3.11-1 of RETS)

MAXIMUM FERMISSIBLE CONCENTRATION OF DISSOLVED OR ENTRAINED NOBLE GASES RELEASED FROM THE SITE TO UNRESTRICTED AREAS

. IN LIQUID WASTE NUCLIDE MPC (uCi/ml)

Kr 85m 2E-4

. Kr 85 SE-4 Kr 87 4E-5 Kr 88 9E-5 Ar 41 7E-5 Xe 133m SE-4

-Xe 133 6E-4 Xe 135m 2E-4 Xe 135 2E-4 i

l l

l l

SOURCE:PSEGODCM 2.0-13 Rev. O, 85/4/2

' m Table 2.1-2

, MAXIMUM DISCHARGE CAPACITY OF LIQUID RADWASTE STREAMS FOR THE HOPE CREEK GENERATING STATION t

Maximum Discharge Capacity Liquid Radwaste Stream Flow Ra te (GPM)

1. Waste Sample . Tanks 176 *

2. . Floor Drain Sample Tanks 176 *

3. Detergent Drain Tanks 25 *

4. Condensa te storage Tanks 1300 +

I

• -- Section 11'.2.3, Ref. 2.

+ -- Chapter 9, Ref. 2.

SOURCE:PSEGODCM 2.0-14 Rev. O, 85/4/2

4 2.2 LIQUID EFFLUENT DOSE CALCULATIONS Technical Specification 3.11.1.2 states, in part:

The dose or dose commitment to a MEMBER OF THE PUBLIC from radioactive materials in liquid effluents released, from p each reactor unit, to UNRESTRICTED AREAS shall be limited:

a. During any calendar quarter to less than or equal to 1.5 mrems to the total body and to less than or equal to 5 mrems to any organ, and

b. During any calendar year to less than or equal to 3 mrems to the total body and to less than or

equal to 10 mrems to any organ.

~

There is no potable water pathway for liquids from HCGS. Thus, for liquid dose calculations, only the fish and invertebrate consumption pathways are applicable (Ref. 2, Section 11.2.4) .

The methodology by which dose computations shall be performed

for the purpose of demonstrating compliance with this Technical a Specification is presented below.

The dose contribution to an exposed individual by way of fish and invertebrate consumption from all radionuclides identified in liquid effluents released to unrestricted areas is calculated using the following expressions m

D t

^it 1 il Fy 3 i l=1 l where:

2 Dt = the cumulative dose commitment to the total body or any organ t, due to radioactivity in liquid effluents for the total time period

' m  !

{tl, [ mrem] (Ref. 6, Section 4.3). j I 1=1 l l

1 SOURCE:PSEGODCM 2.0-15 Rev. O, 85/4/2

hti = the length of the lth time period over which Cil and F 1 are averaged for all liquid releases, [ hours].

Cil = the average concentration of radionuclide i, in undiluted liquid effluent during time period d t1 from any liquid release [uci/ml].

F1 = the near field average dilution factor for Cil during any liquid effluent release [ unit-less]. Defined as the ratio of the undiluted liquid waste flow during release to the product of the average flow from the discharge structure to unrestricted receiving water times Z.

F 1

= (average undiluted liquid waste flow)

(average flow from the discharge structure during periods of radioactive materials release) * (Z)

NOTE: The denominator is limited to 1000 cfs (448,000 gpm) or less. (Ref. 6, Section 4.3)

NOTE: If radioactivity in the Cooling Tower Blowdown Line becomes > LLD, prior to the junction with the Liquid Radwaste Effluent Line, I

that concentration must be included in the dose determination. For this part of the dose calculation, Fy = 1/Z and b ty = the entire time period for which the dose is i being calculated.

Z = 10, which is the applicable dilution factor for I

the receiving water body at the Hope Creek Generating ,

Station, (Ref. 2, Chapter 11).

SOURCE PSEGODCM 2.0-16 Rev. O, 85/4/2

k s

a.

Ait= the site related fish and invertebra te consumption dose commitment factor to the to ta l body or any organ t for each identified principal gamma and beta emitter listed in Table 2.2-1 [ mrem /hr per uCi/ml].

. s Ait = Ko (U p, BF g) +(U y

• BI i) DPi where Ko = Units conversion factor, 1.14 E+5 l

= 1 E+6 pCi

• 1 E+3 ml + 8760 hr uCi 1 yr UP = Adult fish consumption (21 kg/yr).

BFi = Bioaccumulation factor-for radionuclide i, in fish, [pci/kg per pCi/l], from Table 2.2-2. The more con se rva tive of salt and f resh wa ter values for radionuclide i is in co rpora ted into Table 2.2-2 for use in the liquid dose calcula tions (Ref. 4, Table A-1).

UI = Adult invertebra te consumption (5 kg/yr).

BI i= Bioaccumulation factor for radionuclide i, in invertebrates [pCi/kg per pCi/l],

from Table 2.2-2. The more conservative I of salt and fresh water values for radionuclide i is incorpora ted into Table 2.2-2 for use in the liquid dose calculations (Ref. 4, Table A-1).

SOURCE:PSEGODCM 2.0-17 Rev. O, 85/4/2 l

I

s gi_

^ DFi = Dose conversion factor for radionuclide i, for adults in preselected organ t [ mrem /pci]

from Table 2.2-3 (Ref. 4, Table E-ll).

70: s l

t 4

f' n

i 4

i i

1

,.E y

')

3 SOURCE:PSEGODCM 2.0-18 Rev. O, 85/4/2

- gr .. -

- .- - -.mmm - . - - is.uu - 6

> =

/

Table 2.2-1 SITE RELATED INGESTION DOSE COMMITMENT FACTOR, A it (FISH AND INVERTEBRATE CONSUMPTION)

Page 1 of 2 HUCLIDE EONE LIVER T. BODY THYROID KIDHEY LUNG GI-LLI l H-3 0.00E+00 2.82E-01 2.82E-01 2.82E-01 2.82E-01 2.82E-01 2.82E-01 C-14. 4.60E+04 9.20E+03 9.20E+03 9.20E+03 9.20E+03 9.20E+03 9.20E+03 Ha-24 6.01E+02 6.01E+02 6.01E+02 6.01E+02 6.01E+02 6.01E+02 6.01E+02 P-32 4.95E+07 3.08E+06 1.91E+06 0.00E+00 0.00E+00 0.00E+00 5.57E+06 l

Cr-51 0.00E+00 0.00E+00 5.58E+00 3.34E+00 1.23E+00 7.40E+00 1.40E+03 Mn-54 0.00E+00 2.40E+05 4.59E+04 0.00E+00 7.16E+04 0.00E+00 7.37E+05 Mn-56 0.00E+00 6.05E+03 1.07E+03 0.00E+00 7.68E+03 0.00E+00 1.93E+05 Fe-55 5.11E+04 3.53E+04 8.23E+03 0.00E+00 0.00E+00 1.97E+04 2.03E+04 Fe-59 8.06E+04 1.90E+05 7.27E+04 0.00E+00 0.00E+00 5.30E+04 6.32E+05 Co-58 0.00E+00 6.03E+02 1.35E+03 0.00E+00 0.00E+00 0.00E+00 1.22E+04 l

Co-60 0.00E+00 1.73E+03 3.82E+03 0.00E+06 0.00E+00 0.00E+00 3.25E+04 Hi-63 4.96E+04 3.44E+03 1.67E+03 0.00E+00 0.00E+00 0.00E+00 7.18E+02 Hi-65 2.02E+02 2.62E+01 1.20E+01 0.00E+00 0.00E+00 0.00E+00 6.65E+02 Cu-64 0.00E+00 2.14E+02 1.01E+02 0.00E+00 5.40E+02 0.00E+00 1.83E+04

, 2n-65 1.61E+05 5.13E+05 2.32E+05 0.00E+00 3.43E+05 0.00E+00 3.23E+05 Zn-69 3.43E+02 6.56E+02 4.56E+01 0.00E+00 4.26E+02 0.00E+00 9.85E+01 Er-83 0.00E+00 0.00E+00 4.80E+01 0.00E+00 0.00E+00 0.00E+00 6.91E+01 Br-84 0.00E+00 0.00E+00 6.22E+01 0.00E+00 0.00E+00 0.00E+00 4.88E-04 Pr-85 0.00E+00 0.00E+00 2.55E+00 0.00E+00 0.00E+00 0.00E+00 1.19E-15 Rb-86 0.00E+00 1.13E+05 5.27E+04 0.00E+00 0.00E+00 0.00E+00 2.23E+04 Rb-88 0.00E+00 3.24E+02 1.72E+02 0.00E+00 0.00E+00 0.00E+00 4.48E-09 Rb-89 0.00E+00 2.15E+02 1.51E+02 0.00E+00 0.00E+00 0.00E+00 1.25E-11 Sr-89 3.97E+04 0.00E+00 1.14E+03 0.00E+00 0.00E+00 0.00E+00 6.36E+03 Sr-90 9.76E+05 0.00E+00 2.40E+05 0.00E+00 0.00E+00 0.00E+00 2.82E+04 Sr-91 7.30E+02 0.00E+00 2.95E+01 0.00E+00 0.00E+00 0.00E+00 3.48E+03 Sr-92 2.77E+02 0.00E+00 1.20E+01 0.00E+00 0.00E+00 0.00E+00 5.49E+03 Y-90 6.06E+00 0.00E+00 1.63E-01 0.00E+00 0.00E400 0.00E+00 6.42E+04 Y-91m 5.73E-02 0.00E+00 2.22E-03 0.00E+00 0.00E+00 0.00E+00 1.68E-01 Y-91 8.88E+01 0.00E+00 2.37E+00 0.00E+00 0.00E+00 0.00E+00 4.89E+04 Y-92 5.32E-01 0.00E+00 1.56E-02 0.00E+00 0.00E+00 0.00E+00 9.32E+03 Y-93 1.69E+00 0.00E+00 4.66E-02 0.00E+00 0.00E+00 0.00E+00 5.35E+04 2r-95 1.59E+01 5.11E+00 3.46E+00 0.00E+00 8.02E+00 0.00E+00 1.62E+04 Zr-97 8.81E-01 1.78E-01 8.13E-02 0.00E+00 2.68E-01 0.00E+00 5.51E+04 Hb-95 4.47E+02 2.49E+02 1.34E+02 0.00E+00 2.46E+02 0.00E+00 1.51E+06 No-99 0.00E+00 1.28E+02 2.43E+01 0.00E+00 2.89E+02 0.00E+00 2.96E+02 Tc-99m 1.59E-02 4.50E-02 5.73E-01 0.00E+00 6.83E-01 2.20E-02 2.66E+01 Tc-101 1.64E-02 2.36E-02 2.31E-01 0.00E+00 4.24E-01 1.20E-02 7.09E-14 Ru-103 1.10E+02 0.00E+00 4.73E+01 0.00E+00 4.19E+02 0.00E+00 1.28E+04 Ru-105 9.15E+00 0.00E+00 3.61E+00 0.00E+00 1.18E+02 0.00E+00 5.59E+03 SOURCE:PSEGODCM 2.0-19 Rev. O, 85/4/2

-- - - - - - - ., _ ._.___.._._._._.._ a _ .. '

Table 2.2-1 SITE RELATED INGESTION DOSE COMMITMENT FACTOR, A it (FISH AND INVERTEBRATE CONSUMPTION)

Page 2 of 2 NUCL1DE BONE LIVER T. BODY THYR 01D KIDNEY LUHG GI-LLI Ru-106 1.63E+03 0.00E+00 2.07E+02 0.00E+00 3.15E+03 0.00E+00 1.06E+05 Ag-110m 1.56E+03 1.45E+03 8.60E+02 0.00E+00 2.85E+03 0.00E+00 5.91E+05 Te-125m 1.19E+04 4.31E+03 1.59E+03 3.57E+03 4.83E+04 0.00E+00 4.75E+04 Te-127m 3.00E+04 1.0?E+04 3.66E+03 7.67E+03 1.22E+05 0.00E+00 1.01E+05 Te-127 4.88E+02 1.75E+02 1.06E+02 3.61E+02 1.99E+03 0.00E+00 3.85E+04 Te-129m 5.10E+04 1.90E+04 8.07E+03 1.75E+04 2.13E+05 0.00E+00 2.57E+05 Te-129 1.39E+02 5.23E+01 3.39E+01 1.07E+02 5.85E+02 0.00E+00 1.05E+02 Te-131m 7.67E+03 3.75E+03 3.13E+03 5.94E+03 3.80E+04 0.00E+00 3.73E+05 Te-131 8.74E+01 3.65E+01 2.76E+01 7.18E+01 3.83E+02 0.00E+00 1.24E+01 Te-132 1.12E+04 7.23E+03 6.78E+03 7.98E+03 6.96E+04 0.00E+00 3.42E+05 I-130 4.87E+01 1.44E+02 5.67E+01 1.22E+04 2.24E+02 0.00E+00 1.24E+02 I-131 2.68E+02 3.83E+02 2.20E+02 1.26E+05 6.57E+02 0.00E+00 1.01E+02 I-132 1.31E+01 3.50E+01 1.22E+01 1.22E+03 5.57E+01 0.00E+00 6.57E+00 I-133 9.15E+01 1.59E+02 4.85E+01 2.34E+04 2.78E+02 0.00E+00 1.43E+02 I-134 6.83E+00 1.86E+01 6.63E+00 3.21E+02 2.95E+01 0.00E+00 1.62E-02 I-135 2.85E+01 7.47E+01 2.76E+01 4.93E+03 1.20E+02 0.00E+00 8.44E+01 Cs-134 3.33E+05 7.93E+05 6.48E+05 0.00E+00 2.57E+05 8.52E+04 1.39E+04 Cs-136 3.49E+04 1.38E+05 9.91E+04 0.00E+00 7.66E+04 1.05E+04 1.56E+04 Cs-137 4.27E+05 5.84E+05 3.83E+05 0.00E+00 1.98E+05 6.59E+04 1.13E+04 Cs-138 2.96E+02 5.84E+02 2.89E+02 0.00E+00 4.29E+02 4.24E+01 2.49E-03 Ba-139 1.34E+01 9.53E-03 3.92E-01 0.00E+00 8.91E-03 5.41E-03 2.37E+01 Ba-140 2.80E+03 3.52E+00 1.83E+02 0.00E+00 1.20E+00 2.01E+00 5.77E+03 Ba-141 6.50E+00 4.91E-03 2.19E-01 0.00E+00 4.57E-03 2.79E-03 3.06E-09 Ba-142 2.94E+00 3.02E-03 1.85E-01 0.00E+00 2.55E-03 1.71E-03 4.14E-18 La-140 1.57E+00 7.94E-01 2.10E-01 0.00E+00 0.00E+00 0.00E+00 5.83E+04 La-142 8.06E-02 3.67E-02 9.13E-03 0.00E+00 0.00E+00 0.00E+00 2.68E+02 Ce-141 5.56E+00 3.76E+00 4.26E-01 0.00E+00 1.75E+00 0.00E+00 1.44E+04 Ce-143 9.80E-01 7.25E+02 8.02E-02 0.00E+00 3.19E-01 0.00E+00 2.71E+04 Ce-144 2.90E+02 1.21E+02 1.56E+01 0.00E+00 7.19E+01 0.00E+00 9.80E+04 Pr-143 5.79E+00 2.32E+00 2.87E-01 0.00E+00 1.34E+00 0.00E+00 2.54E+04 Pr-144 1.90E-02 7.87E-03 9.64E-04 0.00E+00 4.44E-03 0.00E+00 2.73E-09 Nd-147 3.96E+00 4.58E+00 2.74E-01 0.00E+00 2.68E+00 0.00E+00 2.20E+04 W-187 2.98E+02 2.49E+02 8.70E+01 0.00E+00 0.00E+00 0.00E+00 8.15E+04 Np-239 3.00E-01 2.95E-02 1.63E-02 0.00E+00 9.20E-02 0.00E+00 6.05E+03 i

I r

SOURCE:PSEGODCM 2.0-20 Rev. O, 85/4/2

l l Table 2.2-2 BIOACCUMULATION FACTORS (pCi/kg per pCi/ liter)*

ELEMENT FISH INVERTEBRATES H 9.0E-01 9.3E-01 C 4.6E+03 9.1E+03 NA 1.0E+02 2.0E+02 P 1.0E+05 3.0E+04 i CR 4.0E+02 2.0E+03 MN 5.5E+02 9.0E+04 FE 3.0E+03 2.0E+04 CO 1.0E+02 1.0E+03 NI 1.0E+02 2.5E+02 CU 6.7E+02 1.7E+03 ZN 2.0E+03 5.0E+04 BR 4.2E+02 3.3E+02 I RB 2.0E+03 1.0E+03 l SR 3.0E+01 1.0E+02 Y 2.5E+01 1.0E+03 ZR 2.0E+02 8.0E+01 NB 3.0E+04 1.0E+02 MO 1.0E+01 1.0E+01 TC 1.5E+01 5.0E+01 RU 1.0E+01 1.0E+03 RH 1.0E+01 2.0E+03 AG 3.3E+03 3.3E+03 TE 4.0E+02 6.lE+03 I 1.5E+01 5.0E+01 CS 2.0E+03 1.0E+03 BA 1.0E+01 2.0E+02 LA 2.5E+01 1.0E+03 CE 1.0E+01 1.0E+03 PR 2.5E+01 1.0E+03 ND 2.5E+01 1.0E+03 W l.2E+03 3.0E+01 NP 1.0E+01 4.0E+02 Values in Table 2.2-2 are taken from Ref. 4, Table A-1. The more conservative of salt and fresh water values have been included in Table 2.2-2 for the purpose of liquid dose calculations.

SOURCE PSEGODCM 2.0-21 Rev. O, 85/4/2

l 1

l l

Table 2.2-3 l ADULT INGESTION DOSE FACTORS *

(mrem /pci ingested)

Page 1 of 2 NUCL10E SONE LIVER T.80GY TNYROID K1DNEY LONG GI-LLI H 3 NO DATA 1.05E-07 1.05 E-0 7 1.05E-07 1.05E-07 1.05E-07 1 05E-07 C 14 2.84E-06 5.68E-07 5 68 E-0 7 5.68E-07 5.68E-07 5.68E-07 5.68E-07 NA 24 1.70E-06 1.70E-06 1. 70 E-0 6 1.70E-06 1.70E-06 1.70E-06 1.70E-06

=---.--.---.........

P 32 1.93E-04 1.20E-05 7.46E-06 NO DATA NO DATA NO DATA 2.17E-05 CR 51 NO DATA NO DATA 2.6cE-09 1.59E-09 5.86E-10 3.53E-09 6.69E-07 NN 54 NO DATA 4.57E-06 8. 72 E-0 7 NO DATA 1.36E-06 NO DATA 1 40E-05

= = = _ _ _ = _ _ _ . - - - - - -

MN 56 NO DATA 1 15E-07 2.04E-08 NO DATA 1.46E-07 NO DATA 3.67E-06 FE 55 2.75E-06 1.90E-06 4.4 3 E-0 7 NO DATA NO DATA 1.06E-06 1.09E-06 FE 59 4.34E-06 1.02E-05 3.91E-06 NO DATA NO DATA 2.85E-06 3.40E-05 CO 58 NO DATA 7.45E-07 1.67E-0 6 NO DATA NO DATA NO DATA 1.51E-05 CO 60 NO DATA 2.14F-06 4.72E-06 NO DATA NO DATA ,,NO DATA 4.02E-05 MI 63 1.30E-04 9.01E-06 4.36E-06 NO DATA NO DATA NO DATA 1.88E-06 NI 65 5.28E-07 6.86E-08 3.13 E-0 8 NO DATA NO DATA NO DATA 1.74E-06 CU 64 NO DATA 8.33E-08 3.91E-08 NO DATA 2.10E-07 NO DATA 7.10E-06 ZN 65 4.84E-06 1 54E-05 0. 96E-0 6 NO DATA 1.03E-05 NO DATA 9.70E'-06

...= ....--.....--...--........--.- =

ZN 69 1.03E-08 1.97E-08 1.37E-09 NO DATA 1.28E-08 NO DATA 2.96E-09 8R 83 NO DATA NO DATA 4. 02 E-0 8 NO DATA NO DATA NO DATA 5.79E-08 BR 84 NO DATA NO DATA 5.21E-08 NO DATA NO DATA NO DATA 4.09E-13 BR 85 NO DATA NO DATA 2.14 E-0 9 NO DATA NO DATA NO DATA LT E-24 A8 86 NO DATA 2.11E-05 9. 83 E-0 6 NO DATA NO DATA NO DATA 4.16E-06 R8 88 NO DATA 6.05E-08 3.21E-08 NO DATA NO DATA NO DATA 8.36E-19

.. .=

R8 SV NO DATA 4.01E-08 2. 82 E-0 8 NO DATA NO DATA NO DATA 2.33E-21

$R 89 3.08E-04 NO DATA 8. 84 E-0 6 NO DATA NO DATA NO DATA 4.94E-05 SR 9 7.58E-03 NO DATA 1. 86 E-0 3 NO DATA NO DATA NO DATA 2.19E-04 )

.... s..---..........--.......--. ----.--.-- .-----.------.............--

SR 9 5.67E-06 NO DATA 2.29E-0 7 . NO DAT A NO DATA NO DATA 2.70E-05 l S R 9. 1.15E-06 NO DATA 9.30E-08 NO DATA NO DATA NO DATA 4.26E-05  !

Y 90 *. 62E-09 NO DATA 2.58E-10 NO DATA NO DATA NO DATA 1.02E-04 l l

Y 91N t.09E-11 NO DATA 3.52E-12 NO DATA NO DATA NO DATA 2.67E-10 1 Y 91 1.41E-07 NO DATA 3. 77E-09 NO DATA NO DATA NO DATA 7.74E-05 l Y 92 8 45E-10 NO DATA 2.47E-11 NO DATA NO DATA NO DATA 1.48E-05 Y 93 2 68E-09 NO DATA 7.40E-11 NO DATA NO DATA NO DATA 8.50E-05 ZR 95 3.0*E-08 9.75E-09 6. 60 E-0 9 NO DATA 1.53E-08 NO DATA 3.09E-05 2R 97 1.68E-09 3.39E-10 1.55E-10 NO DATA 5.12E-10 NO DATA 1.05E-04 M8 95 6.22E-09 3.46E-09 1. 66E-0 9 NO DATA 3.42E-09 NO DATA 2.10E-05 NO 99 NO DATA 4.31E-06 8. 20E-0 7 NO DATA 9.76E-06 NO DATA 9.99E-06 TC 99M 2.47E-10 6.98E-10 8. 89E-09 NO DATA 1.06E-08 3.42E-10 4.13E-07

• Values in Table 2.2-3 are taken from Ref. 4, Table E-ll.

85/4/2 i

SOURCE:PSEGODCM 2.0-22 Rev. O,

Table 2.2-3 ADULT INGESTION DOSE FACTORS *

(mrem /pCi ingested)

Page 2 of 2 NUCL10E SONE LIVER T.80DY THYRO 10 RIDNEY LUNG G1-LL1

3. 59E-0 9 NO DATA 6.59E-09 1.87E-10 1.10E-21 TC101 2.54E-10 3.66E-10 7.06E-07 NO DATA 2.16E-05 RU103 1.85E-07 NO DATA 7. 97 E-0 8 NO DATA 6.08E-09 NO DATA 1 99E-07 NO DATA 9.42E-06 RU105 1.54E-08 NO DATA

3. 48 E-07 NO DAT A 5.31E-06 NO DATA 1.78E-04 RU106 2.75E-06 NO DATA 6.04E-05 AG110N 1 60E-07 1.48E-07 8 79E-08 NO DATA 2.9.1E-07 NO DATA 1 09E-05 NO DATA 1.07E-05 TE125M 2.68E-06 9.71E-07 3 59E-07 8.06E-07 2.42C-06 8.25 E-0 7 1.73E-06 2.75E-05 NO DATA 2.27E-05 TE127M 6.77E-06 4.48E-07 NO DATA 8.68E-06 TE127 1.10E-07 3.95E-08 2. 38 E-0 8 8.15E-08

1. 82 E-06 3.95E-06 4.80E-05 NO DATA 5.79E-05 TE129N 1.15E-05 4.29E-06

7. 6 > E-0 9 2.41E-08 1.32E-07 NO DATA 2.37E-08 TE129 3.14E-08 1.18E-08 8.40E-05 TE131M 1.73E-06 8.46E-07 7.05 E-0 7 1.34E-06 8.57E-06 NO. DATA

6. 22 E-09 1 62E-08 8.63E-08 NO DATA 2.79E-09 TE131 1 97E-08 8.23E-09 1.53E-0 6 1.80E-06 1.57E-05 NO DATA 7.71E-05 TE132 2.52E-06 1.63E-06 1.92E-06 1 130 7.56E-07 2.2 3E-06 8. 80E-0 7 1.89E-04 3.48E-06 NO DATA 3.41E-0 6 1 95E-01 1.02E-05 NO DATA 1.57E-06 I 131 4.16E-06 5.95E-06 1 90E-0 7 1.90E-05 8.65E-07 NO D AT A 1.02E-07 1 132 2.0 3E-0 7 5.43E-07 4.31E-06 NO DATA 2.22E-06 7.53 E-0 7 3 63E-04 1 133 1.42E-06, 2.47E-06 2.88E-07 1.03E-0 7 4.99E-06 4.58E-07 NO DATA 2.51E-10 l 1 134 1.06E-07 1.16E-06 4.28E-0 7 7.65E-05 1.86E-06 NO DATA 1 31E-06 1 135 4.43E-07 4.79E-05 1.59E-05 2.59E-06 C5134 6.22E-05 1.48E-04 1. 21 E-0 4 NO DATA 6.51E-06 2.57E-05 1. 85 E-0 5 NO DATA 1.43E-05 1 96E-06 2 92E-06 C5136 C5137 7.97E-05 1.09E-04 7.14 E-0 5 NO DATA 3.70E-05 1.23E-05 2.11E-06 5 52E-08 1.09E-07 5.40E-0 8 NO DATA 8.01E-08 7.91E-09 4.65E-13 C5134 6.46E-11 3 92E-11 1.72E-07 8A139 9.70E-08 6.91E-11 2. 44E-0 9 NO DATA 2.03C-05 2.55E-08 1. 3 5E-0 6 NO DATA 8.67k-09 1.46E-08 4.18E-05 SA140- 3.31E-11 2.02E-11 2.22E-17 84141 4.71E-08 3.56E-11 1. 59E-0 9 NO DATA 3.00E-26 2.13E-08 2.19E-11 1. 34 E-0 9 NO DATA 1.85E-11 1.24E-11 64142 3.33C-10 NO DATA NO DATA NO DATA 9.25E-05 LA140 2.bOL-09 1.26E-09 1.28E-10 5.82E-11 1 45E-11 NO DATA NO DATA NO DATA 4.25E-07 l LA142 2.94E-09 NO DATA 2.42E-05i CE141 9.36E-09 6.33E-09 T.18E-10 NO DATA j 5.17E-10 NO DATA 4.56E-05 CE143 1.65E-09 1.22E-06 1. 35 E -10 NO DATA 2.04E-07 2.62E-08 NO DATA 1.21E-07 NO DATA 1 65E-04 CE144 4.A8E-07 4.03E-05 PR143 9.20E-09 3.69E-09 4.56E-10 NO DATA 2.13E-09 NO DATA 1.5sE-12 NO DATA 7.05E-12 NO DATA 4.33E-18 PR144 3.01E-11 1.25E-11 3 49E-05 ND147 6.29E-09 7.27E-09 4. 35 E-10 NO DATA 4.25E-09 NO DATA 3.01E-0 8 NO DATA NO DATA N0' DATA 2.82E-05 N 167 1.03E-07 8.61E-08 1.17E-10 6. 45 E -1 1 NO DATA 3.65E-10 NO DATA 2.40E-05 NF239 1.19E-09

• Values in Table 2.2-3 are taken from Ref. 4, Table E-ll.

SOURCE:PSEGODCM 2.0-23 Rev. O, 85/4/2

t I

i l

2.3 DEFINITIONS OF LIQUID EFFLUENT TERMS Section of Term Definition Initial Use A = Adjustment factor which will allow the (2.1.1.1) setpoint to be established in a practical manner for convenience and to prevent spurious alarms.

Ait = the site rela ted fish and invertebra te (2.2) consumption dose commitment factor to the total body or any organ t for each identified principal gamma and beta emitter listed in Table 2.2-1 [ mrem /hr per uCi/ml].

BFi = Bioaccumulation - factor f or radionuclide i, (2.2) in fish [pci/kg per pCi/1] from Table 2.2-2.

BI i = Bioaccumulation factor for radionuclide i, (2.2) in invertebrates [pCi/kg per pCi/1] from Table 2.2-2.

c = the setpoint [uci/ml] of the radioactivity (2.1.1) monitor measuring the radioactivity con-centration in the effluent line prior to dilution and subsequent release.

= the concentration of alpha emitters in (2.1.1.1)

Ca liquid waste as measured in the most recent QUARTERLY composite sample for the ta nk under considera tion [uCi/ml].

I SOURCE:PSEGODCM 2.0-24 Rev. O, 85/4/2

Section of Term Definition Initial Use C = the measured concentration of Fe-55 in (2.1.1.1) f liquid waste as observed in the most recent OUARTERLY composite sample for the tank under consideration [uCi/ml].

Cg

= the concentration of each measured gamma (2.1.1.1) emitter observed by gamma-ray spectroscopy of each waste sample [uCi/ml].

Ci =

~

the measured concentration of Cg,Ca, C,, (2.1.1.1)

Cf and Ct. .

Cil = the average concentration of radionuclide (2.2) i, in undiluted liquid effluent during time

/htl from any liquid-release,[uCi/ml].

CMPC = the effluent concentration limit (Speci- (2.1.1.1) fication 3.11.1.1) implementing 10CFR20 for the site, corresponding to the specific mix of radionuclides in the effluent stream being considered for discharge [uCi/ml].

a Cs

= the measured concentrations of Sr-89 (2.1.1.1) and Sr-90 in liquid waste as observed in the most recent OUARTERLY composite i sample for the tank under consideration

[uci/ml].

" * ****"'* " *" #* " "~ " * *

• Ct liquid waste as determined from analysis of the most recent QUARTERLY composite sample for the tank under consideration

[uci/ml].

SOURCE:PSEGODCM 2.0-25 Rev. O, 85/4/2

Section of Term Definition Initial Use DF = dilution factor; ratio of total dilution (2.1.1.1) flow rate to tank flow rate required to assure that the limiting concentrations of 10CFR20, Appendix B, Table II, Column 2 are met at the point of discharge to the Delaware River.

DF' = the greatest value for DF from DF 1, DF 2, (2.1.1.2)

DF 3 ..., used in the determination of the monitor setpoint when liquid radwaste tanks are releasing simultaneously.

DFi = Dose conversion factor for radionuclide i, (2.2) for adults in preselected organ t [ mrem /pCi]

from Table 2.2-3.

Dt = the cumulative dose commitment to the (2.2) total body or any organ t, due to radio-activity in liquid effluents for the total m

time period /htl , [ mrem].

{

l=1 f = the flow setpoint as determined at the (2.1.1) radiation monitor location, in volume per unit time, but in the same units as F, below.

F = the dilution water flow setpoint as (2.1.1) determined prior to the release point, in volume per unit time.

EFd = the setpoint for minimum dilution flowrate (2.1.1.1)

SOURCE:PSEGODCM 2.0-26 Rev. O, 85/4/2

Section of Term Definition Initial Use Fd' = the setpoint for minimum dilution flowrate, (2.1.1.1) considering the buildup of radioactivity from plant operations in the Cooling Tower Blowdown Basin.

fe = maximum permissible effluent discharge (2.1.1.1) flow rate.

F1 = the near field average dilution factor (2.2) during any liquid effluent release

[unitiess]. .

fs = the sum of the expected flow rates for (2.1.1.2) all waste tanks releasing simultaneously.

ft = the expected flow rate of liquid waste (2.1.1.1) tank discharge. the maximum discharge capacities for the liquid waste tanks at HCGS are presented in Table 2.1-2.

. Ko = Units conversion factor, 1.14 E+5 (2.2)

" " " g, MPC3, MPC,, MPCf, and MPCt are (2.1.1.1) limiting concentrations of the appropriate  ;

radionuclides from 10CFR20, Appendix B, Table II, Column 2. For dissolved or entrained noble gases, the concentration shall be limited to the specific MPC values presented in Table 2.1-1.

l SOURCE:PSEGODCM 2.0-27 Rev. O, 85/4/2 I

Section of Term Definition Initial Use SF = the safety factor; a conse rva tive (2.1.1.1) factor used to compensa te for sta tistical fluctua tions and errors of measurements.

- [i t l= the length of the Ith time period over (2.2) which Cil and F1 are averaged for all liquid releases, [ hours].

UF = Adult fish consumption (21 kg/yr). (2.2)

UI = Adult invertebra te consumption (5 kg/yr)'. (2.2)

Z = 10, which is the applicable dilution (2.2) factor for the receiving water body at the Hope Creek Generating Station.

a SOURCE:PSEGODCM 2.0-28 Rev. O, 85/4/2

i i

i Section 3.0 ROUTINE GASEOUS EFFLUENTS 3.1 GASEOUS EFFLUENT MONITOR SETPOINT CALCULATIONS Technical Specifica tion 3.3.7.11 sta tes, in part:

The radioactive gaseous ef fluent monitoring ins trumen ta tion channels shown in Table 3.3.7.11-1 shall be OPERABLE with their alarm / trip setpoints set to ensure tha t the limi th of Specifica tion 3.11.2.1 are not exceeded.

~

Since, according to Section 5.1.1 of Ref. 6, "It is not considered pra c ti ca ble to apply instantaneous ala rm/ trip setpoints to in teg ra ting radia tion monitors sensitive to radioiodines, ra dioa c ti ve ma te rials in pa r ticula te form, and radionuclides other t ha n noble gases," only noble gas monitor setpoints need be specified by the ODCM.

The noble gas limits es tablished by Specifica tion 3.11.2.1 are quoted below in Section 3.2.1; they are in s ta n ta neous dose ra tes of 500 mrem /yr to the total body, and 3000 mrem /yr to the skin at any point outside the Site Boundary. The three noble gas effluent monitors listed in Technical Speci-fica tion Table 3.3.7.11-1 are the following:

RE4811A - the Filtra tion, Recirculation, and Ventilation System noble gas monitor RE4814A - the South Plant Vent noble gas monitor RE4875A - the North Plant Vent noble gas monitor The methodology of this Section applies to se tpoints for these three monitors. The setpoints calcula ted according to this Section are regarded as upper bounds for the actual SOURCE:PSEGODCM 3.0-1 Rev. O, 85/4/2

.3

required to be performed if the existing setpoint level corresponds to a lower count rate than the new calculated value. If no radioactive discharge is planned for a given release point, the monitor setpoint for that release point ,

should be established as close to background as practical to prevent spurious alarms, and yet alarm should an inad-vertant release occur.

Two methods are given. The first (Section 3.1.1) is the method which is used normally. The second (Section 3.1.2) is used during startups when the concentrations of all plant-generated noble gases in the most recent. sample for a given release point are all undetectable. Setpoints calculated by the two methods may be used'on different monitors simultaneously; only those release points for which the most recent sample yielded no detectable plant-generated noble gases will have their monitor setpoint established according to Section 3.1.2.

3.1.1 Normal Setpoint Method The following method applies to the normal circumstance that one or more plant-generated noble gases in the most recent sample for a given release point are detect-able. In this case, for the purpose of satisfying Technical Specification 3.3.7.11, the setpoints of each of the three station vent monitors are estab-lished as follows:

S = the lower of S vt # S ys, where y

500 ay SF Xg S =

Y Fy (X/Q) [K f X gy]

1 SOURCE PSEGODCM 3.0-2 Rev. O, 85/4/2 l

3000 ay SF X iy 1

S =

t-vs F (X/0) /1 [(Li + 1.1 M1) Xiy]

and where:

S vt

= the candidate setpoint for vent.v, based upon the total body dose rate limit of 500 mrem /yr [uci/cc].

S, y

= the candidate setpoint for vent v, based upon the skin dose rate limit of 3000 mrem /yr

[uci/cc]. .

500 = the whole body dose rate limit [ mrem /yr].

3003 = the skin dose rate limit [ mrem /yr].

1 5

ay = the administrative allocation factor for vent v [unitiess], which is the fraction of the station site boundary dose rate limit which is assigned to vent v. Allocation factors may be changed as necessary. However, normally, each allocation factor should be between 0.0 and 0.5 inclusive, and the sum of the three allocation factors should be less than or equal to 0.5. (This limitation to 0.5 is to ensure that the combined releases from the Hope Creek and Salem Stations remain )

within the regulatory limits at the common Site Boundary.) Any increase in this total l allocation factor above 0.5 will be coordinated with the Salem Generating Station to ensure that the total allocation factor for all SOURCE PSEGODCM 3.0-3 Rev. O, 85/4/2

tha t the total a lloca tion f a c tor for all units does not exceed 1.0.

F = the expected flow ra te in vent V [cc/sec].

Flow rates in cfm may be converted to cc/sec by multiplying them by 472.

SF = the safety factor; a con se rva tive factor used to compensate for sta tistical fluctua tions and errors of measurements. The a c tual value will be de te rm i ne d in implementing procedures.

X/Q = the highest annual average relative concentration at the site boundary in any sector.

= 2.65 x 10-6 sec/m3 Figure 2.1-1 of Ref. 2 establishes the minimum Exclusion Area Boundary distance as 901 m. The listed value (which occurs in the NW sector) is the highest annual average X/Q at this distance for any sector in Table 2.3-31 of Ref. 2.

K = to ta l body dose-factor for gamma emissions-i from noble gas radionuclide 1 [ mrem /yr per uCi/m 3 ], from Table 3.1-1.

X iy = the measured conce n tra tion of noble gas radionuclide i in the last grab sample analyzed for vent v [uCi/cc]. For the North Plant Vent and the South Plant Vent, such samples are taken at least monthly. For purges of con ta inme n t through the FRVS, a grab sample will be taken prior to intentionally ini tia ting each such release, or as soon SOURCE:PSEGODCM 3.0-4 Rev. O, 85/4/2 A

as possible after such a release is ini tia ted a u toma tica 1ly.

L = skin dose factor for be ta emissions from i

noble gas radionuclide i [ mrem /yr per uCi/m 33, from Table 3.1-1.

M = air dose factor for gamma emissions from i

noble gas radionuclide i [ mrad /yr per uCi/m 3],

from Table 3.1-1.

1.1 = a factor to convert a bsorbe d dose in air

~

due to gamma ra dia tion , to dose equivalent in skin [ mrem / mrad]. -

The monitor setpoint S y e s ta blis he d by the method above shall be entered into the ra dia tion monitoring system, along with the sample assay da ta (the Xgy) tha t were used to calcula te i t. The opera tiona1 value of the setpoint should contain an allowance for the monitor's background -,unt ra te and its va ria tion.

However, effluent itors at the S ta tion will be maintained such tha t .ey are sensitive to radiation at the levels at which it is emitted from the effluent streams.

3.1.2 Startup Setpoint Method The following method applies to the special circumstance tha t the assay of pla n t-gene ra ted noble gases in the most recent sample for a given release point yields no detectable radionuclides. It is conserva tive because it assumes tha t all the noble gas detected by the monitor is Kr-89, the most conse rva tive radionuclide in Table 3.1-1. Thus, this method results in the SOURCE:PSEGODCM 3.0-5 Rev. O, 85/4/2

overestima tion of the true dose delivered by the actual noble gas mixture being released. It is therefore recommended tha t this method not be used except when it is necessary due to the unde te c ta bili ty of the noble gases in the sample from a particular release point.

In this case, for the purpose of satisfying Technical Spe ci f ica tio n 3.3.7.11, the setpoints of any of the three s ta ti o n vent monitors may be established as follows:

S y' = the lower of Svt' Of Sys', where 500 ay SF

• S ' "

vt Fy (x/0) K Kr-89 3000 ay SF S ' = .

Fy (X/0) (LKr-89 + 1.1 MKr-89}

where Sy' is the conse rva tive setpoint for s ta r tup

[uCi/cc], LKr-89 and MKr-89 are dose factors for Kr-89 from Table 3.1-1, and other terms are as defined above.

The monitor setpoint Sy' established by the method above will be entered into the radia tion monitoring system. For the sample assay da ta, the LLD for Kr-89 in the most recent sample for the particular release point will be entered into the ra dia tion monitoring system. The opera tional value of the setpoint should contain an allowance for the monitor's background count rate and its variation. However, effluent monitors at the S ta tion will be ma in ta ine d such tha t they are sensitive to ra dia tion at the levels at which it is emitted from the effluent streams.

SOURCE:PSEGODCM 3.0-6 Rev. O, 85/4/2

Table 3.1-1 DOSE FACTORS FOR EXPOSURE TO A SEMI-INFINITE CLOUD OF NOBLE GASES

• Dose to People + Dose to Air I Nuclide Gamma-Body (K) Beta-Skin (L) Gamma (M) Beta (N)

Kr-83m 0.08 ----

19.3 288 Kr-85m 1,170 1,460 1,230 1,970 Kr-85 16.1 1,340 17.2 1,950 Kr-87 5,920 9,730 6,170 10,300 Kr-88 14,700 2,370 15,200 2,930 Kr-89 16,600 10,100 17,300 10,600 Kr-90 15,600 ,

7,290 16,300 7,830 Xe-131m 91.5 476 156 1,110 Xe-133m 251 994 327 1,480 Xe-133 294 306 353 1,050 Xe-135m 3,120 711 3,360 739 Xe-135 1,810 1,860 1,920 2,460 Xe-137 1,420 12,200 1,510 12,700 Xe-138 8,830 4,130 9,210 4,750 Ar-41 8,840 2,690 9,300 3,280 Notes:

• -- Values taken from Ref. 4, Table B-1.

1. -- mrad /yr per uCi/m 3

+ - - mrem /yr per uCi/m 3 SOURCE PSEGODCM 3.0-7 Rev. O, 85/4/2

3.2 GASEOUS EFFLUENT DOSE CALCULATIONS 3.2.1 Site Boundary Dose Technical Specification 3.11.2.1 states:

The dose rate due to radioactive materials released in gaseous effluents from the site to areas at and beyond the SITE BOUNDARY shall be limited to the following:

a. For noble gases: Less than or equal to 500 mrems/yr to the total body and less than or equal to 3000 mrems/yr to the skin, and

b. For iodine-131, for tritium, and for all radionuclides in particulate form with half-lives greater than 8 days Less than or equal to 1500 mrems/yr to any organ.

The following two subsections give Ehe methods by which dose computations are performed for the purpose of demonstrating compliance with this Technical Speci-fication.

3.2.1.a Dose due to Noble Gases For the purpose of implementation of Technical Specifica-tion 3.ll.2.1.a, the dose at the Site Boundary due to noble gases is calculated as follows:

D = current site boundary total body dose t

rate [ mrem /yr3

=

X/O [K g h3 g

i D, = current site boundary skin dose rate

[ mrem /yr]

=

X/O [ (L1 + 1.1 Mg) b]y i

SOURCE PSEGODCM 3.0-8 Rev. O, 85/4/2

where bi = the release rate of noble gas radionuclide i as determined from the concentration measured in the analysis of the appropriate sample required by the Technical Specification Table 4.11-2 [uci/sec].

X/O = the highest annual average concentration in any sector, at the site boundary (for value, see Section 3.1.1) [sec/m3]. For post-release computations, the actual X/O for the period of the release (calculated according to Section 3.3 of this ODCM) may be substituted for X/Q.

'3.2.1.b Dose due to Radionuclides other than Noble Gases For the purpose of implementation of Technical Specifica-tion 3.ll.2.1.b, the dose at the Site Boundary due to radioiodines, tritium, and radionuclides in particulate form with half-lives greater than 8 days is calculated as follows:

sb = current site boundary dose rate to organ o [ mrem /yr]

= X/O [P ig h']

t i

where b'=

i the release rate of non-noble gas radionuclide i as determined from the concentration measured in the analysis of the appropriate sample required by the Technical Specification Table 4.11-2 [uCi/sec].

SOURCE:PSEGODCM 3.0-9 Rev. O, 85/4/2

l

'X/Q = the highest annual average concentration in any sector, at the site boundary (for value, see Section-3.1.1) [sec/m 3]. For post-release calculations, the actual site

, boundary X/O in the affected sector for

! .the period of the release may be substituted.

P = dose parameter for radionuclide i and organ o, io for inhalation, from Table 3.2-1 [ mrem /yr per uCi/m 33, 2

{ 3.2.2 Air Dose ,

Technical Specification 3.11.2.2 states:

The air dose due to noble gases released in gaseous effluents, from each reactor unit, to areas at and

, beyond the SITE BOUNDARY shall be limited to the following:

i a. During any calendar quarter: Less than or equal 4

to 5 mrads for gamma tadiation and less than -

or equal to le mrads for beta radiation, and

b. During any calendar years Less than or equal ,.

to le mrads for gamma radiation and less than i

or equal to 20 mrads for beta radiation.

j For the purpose of demonstrating compliance with this j

Technical Specification, the air dose at the Site l Boundary is determined as follows:

-8 [M y hg ]

D = 3.17 x 10 X/Q 9

i

. D b

= 3.17 x le X/Q [N g Of 3 i

l' l

SOURCE:PSEGODCM 3.0-10 Rev. 9, 85/4/2

1 I

where:

D = the site boundary air dose due to gamma g

emissions from noble gas radionuclides [ mrad].

D = the site boundary air dose due to beta emissions b

from noble gas radionuclides [ mrad].

3.17 x 10-8 = the fraction of one year which is one second.

Og = cumulative release of noble gas radionuclide i over the period of interest [uci].

X/O = the highest annual average concentration in any sector, at the site boundary (for value, see Section 3.1.1) [sec/m 3]. For post-release calculations, the actual site boundary X/O in the affected sector for the period of the release may be substituted.

Ng = air dose factor for beta emissions from noble gas radionuclide i [ mrad /yr per uCi/m 3,3 from Table 3.1-1.

3.2.3 Dose to a Member of the Public Technical Specification 3.11.2.3 states:

The dose to a HEMBER OF THE PUBLIC from iodine-131, tritium, and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents released, from each reactor unit, to areas at and beyond the SITE BOUNDARY shall be limited to the followings

a. During any calendar quarter Less than or equal to 7.5 mrems to any organ, and

b. During any calendar years Less than or equal to 15 mrems to any organ.

SOURCE:PSEGODCM 3.0-11 Rev. O, 85/4/2

\

For the purpose of demonstrating compliance with this Technical Specification, a Maximum Exposed Individual is defined. This person has those residence and consump-tion patterns of real Members of the Population in the environment of HCGS which lead to the highest computed doses. Technical Specification 3.11.2.3 is then satisfied if the calculated doses for the Maximum Exposed Individual are less than the limits of the Tech Spec. The dose to the Maximum Exposed Individual is calculated as follows:

D mP = dose to organ o of a Member of the Public, from radioiodines, tritium, and radionuclides in particulate form with half-lives greater than 8 days

[ mrem]

= 3.17 x 10-8 [ Rg ), wig' hg' ]

ij where:

W g3' = relative concentration or relative deposition for the Maximum Exposed Individual, as appro-priate for exposure pathway j and radionuclide i.

wi $' is defined as follows, where the origin of the numerical values is explained in the Note to Table 3.2-4:

= X/O' for inhalation and all tritium pathways, 9.9 E-08 sec/m 3 , and

= D/Q' for other pathways and non-tritium nuclides, 4.4 E-10 m-2, SOURCE:PSEGODCM 3.0-12 Rev. O, 85/4/2 8

i; - .

R dose factor for organ o due to radionuclide ijn =

i and pathway j, from Table 3.2-2 [ mrem /yr per uCi/m3 , or m2 - mrem /yr per uCi/sec].

O'f

= cumulative release of non-noble gas radionuclide i over the period of interest [uci].

SOURCE:PSEGODCM 3.0-13 Rev. O, 85/4/2

Table 3.2-1 PATHWAY DOSE FACTORS FOR SECTION 3.2.1.b (Pgg)*

Page 1 of 7: Dose Factors for Total Body I ISOTOPEI IlottLATION I i 190ftPEI INEAT191 1 1 190TOPEI IN E Ail 0N l IH.3 1 1.125E*03 1 19R-92 1 5.254E.01 1 11-131 1 2.727E*04 I IC-14 1 6.734E*t3 1 IY-90 1 1.166E+02 I 11-132 1 1.876E+03 I 114-24 1 1.610E+04 I lY.91M i 1.843E.02 I 11-133 1 7.696E+03 I IP-32 1 9.979E*84 I lY-91 1 2.438E+04 1 11-134 I 9.953E*02 I ICR-51 1 1.543E*02 I IY-92 1 5.009E.01 1 II.135 1 4.144E*03 I 1194-5 4 1 9.509E+03 I lY.93 1 5.166E*t0 I 1C5-134 1 2.246E+05 I 1196-56 1 3.119E-01 1 12R-95 1 3.70K+04 I ICS-136 1 1.162E+05 I .

IFE-55 I 7.770E*03 1 12R-97 1 1.598E+01 1 105 137 1 1.21!4E+05 1-IFE-59 l 1.669E*04 1 14-95 I 6.549E+03 I 10S-130 1 5.550E+02 I 100-58 1 3.164E+03 I IMB-99 I 4.255E+nt i 194-139 I 5.365E-02 I 100-64 1 2.264E*04 I ITE-99M i 5.772E-02 I 10 & 140 1 4.329E+03 I INI-43 1 2.797E+04 I ITC.101 1 1.077E-03 I 10A-141 1 6.364E.03 I INI-65 l 1.643E-41 I I110-103 1 1.073E+03 1 10A-142 1 2.79E.03 1 ICU-44 1 1.07)E+00 I 1111)105 1 5.55K.01 1 IL& l40 1 7.548E+01 I 12N-65 1 7.03 K+44 I l b 186 1 1.691E+64 1 ILA142 1 1.291E.01 I 12N-69 I 9.917E-03 I I G 110M i 9.13 E+03 I

........................ ....... .......'........ ICE.141 1 2.897E+03 1 IBR-63 I 4.736E+82 I ITE-125M i 9.139E+02 I ICE.143 1 2.875E+01 I 19R-84 1 5.476E+02 I ITE-127M i 3.019E*03 I lE.144 1 3.615E*05 I IOR-05 1 2.531E+01 1 ITE.127 I 6.105E.01 1 IPR-143 1 9.13*E*02 I 15-84 1 1.143E*05 I ITE-129M i 3.041E+03 I IPR 144 1 2.997E-03 I 188-89 1 3.663E*02 I ITE-129 1 2.383E.02 1 14-147 1 6.800E+02 I 198-89 I 2.897E*02 I ITE.131M i 5.069E*01 1 IW-107 1 4.329E*00 I 19R.89 l 1.724C+04 I ITE.131 1 6.596E.03 I tr-239 1 2.350E*01 I 19R-90 1 6.430E+n6 I ITE-132 1 2.634E*t2 i ISR-91 1 4.506E*00 I II.130 1 8.436E+03 I

• -- See Note, page 3.0-21 Units: mrem /yr per uCi/m 3 SOURCE:PSEGODCM 3.0-14 Rev. O, 85/4/2

Table 3.2-1 PATHWAY DOSE FACTORS FOR SECTION 3.2.1.b (Pgg)*

Page 2 of 7: Dose Factors for Bone 1 ISOTOPEI INNALATION I I ISOTOPEI I M ATION I I ISOTOPEI Il4%LAT10N I lH.3 1 0.000E*00 l 19t-92 1 1.310E*01 1 11 131 1 4.818E+04 l l

1C-14 1 3.589E+04 I lY.90 1 4.107E*03 I 11-132 1 2.116E*03 I IN4-24 1 1.610E+04 I lY.91N I 5.069E-01 1 11-133 1 1.659E+04 1 IP-32 1 2.606E+06 I lY-91 I 9.139E+05 I 11-134 1 1.173E+03 I 109-51 I 0.000E*00 l lY.92 1 2.035E+0! I 11 135 1 4.921E*03 I IfM 54 1 0.000E+00 I lY-93 1 1.865E*02 I 1C5 134 I 6.512E*05 1 1 .................. .. ........................ . .....................

IfW.56 I 0.000E*00 1 125t-95 1 1.999E+05 I ICS-136 I 6.512E+04 I IFE.55 l 4.736E*04 1 121t-97 1 1.876E+02 I ICS-137 I 9.065E+05 I IFI'.59 1 2.060E*04 1 15-95 1 2.350E+04 I 1C5 138 1 6.327E*02 I 100 50 1 0.000E*00 l Itc.99 1 0.000E+00 1 IBA-139 1 1.841E*00 I ICO-60 1 0.000E*00 l ITE.99tl i 1.780E-03 l 194-140 1 7.400E*04 I lHi-63 1 8.214E*05 I ITC.101 1 8.103E-05 l 104 141 1 1.957E-01 I INI.65 1 2.990E*00 1 1 6 103 1 2.794E+03 1 194142 1 4.995E-02 I ICO.64 1 0.000E+00 1 1110-105 1 1.520E+00 1 IL4140 1 6.439E*02 I 124-65 1 4.255E+04 I 1 5 106 1 1.362E*05 1 ILA-142 1 1.295E*00 I 12N-69 I 6.697E-02 I tilG.110tl 1 1.687E*04 I ICE.141 1 3.922E*04 I 198-83 1 0.000E+00 I ITE-125M i 6.734E+03 I ICE.143 1 3.659E*02 I 198-84 1 0.000E*00 I ITE-127M i 2.486E*04 I ICE.144 I 6.771E*06 I lle-OS I 0.000E+00 1 ITE.127 1 2.771E*00 I 1P11-143 1 1.846E+04 1 IPB.96 1 0.000E+00 l ITE.129M i 1.920E*04 I IPlt-144 1 5.957E-02 I IPB-99 1 0.000E*00 I ITE-129 I 9.768E-02 I I4-147 1 1.000E*04 I IP9 99 1 0.000E*00 l ITE-131N I 1.343E*02 I IW-187 1 1.632E*01 1 1999 I 5.994E*05 I ITE.131 1 2.172E-02 1 l*-239 I 4.662E*02 1

\

I 158 90 1 1.010E*06 I ITE-132 1 4.810E*02 1 1 8.177E*03 I l 19 91 1 1.214E*02 I 11 130 i

1

• -- See Note, page 3.0-21 Units: mrem /yr per uCi/m 3

SOURCE PSEGODCM 3.0-15 Rev. O, 85/4/2 i

e

Table 3.2-1 PATHWAY DOSE FACTORS FOR SECTION 3.2.1.b (Pg)*

Page 3 of 7: Dose Factors for Liver I IS0TOPEI let ATION I I ISOTOPEI I R ATION I I ISOTOPEI I M ATION I IN 3 1 1.125E+03 1 1 9 -92 1 0.000E*00 t 11 131 1 4.910E*B4 I 10 14 1 6.734D03 I lY-90 1 0.000E*00 1 11-132 1 4.070E*03 I INA.24 1 1.610D64 I lY.91n 1 0.000E+04 I 11 133 1 2.031E*04 I IP-32 1 1.143E+05 I IY.91 1 0.000E+tt i 11 134 1 2.161E*03 I ICil-51 1 0.000E*00 I lY.92 1 0.000D00 I 11 135 I 9.732E+03 I Ilm-54 1 4.292E+04 I lY.93 1 0.000E*00 I 105 134 1 1.014E+06 I 114-56 1 1.654E*t4 1 15-95 1 4.181994 I 1C5-136 1 1.709E+05 I IFE-55 1 2.516E+44 1 1R-97 1 2.716D01 1 105 137 I 8.251E*05 I IFE-59 1 3.345E+64 1 1 4 -95 I 9.176E+03 1 105 130 I 9.399E*02 I 100-59 1 1.772D03 I IMO-99 1 1.724D02 1 184 139 I 9.942E-04 I 100 60 1 1.314D64 I ITC.99M i 3.482E.03 1 104-140 1 6.475D01 I INI.63 4 4.625E+64 I ITC.101 I 9.510E-05 I 106-141 1 1.092E-04 I INI-65 1 2.956E-01 1 Inli-103 I 0.000Det I 106 142 I 3.600E-05 I ICU-64 1 1.994D40 1 1 6 105 1 0.000000 l II.A-140 1 2.250D02 I 12N-65 1 1.132E+09 I I E 106 I 8.000D00 1 ILA 142 1 4.107E.01 I 12N.69 I 9.657E.82 l 1 4 110N I 1.140D04 I ICE-141 1 1.954E*04 I IW.83 1 0.000D00 I ITE.125N i 2.32?E+03 I ICE.143 1 1.907E+02 I 19 94 1 0.000E+44 I ITE.127M l B.547D03 I trE.144 1 2.116E*06 I 19 95 1 0.000Det i ITE.127 I 9.509E.01 1 IPR.143 I 5.550E+03 I 1 5 86 1 1.993D05 I ITE.129N I 6.945D13 I IP&l44 1 1.946E.02 1 ,

199-99 I 5.624E*02 I ITE-129 1 3.49?E.02 l IMD.147 l 9.732E+03 I IP9 99 1 3.452E+02 I ITE-131M i 5.92nE+01 I 116 197 I 9.657D00 l 19 99 1 0.000D40 I ITE.131 i F.436E-03 I INP-239 1 3.345D01 I 19 96 I 0.000E*l0 1 ITE-132 1 2.723002 I 19 91 1 0.000D00 1 11 134 1 1.639 0 04 I

• -- See Note, page 3.0-21 Units: mrem /yr per uCi/m 3 SOURCE:PSEGODCM 3.0-16 Rev. O, 85/4/2

l Table 3.2-1 PATHWAY DOSE FACTORS FOR SECTION 3.2.1.b (Pg)

• Page 4 of 7: Dose Factors for Thyroid I ISOTOPEI I M LATION I I ISOTOPEI I H LATION I I ISOT08El I H LAil0M i tw) I 1.125E+03 I '

ISR-92 1 0.000E+00 1 11 131 1 1.624E*07 I )

l 10-14 I 6.734E*03 I lY.90 t 0.000E+00 I 11-132 1 1.935E*05 I INA.24 I 1.410E+44 I lY-91n 1 0.000E+00 I 11 133 1 3.040E+06 I l

......... .......... . ..... ................. ........................ 1 IP.32 1 0.000E+00 I lY-91 1 0.000E+00 1 11-134 I 5.06*E*04 i {

109 51 1 8.547E+01 I lY.92 1 0.040E+00 I 11 135 1 7.910E*05 I Ir94-54 1 0.000E+00 I lY.93 I 0.000E+00 l 1C5-134 1 0.000E*00 I

.. . ........ . ............. ... .. . .............. ..... {,

if98 56 1 0.000E*tt i 12R.95 1 0.000E*t0 1 ICS-136 1 0.000E*00 I , j II'E.55 1 0.000E+00 1 12R-97 1 0.000E*t0 1 105 137 1 0.000E+00 I IFE-59 I 0.000E+00 1 14 95 l 0.000E*t6 1 105 130 1 0.000E*00 I j 100 58 1 0.000E*00 I 19IG-99 I 0.000E+00 1 194 139 I 0.000E+00 1 100 60 1 0.000E+04 I ITC.99n 1 0.000E*06 1 194 140 1 0.000E+00 I INI.63 1 0.000E+00 I ITC.101 1 0.000E+00 1 104 141 1 0.00E+00 I INI.65 1 0.000E+00 1 1 6 143 I 8.000E+00 1 104 142 1 0.000E+00 I 100 64 1 6.000E+00 l 1 5 105 1 0.000E*00 1 ILA.140 1 0.000E*00 I 124-65 1 0.000E+04 1 1 5 106 1 0.000E*00 I ILA-142 1 0.000E+00 I 12N-69 I 0.000E+tt i IAG-110H I 0.000E*00 I ICE.141 1 0.000E+00 I 198 03 1 0.000E*t0 1 ITE.125t11 1.94E*03 I ICE.143 1 0.000E+06 I 195 94 1 0.000E+00 I ITE 1271 1 6.060E*03 I ICE.144 1 0.000E+00 I ~

108-85 1 0.000E+44 I ITE-127 1 1.961E*00 1 IPR.143 1 0.000E+00 I 1566 1 0.000E+44 I ITE-12in I 6.327E+03 I IPR.144 1 0.000E+00 I

, 199 90 1 0.000E+00 t ITE.124 1 7.141E-02 l IND.147 1 0.000E+00 I IPB-89 I 0.000E+00 1 ITE-13tn I 9.769E*01 I IW.107 1 0.00nE+00 I 158 99 1 0.000E*00 l ITE-131 1 1.69flE-02 I l@-239 I 0.000E+00 I 19 90 1 0.000E+00 I ITE-112 1 3.175E+02 I

........................ ... ................... l' Ice.91 1 0.000E*00 I 11 130 1 1.046E*06 1

• -- See Note, page 3.0-21 Units: mrem /yr per uCi/m 3.

SOURCE:PSEGODCM 3.0-17 Rev. O, 85/4/2 t

L ,

j

/

4 Table 3.2-1 PATHWAY DOSE FACTORS FOR SECTION 3.2.1.b (Pio)*

Page 5 of 7: Dose Factors for Kidney I IS0 V El (*ALATION I I ISOTOPEI IIHLATION I I ISOTOPEI IMALATION I

.. - - .. ....... ............... ...= _ ..........

Ik.3 1 1.125E+03 I ISR 92 I 8.000E+00 1 11-131 1 7.891E+04 I

. .....- ..... . .........._=__ -___ _.

..== ...__.........

1C.14 I 6.734E+03 I ly-90 i C.000E+00 1 11-112 1 6.253E*03 I inn-24 I 1.610E*04 I ly.91n 1 0.000E+00 I 11-133 I 3.378E+04 I

. ..__........ .. .- _ . . . . . . . . . _ . ..... ............... 1 IP.32 1 0.000900 I ly.91 1 0.000E+00 1 11-154 1 3.300E+03 l l ICE-51 1 2.431E*01 I ty.92 1 0.000E+00 I II-1M i 1.339E+04 1 IMN-54 I 1.003E+04 I ly.93 1 0.000E+00 1 ICS-134 1 3.304E*05 1 4fw-56 1 1.672E+00 1 12R-95 I 5.957E+04 I 105-136 I 9.546E+04 1 IFE-55 I 0.000E+00 1 12R-97 1 3.885E*01 1 105-137 I 2.823E*05 I IFE-59 I 0.000D00 l INB-95 l 8.621E+03 I 105-138 I 6hl6E*02 I ICf1-50 1 0.000E*00 1 IMO 99 I 3.922E*02 I 104-1?9 I 8.621E-04 I

........................ ........................ ...-- =====........ ..

100-60 1 0.000E+tt i ITC-99N I 5.069E-02 1 19A-140 1 2.113E+01 1 INl.63 I 0.000E+00 I ,ITC-101 1 1.450E-03 I 194-141 1 9.472E-05 I INI-65 l 0.000E+04 I seg.103 I 7.030E+03 1 194-142 1 2.912E-05 I

......... . .......... .. .. ................ . . . - - ==.......

100-64 I 6.031E+06 I l % 105 1 1.343E+00 I ILA-140 1 0.000E+00 i IN-65 l 7.141E*l4 1 1 6 106 1 1.83*E+95 I II.A-142 1 0.000E*06 1 12N-69 I 5.846E-82 I lag-110N I 2.124E*04 I ICE-141 1 8.54?E+03 I 198-83 1 0.000E+00 I ITE-12SM I 0.000E*00 I ICE-143 1 8.362E+01 I IEW-84 I 0.000E*00 I ITE-12?M i 6.364E*64 I ICE-144 1 1.173E*06 I

... ..... - =. . .. ................,_,, ......... _ .......,_...

IfW-88 I f.000D00 1 ITE-127 I 7.067E+00 I IPR-143 1 3.001E+03 I 196-86 1 0.000Dtt i ITE.129M i 5.032E+04 I IPR-144 I 9.768E-03 I 199-84 1 0.000E+00 1 ITE-129 1 2.568E.01 I IND-147 1 4.81AE+03 1 1499 1 0.00nF+00 1 ITE.131M i 3.996E+02 I IW-187 1 0.000E+00 l 158-64 1 0.000E+00 I ITE.131 1 5.883E-02 I INP-29 I 9.731E+01 I l<c.9a 1 0.000E*00 1 ITE.132 1 1.772003 I 158 91 1 0.000E+00 I i t.D0 1 2.446E+04 I

• -- See Note, page 3.0-21 Units: mrem /yr per uCi/m 3 SOURCE:PSEGODCM 3.0-18 Rev. O, 85/4/2

1 1

9 Table 3.2-1 PATHWAY DOSE FACTORS FOR SECTION 3.2.1.b (Pg)

• Page 6 of 7: Dose Factors for Lung I ISCTOPEI INHALATION 1 1 150TOPEI I MIATION I i 150TOPEI INHALATION I 14 3 1 1.125E*03 1 1 9 -92 1 2.401E*04 1 11 131 1 0.000E+00 I 10 14 1 6.734E*03 I lY-90 1 2.616E+05 I 11-132 1 0.000E+00 I INA-24 1 1.610E*04 I lY-91N I 2.012E*03 I 11-133 1 0.000E*00 I =

....... ............... ........................ .........= _-- __ =...

IP-32 1 0.000E+00 1 IY 91 1 2.627E+06 1 11 134 1 0.000E*00 1 _I

................... ... ................. ..... ........................ I IfD.51 l 1.690E+04 I lY.92 1 2.390E+04 1 11 1M 1 0.000E*00 1 IMH-54 1 1.576E* 06 I lY.93 1 7.437E+04 I 105-134 1 1.210E+05 I INN-56 1 1.314E*0; I 12P-95 1 2.231E+06 I ICS.136 1 1.454E+04 I

..... ................. .. ............ ==.. ........................

IFE.55 1 1.110E*05 I IZR-97 1 1.132E*05 I 1C5 137 1 1.040E+G5 I IFE.59 1 1.269E*06 I INB 95 1 6.142E+05 I ICS.139 i '6.009E+01 I l

............= - _=.. ........................ ........................

ICO.5p i 1.10eE+06 I IMD-99 l 1.354E*05 I 104-139 I 5.772E*03 I

...................... . .._..'................. ...... ..= - ......

100-60 1 7.06N'06 I ITC-99n I 9.500E*02 I 104-140 l 1.743E+06 I INI.63 1 2.749E*05 I ITC-101 1 5.846E+02 1 104 141 1 2.919E+03 1

.... ...... ........................ .................==

INI.65 l 8.17N+03 I I 4 101 1 6.623E+05 1 104-142 1 1.643E*03 I ICel-64 I 9.583E*03 1 1RU.105 1 1.591E+04 I ItA.140 1 1.02SE*05 I 12N-65 I 9.953E*05 I IRU-106 1 1.432E+07 I ItA 142 1 8.695E+03 I 17N-69 l 1.421E*03 I IAG-110M i 5.476E+06 I ICE-141 1 5.439E+05 I

. ..................... .. .................... ........................ t IE4 03 1 0.000E*00 1 ITE-125n 1 4.773E+05 1 10E-143 1 1.154E+05 I

..........- - ..===- - =....= ... ........................

IP-04 I 0.000E*00 1 ITE-127M i 1.400E+96 I ICE-144 1 1.195E*07 I

... ............. ... . .... _ =......... ......._................

109-85 4 0.000E+00 l ITE-127 1 1.003E+04 I IPR.143 1 4.329E*05 I IP9-86 1 0.000E+00 1 ITE-129H I 1.761E+l6 I IPR-144 1 1.565E+03 1 196-00 1 0.000E*00 I ITE-129 1 2.934E+03 1 14-147 1 3.2P2E+05 I

. ... ............ .. . ..................... = - - _ ====....

199-09 1 0.000E+00 1 ITE-131M i 2.057E*05 1 10 107 I 4.107E+04 I -

........................ . .......= =____ ..... ........................

1 9 -09 I 2.157E*06 I ITE-131 1 2.054E*03 I IND.239 1 5.009E+ 04 I 19-9a 1 1.476E*07 I ITE.132 1 3.774E+05 1

=

19 91 1 5.32AE*04 I 11-130 1 0.000E+00 8

• -- See Note, page 3.0-21 )

Units: mrem /yr per uCi/m 3 SOURCE PSEGODCM 3.0-19 Rev. O, 85/4/2 .

-r

\

.. . ., . ., . . . ~,

l l

l 1

l Table 3.2-1 PATHWAY DOSE FACTORS FOR SECTION 3.2.1.b (P.lo)*

Page 7 of 7: Dose Factors for GI-LLI I ISOTnPEI I M ATION I I ISOT0PEI I M ATION I I ISnTOPEI I M ATION I lH-3 1 1.125E+fl3 I ISP-92 1 2.424E+05 1 11-131 1 2.042E+03 I 10-14 1 6.734E+03 I lY.90 1 2.670E+05 1 11-132 I 3.201Ed3 I

............=- ........................ .......=== = - - ..

INA-24 1 1.610E+04 I IV.91n i 1.717E*03 I 11-133 1 5.476E+03 I IP-32 l 4.21AE*04 I lY 91 1 1.030E+05 1 11-134 1 9.546E*02 I

........................ ........................ .............. === ..

ICR-51 1 1.06eE+03 I lY.92 l 2.390E+05 I Il-1M i 4.440E*03 1 IfN-54 1 2.290E+04 I ly.93 I 3.095E*05 I 105-134 1 3.044E+03 I ItN-56 i 1.232E+05 l 129-95 I 6.105E+04 I 105-136 1 4.101E+03 I

..... .................. .. .................... ............= - ..

IFE-55 l 2.860Eo) i 12R-97 I 3.511E*05 i 1C5-137 I .3.619E*03 I IFE.59 1 7.067E+04 1 14 95 1 3.700E+04 I 1r5-118 1 2.697E*02 I 100-58 I 3.437E+04 I ino 99 I 1.26;E+05 I 80A-139 I 5.772E*04 I

...........= - .... .. ......==-_ _ _..... ........................

100-60 l 9.620E+04 I ITC-99M i 4.910E+03 1 104-140 l 1.018E+05 I

..==_-- _

INI-63 I 6.327E*03 I ITC.101 1 1.632E41 1 IBA.141 1 2.753E+02 I

.......=_ __ - -

INI-65 I 8.39'E*04 I IRU.103 4 4.477E+04 1 104-142 1 2.742E+00 I 100-64 1 3.670E*04 I IRu.165 I 9.953E+84 I ILA-140 1 2.257E*05 I

..=== ----- -- .. .. .... ... __.- ........

12N-65 1 1.6?2E+04 I IRU.106 1 4.292E+05 I ILA-142 1 7.585E*04 I

~'

IE-69 I~5.010Ed4 i I5550tl l 1.003E05~I 55541 I 5.661E+64~I IBP-83 1 0.000E+08 I ITE-125M i 3.378E*04 I ICE-143 1 1.27TE*05 I IBR-84 1 0.000E+00 t ITE-127M i 7.141E+04 I ICE-144 1 3.805E*05 I IBP-05 1 0.000E+00 I ITE.127 I 5.624E*04 I IPR-143 1 9.731E+04 I

.= _................. ... = .... ... ............- ==

IRB-86 I 7.992E+03 I ITE-129M i 1.017E+05 I lPR.144 1 1.960E+02 I

........................ ..................... . . . . . = - ==.......

IR0-00 1 1.724E*01 1 ITE.120 1 2.540E+C4 I l @ -147 1 0.214E+04 I

........................ . .................... ..........= -

=..

109-89 1 1.001E*00 1 ITE.131n i 3.079E*05 I N.107 I 9.102E.04 I ISR-89 8 1.672E+05 1 ITE-131 1 1.332E+03 I INP 230 l 6.401E+04 I l @ -90 1 3.434E*05 I ITE-132 I 1.376E+05 i l @ 81 l 1.73*E*05 I 11-130 I 5.106E+03 I i

• -- See Note, page 3.0-21 Units: mrem /yr per uCi/m 3 SOURCE PSEGODCM 3.0-20 Rev. O, 85/4/2 1

NOTE: The Pio values of Table 3.2-1 were calculated according to the methods of Ref. 6, Section 5.2.1, for the child age group. The values used for the various parameters, and the origins of those values, are given below in Table 3.2-5.

I l

{

i SOURCE:PSEGODCM 3.0-21 Rev. O, 85/4/2

Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (Rf3g)*

Page 1 of 21: Dose Factors for Total Body 1 ISOTOPEI INHALATION I GROUIC PLANEl GPS / COW /f11LKI

= - _ _ _ = = . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lu 1 1 6.46PE+02 1 0.000E+do i 2.353E*03 I 10-14 1 5.30eE+03 I 0.000E+00 1 7.940E+08 1 IN4-24 l 1.056E+04 1 1.194E+07 1 2.453E*07 I IP-32 I 7.742E+04 1 0.000E*00 1 9.880E*09 I Irp-51 1 8.946E+01 1 4.659E+06 1 2.56;E*05 I Im 44 1 4.984E*03 1 1.386E*09 I 1.406E+07 I 15-56 1 2.212E-01 1 9.035E+05 I 8.641E-03 I

....................... ...- =. . . . . . . . -

IFE-55 1 3.332E*03 1 0.000E+00 1 3.712E+07 I ire 59 I 9.478E*03 1 2.727E*00 I 2.457E*06 1 100-58 1 1.820E+03 1 3.011E+08 1 9.634E*07 I

. ......................... ====..............

100-60 1 1.177E+04 I 2.152E+10 1 3.311E+08 1 INI-63 1 1.161E*04 1 0.000E+00 1 1.929E+09 I INI.65 l 1.231E-01 1 2.970E*05 1 2.871E-01 I 108-64 1 7.742E-01 1 6.067E+05 l 1.366E+05 1.

12N-65 1 3.100E+04 1 7.463E+08 1 1.397E+10 I 12N-69 1 7.18?E-03 1 0.000E+00 1 5.596E-12 l-18R-83 1 3.80AE*02 1 4.871E+03 1 1.486E+00 I 199-84 I 4.nO4E*02 l 2.026E+05 1 1.990E-22 I 199-85 1 2.044E*01 1 0.000E+00 1 0.000E+00 I 1I18-8 6 I 8.820E+04 I 8.984E*06 1 1.749E+10 1 199-08 1 2.870E+02 1 3.307E*04 1 1.634E-44 I

.............== - - ......................

IRB-A9 1 2.058E+02 I 1.23hE+05 1 3.741E-52 I 1 9 -09 1 1.141E*04 1 2.162E+04 1 5.743E+08 I i

.............- .................- ===....

)

1 9 -90 1 2.590E+n6 1 0.000E+A0 1 4.925E+10 I

............... ==..............- .......

l(D 91 1 3.459E+00 1 2.149E+06 1 1.564E+04 I

.............--- ===.........== __ =......

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m 3 Others -

m 2 mrem /yr per uCi/sec SOURCE:PSEGODCM 3.0-22 Rev. O, 85/4/_2 l

e,-- ,-

Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (Rggy

• Page 2 of 21: Dose Factors for Total Body I ISOTOPEI INHal ATILW I G80Lp0 PUWEl GRS/E0W/MILKI 158 92 1 3.904E-01 1 7.769E+05 I 2.742E-01 I lY.90 1 0.920E*01 1 4.491E+03 1 2.906E+01 I tv-91M i 1.1AeE-02 1 1.002E+05 1 3.051E-20 I IY-91 1 1.569E+04 1 1.073E+06 1 3.104E*03 I ty.92 1 4.606E-01 1 1.904E*05 1 2.404E-09 I lY-93 1 4.074E+00 1 1.052E*05 I 9.745E-02 1 179 95 1 2.030E*04 I 2.446E*04 1 1.871E+03 I 1Z9-97 1 1.170E+01 l 2.960E*06 I 5.065E-01 I l* M i 3.700E*03 1 1.409E+09 I 2.270E*05 1 -

1 4 -99 1 3.234F+01 1 3.995E+06 I 6.453E*07 I ITC_90M i 3.724E-02 1 1.041E*05 1 1.161E+03 I ITC.101 1 0.120E-04 1 2.034E*04 1 4.525E-59 I IR)-101 1 6.790E+02 1 1.004E+06 1 4.615E*03 I IR)-105 1 4.102E-01 1 6.363E+05 l 4.315E-03 1, iml-106 1 1.099E+04 1 4.200E*00 1 3.791E+64 I lag-110M i 4.99AE*03 1 3.445E+09 I 2.965E+99 I ITE.125M i 6.500E+02 1 1.552E*06 1 3.241E+07 I ITE-127tti 2.072E+03 I 9.165E+04 1-8.109E*07 I ITE.127 I 4.096E-01 1 2.994E+03 1 2.214E+03 I ITE 12911 2.226E+03 1 1.972E+07 I 1.364E+09 I ITE-129 1 1.976E-02 1 2.600E+04 1 7.790E-10 I ITE.131M i 3.626E+01 1 8.026E+06 1 1.795E+06 I ITE-131 1 4.990E-03 1 2.919E+04 I 1.530E-32 I ITE.132 1 1.764E*02 1 4.223E*06 1 1.546E*07 I Il-13A I 5.572F+03 1 5.511E*06 1 4.99'E*06 I

.....=- - ====.___ ..__._______....'.......

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m 3 Others -m 2 mrem /yr per uCi/sec SOURCE:PSEGODCM 3.0-23 Rev. O, 85/4/2

Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R )*

Page 3 of 21: Dose Factors for Total Body I ISOT0pEl I6MLATION I Gil0% PL4El GRS/C0pmitkl 11-131 1 1.96nE*04 1 1.721E+07 1 2.24?E+09 I 11-132 1 1.259E+03 1 1.245E*06 1 1.648E+00 I 11 133 i 5.600E+03 1 2.451E+06 I 2.460E*07 I 11-134 1 6.t.50E*02 1 4.46?E*05 1 2.039E-11 I 11-1M I 2.77?E*03 1 2.576E*06 I 1.296E+05 I

.. ......- - ==.... ...........................

105-134 1 7.440E+04 1 6.863E+09 1 1.693E+10 I 105-136 1 5.29?E+04 1 1.507E+08 1 3.442E+09 I 1C5 137 1 4.550E+04 1 1.030E+10 1 6.792E+09 I .

109-130 1 3.076E+0? I 3.599E+05 1 1.051E-22 i 18A.130 I 4.298E-02 1 1.061E+05 1 2.000E.08 i IBA-140 1 2.090E+03 1 2.053E+07 1 1.976E+07 I

....................... ...==- -. .

IRA-141 I 4.970E.03 1 4.172E+04 1 2.005E-46 I 69A-142 1 1.960E-03 1 4.4dE+04 I 0.000E+06 I ILA-14h I 5.152E+01 1 1.923E+07 1 6.551E+04 I Il4-142 1 9.044E.02 I 7.602E+05 1 2.410E-11 I ICE.141 1 1.990E+03 1 1.366E+07 1 4.953E+03 I ire-143 1 2.212E+01 1 2.312E+06 I 4.779E+01 I ICE-144 1 1.764E+05 I 6.946E+07 1 2.073E*05 l l IPR.143 1 6.986E+02 1 0.00nE+00 1 1.172E+02 1 1

.. .. ........ ................................ l IPR-144 1 2.409E-03 1 1.837E+03 1 5.215E-54 I l

....=== ....... .......-- ...=_ ..... \

inn.147 I 4.999E+02 1 8.4n8E*06 I 8.833E+01 I l

..... ..____- ............ ...... - - _=....13-107 1 3.122E+00 1 2.360E+06 1 2.340E*04 I INP-239 1 1.976E*01 1 1.786E*06 1 2.923E+00 I

. ...................................--- ==.

• -- See Note, page 3.0-43 Units:- Inhalation - mrem /yr per uCi/m 3 Others -m 2 mrem /yr per uCi/sec SOURCE:PSEGODCM 3.0-24 Rev. O, 85/4/2 1

l l

e-

- - - - .--gm.

Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (Rgg)*

Page 4 of 21: Dose Factors for Bone I ISOTOPEI INHntATlfN I GROLMD PLANEl GR$/ COW 411LKI lH-3 1 0.000E+00 1 0.000E+00 1 0.000E+00 I

. . . . . . . . . . . . . . . . . . . _ . . . . . . . . - = - - -

=.........

IC-14 1 2.646E+04 1 0.00nE+00 1 3.722E*09 I

...===_ - - - .........

INA-24 l 1. M6E* 04 1 1.194E+07 1 2.453E+07 I IP-32 1 2.030E+06 1 0.000E*00 1 2.549E+11 1 ICh5h5 I b$505kI50 1 4.6kkIh21 0.000E*00~I

..... ........... ===........ .......- __

IMN-54 1 0.000E+00 1 1.386E+09 I 0.000E+00 I IlW-56 I 0.000E+00 l 9.035E*05 1 0.00nE*00 I IFE.55 l 1.974E+04 1 0.000E*00 1 2.150E*08 i IFE-59 I 1.157E+04 1 2.72?E+08 I 3.569E*08 1

- - ...=_ -- ............ ........._____

800-59 1 0.000E*00 1 3.811E+08 1 0.000E+00 I 100-60 1 6,000E+00 1 2.152E+10 1 0.000E+00 I IN1-63 1 3.388E+05 1 0.000E+00 1 5.558E*10 I INI-65 1 2.394E+00 1 2.9 1 5.576E+00 I

............... ........'0E+05. .............

100-64 1 0.000E+00 1 6.067E+05 1 0.000E*00 I 12N-65 1 1.932E+04 1 7.463E+08 I 8.833E+09 I 17N-49 I 5.390E-02 1 0.000E*00 1 4.177E-11 I

. . . . . . . . . . . . - = .. _ _.............._.....

18R-83 1 0.000E+00 I 4.871E+03 1 0.000E+00 I lilR-84 1 0.000E*00 1 2.026E+05 1 0.000E+00 I IIIR-85 1 0.000E+00 1 0.000E+00 1 0.000E*00 I 1819-86 i G.000E*00 1 8.994E+06 1 0.000E+00 1 1k98 1 0.000E ho I 3.307E5041 0.0h0E+00 1 IEh9 I"UI000E+00 I"5$25hkOhI 0.000E5b0 i 1 9 -09 I 3.976E+05 1 2.162E+04 I 2.002E+10 I

.................- ......= ==..

19 90 I 4.088E*07 1 0.000E*00 1 1.934E+11 I

. . - - - - - - - - ..........==-- - .- - - ___......

19 91 1 9.562E*01 1 2.140E+06 1 4. 320E* M i

..............- - ......-- -----......_ =..

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m 3 Others -m 2 ,.am/yr per uCi/sec SOURCE:PSEGODCM 3.0-25 Rev. O, 85/4/2

Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (Rgg)*

Page 5 of 21: Dose Factors for Bone I ISnT0PFI l*R ATION I CsntM PLANFl ERS/C0wtilLKI

=............. .......... ....

Ice-92 1 1.050E+01 l 7.768E*04 I 7.305E+00 i

=- .......... .........

lY 90 1 3.290E*03 1 4.49tE*03 1 1.004E+03 !

IY.91M i 4.074E-01 1 1.On2E*ns I 8.954E.19 I

~

UY.91 1 5.800E+05 1 1.073E*06 1 1.165E+05 I lY 92 1 1.630E+01 1 1.804E*05 I 8.554E-04 I lY-93 I 1.490E+02 1 1.852E+04 1 3.577E*00 I 179 95 1.1.154E+05 1 2.44AE+08 1 1.082E+04 I 129-97 l 1.490E+02 1 2.960E*06 I 6.462E+00 I 14-95 1 1.668E+04 1 1.4n4E6A I 9.532E+09 1 In0-99 I 0.000E+00 I 3.994E*06 1 0.000E*00 I

=._ .- ..

ITE-95n i 1.397E-03 1 1.041E+05 1 4.372E+01 I ITE-101 1 6.510E-05 1 2.034E+04 1 3.630E-59 I

.... = -_____ ............. .... .

IDti.101 1 2.016E+03 1 1.044E+08 1 1.300E+04 I 128 105 l 1.224E+00 1 6.361E*05 1 1.281E-02 I IRI-106 I 8.600E+04 1 4.200E*00 1 3.027E+05 I lal;-110M i 9.982E+03 I 3.449E*00 1 6.139E*00 I ITE-125N I 4.760E*03 1 1.%2E*06 1 2.390E+08 1 ITE.127N I 1.666E+04 1 9.165E+04 1 6.70AE+08 1 ITE-127 I 2.226E+00 1 2.994E+03 1 1.030E*04 I ITE.129M i 1.414E*04 1 1.972E+07 I 8.856E+08 i lie-120 1 7.082E-02 1 2.600E+04 1 3.340E-09 I ITE-131M I 1.067E+02 1 0.026E+06 I 5.372E+06 I ITE-131 1 1.736E-02 1 2.919E+04 1 5.45?E.32 I j ITF-137 1 3.724E*02 l 4.223E*06 I 3.346r+07 I if-13n i 6.356E*03 I 5.511E+A6 IT6eE+n4 i j

1

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m3 2

Others -m mrem /yr per uCi/sec SOURCE:PSEGODCM 3.0-26 Rev. O, 85/4/2

i I

)

Table 3.2-2 i PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R..1]O)* 1 Page 6 of 21: Dose Factors for Bone I ISOTOPEI 16MATION I GRDM) PUhMEl GRS/C0hlotlLKl 11 111 1 3.794E+04 1 1.721E*07 I 4.32?E+09 i 11-132 1 1.694E+01 1 1.245E406 1 2.200E+00 t 81-113 1 1.32aE+04 1 2.451E*06 I 5.768E+07 I

..... .............. ..... .=-- .....11-134 1 9.212E*02 3 4.467E+05 1 2.799E-11 I

........===_ _ - - ....- _ - ==..............11-135 1 3.664E+n3 1 2.526E+06 1 1.786E*05 I 105-134 I 3.962E+05 1 6.863E+n9 I 5.803E+10 I

... .... .. =._ - - . . . . .

~

105-136 1 4.R3nE+04 1 1.502E*00 1 3.135E+09 I 1C5 137 I 5.488E+05 1 1.030E+10 I 8.187E+10 1 .

-- ......- .- __ ...- ------ ==

105-139 1 5.054E*02 1 3.500E+05 1 1.334E-22 I lPA-130 l 1.484E+00 1 1.061E+05 1 7.210E-07 I

- ..... . _.=--

194-140 1 5.600E+04 I 2.053E+07 I 3.835E+08 i

.................- -- --=.....-

194-141 1 1.568E-n1 1 4.172E+04 1 6.613E-45 I 194-142 1 3.976E-02 I 4.445E+A4 I 0.000E+00 I ILA-len I 5.054E+02 1 1.923E+07 1 6.460E+01 I

....................... .== .....- ..

ILA.142 1 1.030E+00 1 7.602E+05 1 2.751E-10 I

. _.- -- =....._ --- .. ...

ICE.141 1 2.772E+04 1 1.366E+07 1 6.899E+04 I

.- =-- ---

ICE.143 1 2.926E+02 1 2.312E+06 I 6.31TE+02 I

............................._..... = =

ICE-144 1 3.192E+06 i 6.946E+07 1 3.699E+06 I

.. _.._ ........_..= .- .

19R.141 1 1.400E+04 1 0.0nnE+00 1 2.365E+03 I IPR.144 1 4.78BE-02 1 1.837E+03 1 1.035E-52 1.

110-147 1 7.938E+03 I 8.400E+06 1 1.404E*03 1 lW.187 I 1.296E*01 1 2.360E+06 I 9.738E+04 I

............ __....= - _.. ..18-239 I 3.710E+02 1 1.706E+06 1 5.784E+01 I

.................-_=_ ____ ..= _ _.........

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m3 Others -m 2 mrem /yr per uCi/sec SOURCE PSEGODCM 3.0-27 Rev. O, 85/4/2

Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3

( R ].i o)*

Page 7 of 21: Dose Factors for Liver I 150TOPEI _l*ALATION I GROUND PlesEl G8S/C0W/filLKI IH-3 1 6.460E+02 1 0.000E+00 1 2.351E+03 I IE-14 1 5.306E*03 1 0.000E+00 I 7.94AE+09 I IW24 1 1.0;6E+04 1 1.194E+07 1 2.453E*07 I 10-32 1 1.124E+05 l 0.000E*00 1 1.499E+10 I Irp.51 1 0.000F+00 1 4.659E+04 1 0.000E*00 I

~

im.54 1 2334E+04 i 1.306E+09 6.205E+07 I I % 56 i 1.54K+00 1 9.035E+05 4 5.013E-02 I IFE-55 1 1.175F+04 1 0.000E+00 1 1.309E+08 I

. ........= .

IFF 54 1 2.352E*04 1 2.727E+00 1 6.234E+0A I Ir0.c4 1 1.219E+n) 1 3.011E*na 1 3.06?E+07 I ir0-64 I 8.01?E*03 1 2.152E+10 1 1.402E*00 1 INI-63 1 2.044r+04 1 0.00nE+00 l 3.43AE*09 1 ,

INI-65 1 2.042E-01 1 2.970E*05 I 6.312E-01 I IEU-64 1 1.076E+00 1 6.067E+05 1 2.951E+05 I 12N-65 1 6.250E+04 I 7.463E+09 I 3.029E+10 I 122-69 I 9.674E-02 1 ' 0.000E+00 I 7.521E-11 I IEP-83 I 0.000E+00 1 4.071E*03 1 0.000E+00 1 1P0-94 I 0.00K+00 1 2.026E+05~l 0.000E+00 1 100-85 1 0.000E+00 l' O.000E+00 1 0.000E+00 I 199-86 1 1.904E+05 I 8.984E+06 1 3.540E+10 I

.- _=...... ..

IDA-8A I 5.572E+02 1 3.307E+04 1 2.902E-44 1 IPB-99 I 3.206E+02 1 1.230E+05 I 5.43tE-52 I

....-= .-

158-99 I 0.00nE+00 1 2.16?E+04 1 0.00nE*no I

.. ..====

158-90 1 0.00K+00 1 0.000E*00 l 0.000E+00 1 ICD 91 1 0.00W+00 l 2.140E*06 I 0.00nE+0n i

.-- __ . .........--- =- ---.._

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m3 Others - m2 mrem /yr per uCi/sec SOURCE:PSEGODCM 3.0-28 Rev. O, 85/4/2

Table 3.2-2 PATHWAY DOSE FACTORS FOR 7':CTION 3.2.3 (Rg3g)*

Page 8 of 21: Dose Factors for Liver ,

I ISOTIPEI 11844T191 l Wluto PLNEl GRS/ COW /HILKI 19 92 1 0.000E*00 1 7.76AE+05 1 0.000E+00 1 Ih3h I 0.00hE+00 i 4.491E+03 1 0.00hbhi~i lY 91M I 0.000E+00 1 1.002E+05 1 0.00rT+00 1 lY 91 1 0.000E+00 1 1.073E+06 1 0.000E+00 I lY.9? I 0300E+00 1 13b4E+05 1 0.000E*00 'I

~

lY-93 1 h000E+00 l 1.052E*05 I 0.000E+00 i 17R-95 1 2.786E+04 1 2.446E+n8 1 2.630E+03 I 179 97 I 2.562E+01 I 2.960E+06 1 1.109E+00 I

........_ -- --- ._ . - ==-.........

IPG 95 1 6.426E+03 1 1.409E+n0 1 3.926E+05 I Irf) 99 1 1.652E*02 1 3.995E+46 1 3.309E+ng I ITC 99M i 2.884E-03 1 1.841E+05 l 9.01?E+01 I ITC-101 1 8.232E-05 1 2.034E+04 1 4.573E-59 I

.......... .... ____ ...- _=

...=

6330-1 0 3 1 0.000E+00 1 1.004E+08 1 0.000E+00 I IIPt)-105 1 0.000E+00 1 6.361E+05 1 0.000E+00 I 1110 186 1 0.000E+00 l 4.200E+08 1 0.000E+00 I IAG-110M I 7.224E*03 1 3.445E+09 I 4.481E+08 I ITE.125M i 1.9851E*03 1 1.55?E+06 I 8.01hE+67 I ITE-127M I 6.902E*03 I 9.165E*04 1 2.222E+08 i ITE-127 I 9.534E-01 1 2.994E+03 I 3.450E+03 I ITE-129M i 6.090E+03 1 1.972E+07 1 3.030E+08 I ITE-129 1 3372E-62 I~2 600E+04 1 1351E-09 I ITE5555El 5.h0?E*01 1 8 026E+06 1 2.163E+06 'I ITE-131 1 0.218E-03 1 2.919E+04 1 2.013E 12 I tTE-132 l 2.366E+02 1 4.223E+06 I 1.657E+07 I 61 13p 1 1.387E*04 1 5.511E*06 l 1.242E*07 I

.......=== _............................._.

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m3 Others -m 2 mrem /yr per uCi/sec S("lRCE PSEGODCM 3.0-29 Rev. O, 85/4/2 l l

)

i

Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R 1 3o)*

Page 9 of 21: Dose Factors for Liver

.. . . . . . . . . . . . = - . ...

I ISOTOPEI impi ATION I f,lmVNO PL#f f E#S/Cf&fillifi 11-131 1 4.43AE+04 I 1.721E+07 I 5.098E+09 I 11-132 1 3.542E*03 1 1.24EE+06 1 4.629E+00 I ll-133 4 1.918E+04 1 2.451E+06 I 8.399E+07 I 11-134 1 1.076E+03 1 4.467E+05 1 5.733E-11 I

... . 3 7.602E+03 1 2.526E+06 1 3.553E+06 I 11-139 105-134 1 7.020E+05 1 6.863E+09 l 1.082E+11 I 105-136 1 1.34SE+05 1 1.502E+08 I 9.219E+09 I 105-137 I' 6.118E+05 l 1.030E+10 I 9.583E+10 I ,

trS 130 1 7.812E+02 1 3.589E+05 1 2.169E-22 I IPA I 9.042E-04 1 1.061E+05 1 4.78EE-10 1

_ _-139 . -

IPA-140 1 5.600E*01 1 2.053E+07 1 3.835E+05 l 196-141 l 1.078E-04 1 4.172E+04 1 4.528E-48 I 194-142 1 3.3fl4E-05 1 4.445E+04 1 0.000E+00 I It A-140 1 2.00?E+02 1 1.923E+07 1 2.547E+01 1 ILA-142 1 3.766E-01 1 7.602E+05 1 1.010E-10 I ICE-141 1 1.666E+04 1 1.366E+07 1 4.207E+04 1 ICE.141 1 1.932E*02 1 2.312E+06 I 4.189E+05 I ire-144 1 1.211E+06 I 6.946E+07 1 1.914E+06 I IP#-143 I 5.236E*03 1 0.000E+00 I 8.844 02 I 199-144 1 1.848E-02 1 1.837E+03 1 4.006E-53 I 1 6 147 I 8.134E+03 I 8.400E+06 1 1.442E*03 I IW-187 8 9.016E+00 1 2.360E*06 I 6.772E+04-I INP-239 1 3.11RC+01 1 1.7A6E+56 1 5.17E+00 I i

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m 3 Others -m 2 mrem /yr per uCi/see SOURCE PSEGODCM 3.0-30 Rev. O, 85/4/2

Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R )*

Page 10 of 21: Dose Factors for Thyroid

............................... _ _ =.. ...

t ISOT0pEl INHALATION I GROLP@ PLANEl GRS/Oni/filLKI IH-3 1 6.468E+02 1 0.000E+00 1 2.353E*03 I

..........==-- - ... ...............

IC-14 1 5.304E+03 1 0.000E+00 1 7.940E*00 I

... - = - ...........---- - ..

INA-24 1 1.056E+04 1 1.194E+07 1 2.453E+07 I IP 53 0.000E bi I '55555E hi~l 0.ihbk hi I

"...I IER-51 1 5.34E+01 1 4.659E+n6 i 1.674E+05 I IMN-54 1 0.000E+09 1 1.386E+09 1 0.000E*00 I Im-56 1 0.000E*00 I 9.035E+05 1 0.00nE+00 1 Ikk$hh i 0.000E+00 I h.000E+iG I 0.000E+00 1 .

IFE-59 1 0.00nE*00 l 2.727E+09 1 0.000E+00 I 100-59 I 0.00nE+00 I 3.911E+08 1 0.000E+00 l

~

5C0-60 1 0.00nE+00 1 2.192E+10 1 0.000E+00 1 INT-63 1 0.000E+00 1 0.000E+00 1 0.000E*00 I INI.65 1 0.000E*00 1 2.970E+05 1 0.000E*00 1

=- - .-- ............... -.

100-64 1 0.000E+00 I 6.067E+05 1 0.000E+00 I 12W-45 1 0.000E+00 1 7.463E+09 1 0.000E+00 1 12N.69 f h b55 00 1 0.000E+00 I"0.000E+00 I idh5~i~iIhinE+0i t EIG3Ik5b3 1 0[hUbE be"I IkB4 1 'hIbihE+00 1 2.026E+05 I U$000E+00~i 19R-05 1 0.000E+00 1 0.000E*00 1 0.000E+00 I

~

IE06 1 0.000E+00 1 8.904E+06 I ".000 0 kit"I IEE'~l b.000EIb0 1 5$505 ni~l 0.000E+00 i I

t h 0E ~ I" b$hhhk hh I "..1.230E+0h i 0.000E+00 -

.............- ====. ...- -

158-99 1 0.00nE+00 1 2.162E+04 I 0.000E+00 I ISP 90 1 0.000E+00 1 0.0nnE*00 1 0.000E+00 I

.........- -- - --- == - ................

149-91 1 0.000E+00 1 2.144E+06 1 0.000E+00 I

..............= =................................

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m3 Others -m 2 mrem /yr per uCi/sec SOURCE:PSEGODCM 3.0-31 Rev. O, 85/4/2

Table 3.2-2 PATHWAY DOSE FACTORS.FOR SECTION 3.2.3 (Rg3g)*

Page 11 of 21: Dose Factors-for Thyroid I ISOT0FI INNaiATION l GDOUND PU WEl G8S/C0Wfillki 15D-92 1 0.000E+00 I 7.768E+05 1 0.000E+09 I

~

ly.9n t 0.005 E+00 1 4.491E+03 l 0.000E*00 I lY 91n 1 0.000E+00 1 1.002E*05 I 0.000E+00 I

, lY-91 1 0.000E+00 l 1.073E+06 1 0.000E*00 I tv-92 8 0.00nE+00 1 1.8n4E*05 1 0.0nnE*00 I l Y-9.5 1 0.000E+00 I.1.892E*05 l 0.000E+00 I 179-99 1 0.000E+00 1 2.446E+00 1 0.000E+00 1 -

129-97 1 0.000E+00 1 2.960E+06 1 0.000E+00 I 44 99 1 0.000E+00 I 1.409E+00 1 0.000E+00 I IMO-99 1 0.0n0E+00 1 3.995E+06 1 0.000E+00 I

~

ITE-99M I 0.000E+00 1 1.841E*05 1 0.000E+00 l

~

ITC-101 I 0.000E+00 l 2.034E+E4 1 0.000E+00 1 IDti-103 I 0.000E+00 1 1.004E+0B I 0.000E+00 I imL104 1 0.000E+00 1 6.363E+05 1 0.000E+00 I imj.in4 1 0.000E+00 1 4.200E* 00 1 0.000E+00 1 IAG-linn 1 0.000E+00 1 3.445E*09 I 0.000E+00 1 ITF-175M i 1$624E+03 1 1.552E+06 I 9.071E+07 1 ITE-127n i 4.872E+03 I 9.165E+04 1 1.935E*08 1 ITE-127 1 1.048E+00 1 2.994E+03 I 8.382E+03 I ITE-120M I 5.474E+03 1 1.972E+07 1 3.401E*06 I ITE-129 I 6.740F-02 1 2.600E+04 I 2.79'E-09 I

~

Ib131Mi 8.932E+01 I 0.026E+06 1 4.383E+06 I

~

ITE-131 1 1$582E-Oh I 2.919E+04 I 4.063E-32 I

_........=, _

. ==

ITE-132 1 2.786E*02 1 4.223E+06 I 2.445E+07 I it_13n I 1.9%bi6 I h311E*06 i 1.393E+09 I

........ -_ === . -- ..

• '-- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m 3 Others -

m2 mrem /yr per uCi/sec SOURCE:PSEGODCM 3.0-32 Rev. O, 85/4/2

Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (Rgg)*

Page 12 of 21: Dose Factors for Thyroid I ISOTOPEI letATl[M I GROND PLMEl GRS/ COW /MILKI

..... ...==_ - - -...............__..............

11 131 1 1.484E*07 I 1.721E+07 I 1.675E+12 i 11-132 I 1.694E+n5 1 1.24;E+04 I 2.170E+02 I 11-133 1 3.556E+06 1 2.451E+06 1 1.527E+10 I 11 134 1 4.452E+04 I 4.467E+05 1 1.337E.09 I 11-139 I 6.958E+05 1 2.526E+06 1 3.105E+07 I I 5 555 I~ bib 00E+00 l 6.863E+09 1 0.000E+00 I

.. ...- - .===- - ........ .......... .

105 136 1 0.000E+00 1 1.502E+08 I 0.000E+00 I 1CS-137 1 0.00nE+00 1 1.030E+10 1 0.000E+00 I.

1C5 138 I b.00nE+00 1 3.509E+h5 1 0.bh0E+00 'I

.............._ .___.- - .=

IBA.139 i 0.00nE+n0 1 1.041E*05 1 0.000E+00 I IBA.140

~ ........

1 0$hhhkIb0 5"_2$051E+07 i'O.000E+00 I 19A-141 1 0.000E+03 1 4.172E+04 1 0.000E+00 I 104-142 1 0.000E+00 I 4.445E+04 I 0.000E+08 I ILA-140 1 0.000E+00 1 1.923E+07 1 0.000E+00 I ILA.142 1 0.000E+00 1 7.6n2E+05 I 0.000E+00 I ICE-141 1 0.00nE+00 l 1.366E+07 1 0.000E+00 I trE-143 1 0.000E+00 1 2.312E+06 1 0.000E+00 I ICk554 I bIbh5k+00 1 6.956E+07 1 0.000E+be I .

IPR.143 1 0.000E*00 1 0.000E+00 l 0.000E+00 I IPR-144 1 0.000E+00 1 1.837E+03 1 0.000E+00 1

...........=== ...

lHD.147 1 0.00hE*00 1 8.408E+06 1 0.000E+00 I IW-187 1 0.00nE+00 1 2.360E+h6 1 0.00nE+00 1 iW-239 I 0.0h0E*00 1 1.706E*06 1 0.000E+00 I

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m3 Others -m 2 mrem /yr per uCi/sec SOURCE:PSEGODCM 3.0-33 Rev. O, 85/4/2

Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R 1 3o)*

Page 13 of 21: Dose Factors for Kidney

..- ._ _ .. ............- - =....

I ISOTOPEI !*4et ATION I EJ0tM PLe*El CAS/ COW!1ll.Kl lH.) I 6.466F+ 02 1 0.000E+0A I 2.353E+03 I IC.14 1 5.306E+03 1 0.000E+00 1 7.940E+00 I Im-24 1 1.056E+04 1 1.194E*07 1 2.453E+07 I IP-32 1 0.000E+00 1 0.000E+00 1 0.000E+00 I 109-51 1 1.323E+01 1 4.659E+06 1 3.657E*04 1 1 % 54 1 4.904E+03 1 1.306EIO9 I 1.375E+07 I 1%% i 1.10nE*00 1 9.035E+05 1 4.300E-02 1 IFE-55 1 0.000E+00 1 0.000E+00 1 0.000E+00 I IFE-59 1 0.000E+00 1 2.727E+00i 0.000E+00 I IEG-50 l 0.000E+00 1 3.011E+00 1 0.000E*00 1 IE0-60 I 0.000E+00 1 2.152E+10 1 0.000E+00 I INI-63 1 0.000E+00 1 0.000E+00 1 0.000E+00 I INI-6h I 0.000E+00 1 2.00E+05 1 0.0iOE+00i IEll-64 1 3.93E*00 1 6.067E+05 1 4.990E*05 1 12N-65 1 3.240E+04 I 7.463E*00 1 1.469E+10 1 12N-69 I 4.010F-02 1 0.000E*00 1 3.125E-11 I tP8-03 1 0.000E+00 1 4.071E+03 1 0.000E*00 I iP8-04 1 0.000E*00 1 2.026E+05 1 0.000E*00 I 198-05 l 0.000E*00 1 0.000E+00 1 0.000E+00 I

~

I'1506 I EIhh0E+00I'~0.904EO6 I 1 0.000E+00 I

........ .--= .--

199-00 1 0.000E+00 1 3.307E+04 1 0.000E+00 I

~~

i99-00 l 0.000E+00 i 1.230E*05 1 0.00nE+00 I ICD-09 I 0.000E*00 1 2.162E+04 1 0.000E*00 I ICD-90 1 0.000E+00 1 0.000E+00 1 0.000E*00 I Ico 91 1 0.000E+00 1 2.140E+06 1 0.000E*00 I

.....=_____ - ..

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m3 2

Others -m mrem /yr per uCi/sec SOURCE PSEGODCM 3.0-34 Rev. O, 85/4/2

15a1>1e 3. 2 -2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R ].i o)*

Page 14 of 21: Dose Factors for Kidney

............ ........=__ --

I 190TOPEI IHLATION I G80M PLANEl GRS/C0lutilLKl 19R-92 1 0.000E+n0 I 7.7e9E+05 1 0.000E+00 I

---=.......

lY.90 1 0.000E+n0 1 4.491E+03 1 0.000E+00 1 Ih.91n 1 0.006E+00 1 1.002E65 1 0.000E hh I Ih595 ~ i 0.600kIhh'~l 1.073E+06 1 0.000E5hh~I IhI*h"I b.000E*00 i 1.504E05 1 0.00bi+5hI Ih.93 I'~h.0bOE+00 l 1.052E I O5 l 0.0bnE+55 I I?R 95 I 3.100E+04 1 2.446E+00 1 2.843E+03 I

.. .....=_ ........._ .....

12R.97 1 2.590E+01 1 2.96AE+06 1 1.110E+00 I ,

.....................=_ -- ...... .- --

IMB 95 I 4.710E+03 1 1.409E+08 1 2.814E*05 I

............ ..._ ........- -- -=

IMO 99 I 2.646E+02 I 3.99;E*06 I 4.944E+00 I

=......_ .........-

ITC 99M i 3.100E-02 l 1.041E+05 I 9.700E+02 I ITCI5b5 I 9.7EE.04 I h.034E+04 I 5.437E-Sh"I IRU.103 1 4.242E+03 1 1.004E+08 1 2.671E+04 I IRU.105 1 0.900E-01 1 6.363E+05 l 9.420E-02 1 IRO.106 1 1.064E*05 1 4.200E*00 1 3.500E+B5 I IAG-110M i 1.092E+04 1 3.445E+09 I 6.410E+08 i

........................... .= - = =- ...........

ITE.1?EN I 0.00nE+00 1 1.552E*n6 1 0.000E*00 I ITE-127M i 3.752E+04 1 9.165E+04 1 1.649E+09 I ITE.127 I 4.850E+00 l 2.994E+03 I 2.513E*04 I ITE.129I11 3.178E*04 1 1.972E+07 1 2.214E*09 1.

ITE-1? I 1.75aE-01 1 2.600E+nd 1 0.315E-09 I ITE-131M i 2.646E*n2 I 8.026E+06 1 1.40AE+07 I

.........==- -- ........................

ITE.131 1 3.99hE-02 I 2.919E*04 l 1.394E-11 I ITE-132 1 1.035E+03 1 4.223E*06 1 1.036E*09 I 11-130 1 1.92eE+04 I 5.511E*06 1 1.364E+07 i

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m 3 ]

-m 2 mrem /yr per uCi/sec Others SOURCE:PSEGODCM 3.0-35 Rev. O, 85/4/2

N Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.' (R.jo)*

l Page 16 of 21: Dose Factors for Lung 1 ISOTOPEI IHLATION I CJOUND PLNEl GRS/E0hl/tilLKI lH-3 1 6.468E+02 1 0.000E+00 1 2.353E+03 I

................= -- .....== .............

IC-14 1 5.306E*03 1 0.00hE*00 I 7.940E+R0 I

. . . . . . . . . . . . . . . . . . . . . . . = -_

INA.24 1 1.056E+04 1 1.194E+07 1 2.453E+07 I IP 12 1 0.000E+00.1 0.000E+00 1 0.000E*00 I Ire.51 1 1.?g4E+04 I 4.6ME*06 1 3.25?E*05 I

= =====..............

1 % 54 1 9.996E+05 1 1.306E*09 I 0.000E+00 I 1556 1 1.253E+04 1 9.035E+05 1 0.000E+00 I IFE-55 I 0.694E+nd 1 0.000E+00 1 6.709E+07 I .

......................=__ _ --

Irl'.59 I 1.015E+06 I 2.727E+68 I 1.042E+08 1

.................._ = - - - .........

100-59 I 7.77AE+05 I 3.811E+00 1 0.000E+00 1

= ___ -- ........ ..

ICD-60 1 4.508E+06 1 2.152E+10 1 0.000E*00 I INI-63 I 2.006E+05 I 0.000E+00 l 0.000E+00 I

...........................=_-== __ ..............

INI-65 1 0.120E*03 1 2.970E+05 1 0.000E+00 I

..................._- -- __ =.....................

100-64 I 9.296E+03 1 6.06?E+05 I 0.000E+00 I 12W-65 1 6.469E+05 1 7.461E+00 1 0.000E+00 I 12N-69 1 1.470E+03 1 0.000E+00 1 0.000E*00 I 19R-83 1 0.000E+00 1 4.971E+03 1 0.000E+00 I Ik0i i 6.000E+00 1 5 5h56Eh5"..I0.060kIbi~i

....=- -_-=_= _ . .......

19R-05 1 0.00K+00 1 0.000E+00 l 0.000E+00 I 109-96 I 0.000E+00 1 8.994E+06 1 0.000E+00 t

.......... _ ________=............................

IDB.8R I 0.000E*00 I 3.307E+04 I 0.000E*00 I

..............= ............................

IRB-69 1 0.000E+00 1 1.230E+05 1 0.000E+00 I 19-89 I 2.030E*06 l 2.162E+04 1 0.000E+00 I 19 90 1 1.124E+07 I 0.000E*00 1 0.000E+00 I 19 91 1 5.26aE+nd i 2.149E*06 I 0.000E*00 t

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m 3

-m 2 mrem /yr per uCi/sec Others SOURCE:PSEGODCM 3.0-37 Rev. O, 85/4/2

Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R..23o)*

Page 17 of 21: Dose Factors for Lung t 191TF1 twW ATION I G20 Leo PLANEl CSS /E0W/MILXI

................. ...=_-

ICs.92 1 2.300E+04 1 7.768E+05 1 0.000E+00 1 UY.90 t bib 05 1 4.491EE3 I i.iO0E+00 I lY.91M i 2.70+E*03 1 1.002E+05 I 0.000E+00 l IV.91 1 2.450E+06 1 1.073E+06 1 0.00nE*00 1

- z. .=-

IY 97 1 2.45aE+04 1 1.004E+05 1 0.000E+00 I

....- .- ..-- ===.. ,

lY.93 1 7.644E+04 1 1.052E+05 1 0.000E*00 1 170-95 l 1.750E*06 1 2.446E+00 1 0.00nE+00 I 129 97 1 1.103E*05 1 2.9A0E+06 1 0.000E+00 I 14 95 1 4.789F+05 1 1.409E+00 1 0.000E*00 I IMn.99 I 1.140E*05 I 3.905E*06 1 0.00nE+00 I ITE.9 M I 8.106E+02 1 1.841E*05 I 4.713E*01 1 ITE-101 1 5.03RE+02 1 2.034E+04 1 2.494E-59 I 190 101 1 5.516E+05 1 1.084E+00 l 0.000E+00 I 194 105 l 1.40E*04 1 6.363E+05 I 0.000E+00 I 1P0 1n4 1 1.196E+07 1 4.200E+00 1 0.000E+00 I l#-110M i 3.669E*06 1 3.445E+09 1 0.000E*00 I ITE.125M I 4.466E*05 1 1.552E+06 1 0.000E+00 I ITF.127M I 1.312E*06 I 9.165E+04 1 0.000E+00 I

.... ==.. . . ........

ITE-127 1 1.035E*04 I 2.994E+03 1 0.000E+00 I ITE-129N I 1.690E+06 1 1.972E+0 / I 0.000E+00 I

..- - .- _ _=

ITE-129 1 2.9%E+03 1 2.600E+04 1 0.000E+00 I ITF-131M I 1.900E*05 1 8.026E+06 1 0.00nE*00 I ITE-131 1 2.050E+03 1 2.919F+04 I 0.000E+00 I ITE-139 i 3[402E*05 I 4.223E+06 I n.00nE+00 I

=........... .

II.136 i 0 00F+00 1 5.511E*06 1 0.00nE*00 I

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m3 Others -m 2 mrem /yr per uCi/sec SOURCE:PSEGODCM 3.0-38 Rev. O, 85/4/2

i Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (Ri$g)*

Page 18 of 21: Dose Factors for Lung I ISOTOPEl INHALATION I C#0lDO PLANEl GRS/CO M ILVI

................. ..........= ... _-....11-131 1 0.00DE+0h i 1.721E+07 1 0.000E+00 t

..........................___ -- _=

11 112 1 0.000E+no i 1.245E+06 1 0.000E+00 I 11 113 1 0.000E+00 1 2.451E+n6 1 0.000E+00 1 11-134 1 0.00hE+00 1 4.467 E+A5 1 0.00DE*00 I

.....-_=--- --- ....................

it.115 1 0.00nE+00 1 2.52AE+06 I 0.00hE*00 I

.....................=--- .- _ ....

10S-134 I 7.96eE+04 1 6.861E+09 1 1.142E+10 1

. . . . . . . . . . . . . . . . . . . ............- ===-

105-136 1 1.176E+04 1 1.502E+09 1 7.51?E+08 1 105-137 I 7.12eE+04 1 1.030E+10 1 1.041E+10 I .

ICS-138 I 6.53AE+01 l 3.599E+05 1 1.609E-23 I

..............=== -

IAA-119 I 5.050E+03 1 1.061E*05 1 2.901E.10 I

. . . . . . . . . . . . - _ =........ _ _ - -.......

194-140 1 1.59eE*06 1 2.053E*07 1 2.355E*05 I IBA-141 1 2.960E+03 1 4.172E+04 I 2.754E-48 i

...............- __ ...= ....- ===....

IBA-la? I 1.554E*03 1 4.44;E+04 1 0.000E+00 I ,

..............._ __ =...........= _ ... ..

ILA-140 1 1.600E+05 1 1.921E*07 1 0.000E+00 I ILA 142 I 8.219E+03 i 7.602E+05 1 0.000E+00 1 ICE.141 1 5.166E*05 1 1.366E+07 1 0.000E+00 I

......... = -- _.....

ICE.141 1 1.162E+05 1 2.31?E*06 1 0.00nE+00 I ICE-144 I 9.04?E+06 I 6.946E+07 1 0.00nE+00 I IPR.143 1 4.326E+05 1 0.000E+00 I 8.000E+00 I

IPR-144 1 1.610E+03 1 1.837E+03 1 0.000E*00 I i ...............=- ..............................

IND.147 1 3.220E+ns I 8.408E+06 1 0.000E*00 I W-187 1 3.962E+04 I 2.360E+06 I 0.000E+00 I INP-2% 1 5.95hE+n4 1 1.706E+86 1 0.00AE*00 I 1

i

• -- See Note, page 3.0-43 l

l Units: Inhalation - mrem /yr per uCi/m3 Others -m 2 mrem /yr per uCi/sec l

SOURCE PSEGODCM 3.0-39 Rev. O, 85/4/2

1 Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R..1]o)*

Page 19 of 21: Dose Factors for GI-LLI

..........= .... ........... .. .

I 140TflPFl ]MATION l GD0leNO PU$El EpS/E0W/1911.Kl 4n-3 I 6.469E+02 1 0.0nnF+00. I 2.353E+03 1

__===.........-_ -_ ..

tr 14 1 5.10eE+A3 1 0.000E+00 1 7.940E+06 I INA 24 l 1,056F+04 1 1.194E+07 I 2.493E+07 I

......._ ==. ..

19 32 e 1.610E*04 I 0.000E+00 1 3.448E+09 I

...........= -- . ..........

iro.51 8 3.970F+02 I 4.659E*06 I 7.479E+06 i

• 44 8 7.94E*03 1 1.3A6E+09 1 2.270E*07 1 INN.$4 1 7.16@[+04 l 9,Q35[+Q9 l 4,$54[+$$ l IFF-55 1 1.n9'E+03 1 0.000E+00 1 1.763E+R7 I

...._ .___ ..-- = ..

ire-59 I 2.47AE*04 1 2.727E+08 I 2.979E+00 t iro.50 I 1.113E*04 1 3.811E+08 I 9.623E+07 I 100-60 I 3.192E+04 1 2.152E+10 1 3.337E+06 i INI-63 I 2.422E+03 I Q.000E+00 1 1.709E+06 I INl.6C I 5.012F+04 1 2.970E+05 1 4.805E+01 I

... ......._ ..... . =.....

Ir0-64 1 1.498F+04 1 6.067E*05 1 6.056E*06 I 17A64 1 5.138F+04 1 7.463E*00 1 2.559E+10 t 17*69 I 1.322E*04 I 0.000E*00 I 6.133E-09 I

. . . . .-- .. - ..-=-- ...

100-83 I 0.000E+04 I 4.871E+03 I 0.000E+00 I IM-84 1 0.n00E+00 1 2.n26E+05 I 0.00nE+00 I 190-89 1 0.00nr+00 1 0.On0E+00 1 0.000E+00 I 199-86 1 3.030E*03 1 6.994E+06 I 9.059E+99 i

.......- - ...._ _ - _=............

Im-08 I 3.3A9E+n2 1 3.307E+04 1 2.904E-44 I

................. ..._ =-- ..

1G9-85 I 6.A18E*01 I 1.230E+05 1 1.050E-52 I

......= .. .................

tco A0 I 6. W F+04 1 2.162E+04 1 4.lleE+06 I tcs.9n i 1.310E*05 1 0.000E+00 1 2.415E*09 I

................. .=-- -

.... ==

IGP 91 I 7.336E+04 1 2.140E*06 1 5.115E+05 I

.....=_ ==_ _............ - ......

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m 3 Others -

m2 mrem /yr per uCi/sec SOURCE:PSEGODCM 3.0-40 Rev. O, 85/4/2

Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (R.jo)*

l Page 20 of 21: Dose Factors for GI-LLI I IctiTOPEI INHAl.ATION i GROU@ PUWEl GRS/C0hl/Mitki Ice 92 1 1.400E+PS I 7.769E+05 I 7.962E*01 I lY.90 1 1.040E+ns i 4.491E+03 1 1.496E+06 I lY-91M i 2.352E+03 1 1.002E+05 1 2.985E-15 I lY-91 1 7.02RE*04 1 1.073E*06 I 8.354E*06 1 iY 92 I 1.2e6E*05 I 1.004E+05 i 1.631E+01 I IY 91 1 1.666E+AS l- 1.852E+05 1 2.826E+94 I 179 95 1 2.170E+04 1 2.446E+08 l 1.314E+66 I

...=- .......................... ..........

179 97 1 1.400E+n5 1 2.960E*66 1 7.073E+04 I.

(N@.9$ j 1.267E*04 1 1.89E+08 1 3.314E+08 I IM0 99 I 4.872E+04 1 3.995E*06 I 1.090E+08 l ITE.99n i 2.030E+03 1 1.041E+05 1 2.619E+04 1 ITC-101 1 8.442E*02 1 2.034E+n4 : 7.771E-57 I

_ - = ......

1R18-103 1 1.610E+04 1 1.084E+08 1 1.678E+05 1 1R0 105 1 4.844E*04 1 6.363E*05 I 5.096E+96 I IRU-106 1 1.639E+05 1 4.20RE+08 1 2.299E+96 1 -

IAG-110M i 3.304E*04 1 3.445E+09 1 2.324E+10 I

............................- .. = _ ......

ITE.125M i 1.291E+nd i 1.552E+06 1 1.143E+A6 I

... - - ____...................===- _=.....

ITE-127M i 2.73r.(+04 I 9.16SE+04 1 2.703E*00 I ITE-127 1 2.436E*04 1 2.994E+03 1 2.162E+R5 I ITE-129M i 6.902E+04 1 1.972E+07 1 5.287E+08 I ITE.129 1 2.632E+04 1 2.600E+04 1 2.6?nE.07 I

.=__ - ..... ...................................

ITE-131N I 1.191E+05 I 8.026E+06 1 3.640E+07 I ITF-131 I 8.219E+01 1 2.919E+04 1 2.202E-30 I ITF-132 I 4.410E+n4 1 4.223E*06 1 6.130E+07 I il-lin i 1.98eE*01 1 5.511E*D6 1 2.66tE+n6 I

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m 3 Others -m 2 mrem /yr per uCi/sec SOURCE:PSEGODCM 3.0-41 Rev. O, 85/4/2

Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3

( R ].i o)*

Page 21 of 21: Dose Factors for GI-LLI I IW0 ret twMATION I rJ0 Leo PL ANEl Ess/C0ivttitKI 11-131 1 1.050E+03 1 1.791E*07 1 1.820E*00-1 II 137 i 1.904E+03 1 1.244F+06 1 3.750E+00 1 Il-131 I 2.15AE*03 1 2.451E+06 l 1.421F*07 I 11 134 1 1.2A9E+n3 1 4.467E*05 1 5.927E-11 I iI.135 1 1.034E*03 1 2.526E+06 1 1.206E+09 I

...........= =- - .._

irs-134 1 1. 334E+0.1 1 6.863E+09 I 2.940E+00 I irs-134 1 1.42AE+03 1 1.502E.00 l 1.400E+09 i 105-137 1 1.334E*03 1 1.030E+10 1 2.996E*00 I .

~

E4-13A I 0.764F+02 1 ' ).589E+09 1 3.4AAE.22 I 19-139 I 5.09AE*04 l 1.061E+05 1 4.972F-09 1 IM-140 1 3.016E+04 1 2.093E*07 I 9.41AE+07 I IM-141 1 4.74AE*03 1 4.172E+04 I 8.075E-44 I IFe-149 I 6.93nF*02 1 4.445E+04 1 0.000E*00 I

.--= ....... ..- - ......

11A.len 1 0.404E+ne 1 1.923E+07 1 2.991E+05 I ItA-147 1 5.950E+04 I 7.602E+09 1 1.716E-05 I irr.14I I 2.156E+04 1 1.366E+07 1 2.174E+07 I ICF-lai I 4.970F+04 1 2.317E+06 1 2.444F+06 I ICE-144 i 1.484E*05 l 6.944E*07 1 2.123E*00 1 IP9-141 I 3.724E*04 1 0.000E+00 1 1.240E+46 1 l

108-144 1 4.2A4E+03 1 1.037E+03 1 1.8A3E.48 I lNO 147 l },{22f+$4 l $,40$[406 l 9,])7[+Q$ j tu-107 1 3.654F+04 I 2.3A0F+06 1 3.979F+06 I l i

i+#.239 1 2.492E*04 1 1.706E*06 i 1.496E+A4 I l 1

1

• -- See Note, page 3.0-43 Units: Inhalation - mrem /yr per uCi/m3 Others -

m2 mrem /yr per uCi/sec SOURCE:PSEGODCM 3.0-42 Rev. O, 85/4/2 1

I L. j

NOTE: The R gjo values of Table 3.2-2 were calculated according to the methods of Ref. 6, Section 5.3, for the pathways and. age group of the designated Maximum Exposed Indi-vidual. The designation of the Maximum Exposed Individual is explained in the Notes to Tables 3.2-3 and 3.2-4.

The values used for the various parameters required for the calculations, and the origins of those values, are given below in Table 3.2-5.

SOURCE PSEGODCM 3.0-43 Rev. O, 85/4/2

Table 3.2-3 ,

CONTROLLING RECEPTORS, LOCATIONS, AND PATHWAYS SECTOR (MILES / METERS) PATHWAYS 0 AGE GROUP N +'I ---

NNE 5.0 / 8,000 Vegetation, Child Grass / Cow / Milk I 4.5 / 7,200 Vegetation Child NE I Child ENE 3.4 / 5,500 Vegetation I 3.3 / 5,300 E --- Child ESE +'I ---

SE +'I ---

SSE +'I ---

I 4.2 / 6,800 Child S Vegetation ,

SSW I 5.0 / 8,000 Vegetation Child SW I 4.3 / 6,900 Vegetation Child I 4.4 / 7,100 WSW Vegetation Child W 4.9 / 7,900 Grass / Cow / Milk Infant WNW 3.4 / 5,500 Vegetation Child NW I 4.0 / 6,400 Child Vegetation

• • 5.0 / 8,000 Infant Grass / Cow / Milk NNW I 4.3 / 6,900 Vegetation Child

• -- S e e ' n o t e on following page for the method of choice of these controlling receptors.

@ -- Listed pathways are in addition to inhalation and ground plane exposure.

+ -- This sector is uninhabited within 5 miles of the Station.

1. -- If a cow were located at 5.0 miles (8,000 meters) in this sector, an infant consuming its milk would receive a greater total radiation dose than would the real receptor listed.

• * - This hypochetical infant exposed to the Grass / Cow / Milk pathway represents the Maximum Exposed Individual for the Site.

SOURCE: PSEGODCM 3.0-44 Rev. O, 85/4/2

Note: The controlling receptor in each sector was identified in the following way. Receptor locations and associated pathways were obtained from Table 2.1-8 of Ref. 3, as updated by Appendix F of Ref. 7. A child was assumed at each location, except that where a milk cow was listed, an infant was also assumed. In addition, as a safeguard against underestimation of dose to people just beyond the 5-mile zone, a hypothetical grass-cow-milk-infant pathway was assumed at 5 miles from the site in each sector which does not have an actual milk pathway (see Ref. 6, Section 5.3.1).

Annual. average X/O for each receptor was obtained by interpolation of values in Table 2'.3-31 of Ref.

2. Annual average D/O values for each receptor were obtained by interpolation of values in Table 2.3-33 of Ref. 2. Expected annual releases of each nuclide were taken from Table 3.5-22 of Ref. 3.

The pathway dose factors given below in Tables 4.3-1 and 4.3-2 were then used in the methodology of Section 3.2.3 of this Manual to compute estimated annual doses to each candidate receptor for the real pathways existing at that location. The controlling receptor for each sector was then chosen as the candidate receptor with the highest estimated total annual dose of any receptor in the given sector.

SOURCE PSEGODCM 3.0-45 Rev. O, 85/4/2

Table 3.2-4 ATMOSPHERIC DISPERSION PARAMETERS FOR CONTROLLING RECEPTOR LOCATIONS

• SECTOR X/O D/Q DISTANCE (MILES / METERS)

+

N ---

NNE 7.6 E-08 2.0 E-10 5.0 / 8,000 NE 8.8 E-08 2.2 E-10 4.5 / 7,200 ENE 9.4 E-08 2.3 E-10 3.4 / 5,500 E 9.3 E-08 2.2 E-10 3.3 / 5,300 ESE * ---

+

SE ---

l SSE + ---

l l

S 9.6 E-08 3.3 E-10 4.2 / 6,800~

SSW 6.8 E-lO 2.2 E-10 5.0 / 8,000 l SW 9.5 E-08 2.9 E-10 4.3 / 6,900 W5W 7.6 E-08 2.7 E-10 4.4 / 7,100 W 7.4 E-06 3.0 E-10 4.9 / 7,900 WNW l.4 E-07 7.0 E-10 3.4 / 5,500 NW l.3 E-07 6.5 E-10 4.0 / 6,400 NW # 9.9 E-03 4. 4 E--10 5.0 / 8,000 NNW 8.1 E-08 3.1 E-10 4.3 / 6,900

• -- Annual a ve ra ge rela tive dispersion and deposition values for the receptor locations in Table 3.2-3. (All receptors g

are real people, except as noted.) Values were obtained

( by in te rpola tion in Tables 2.3-31 and 2.3-33 of Ref. 2.

As a result of the analysis described in the Note to Table 3.2-3 of this Manual, the Maximum Exposed Individual for the Station was identified as a hypothetical infant consuming the milk of a cow pas tured a t 5.0 miles in the NW sector.

Therefore the site X/Q' and D/Q' (Section 3.2.3) are those from this Table for tha t location. [The real receptor with the highest exposure is an infant consuming the milk of a cow pastured a t 4.9 miles in the W sector.]

+ -- This sector is uninhabited within 5 miles of the S ta tion .

8 -- T hi s hypo the tica l infant is the Maximum Exposed Individual for the Site.

SOURCE:PSEGODCM 3.0-46 Rev. O, 85/4/2

l Table 3.2-5 PARAMETERS USED IN DOSE FACTOR CALCULATIONS Page 1 of 4 l

,, Origin of Value Table in Section of Parameter Value R.G. 1.109 NUREG-0133

• • • For P.***

1 1

i l

1 DFA Each radionuclide E-9 i

., BR 3700 m3 /yr E-5

{_

• • • For R g (Inhalation)***

I BR

Each' age. group E-5 DFA Each age group, nuclide E-9 and I i

and_ organ E-10

• • • For Ri (Ground Plane) ***

SF 0.7 E-15 DFG Each radionuclide E-6 i

(Note 4)

x l- t. 4.73 E+08 sec 5.3.1.2 i

! v.

l I

i l

SOURCE:PSEGODCM 3.0-47 Rev. O, 85/4/2 i

~

_ _ . _ _ _ _ _ _ _ _ _ _ _ _ _ _ ___.a

s Table 3.2-5 I^' PARAMETERS USED IN DOSE FACTOR CALCULATIONS Page 2 of 4 Origin of Value Table in Section of Parameter Value E.G. 1.109 NUREG-0133 f

I

• • • For R (Vegetation)***

i 1

r Each element type E-1 l

I 2

Yy 2.0 kg/m E-15

-1 kw 5.73 E-7 sec -

5.3.1.3 DFL Each age group, organ, E-13 and i

and nuclide E-14 UL Each age group E-5 fg 1.0 5.3.1.5 l t 8.6 E+04 sec E-15 n

U,8 Each age group E-5 f 0.76 5.3.1.5 g

t 5.18 E+06 sec E--15 h

H 8.1 gm/m 3 *** Note 1***

= fj

• • • For R (G ras s/ Cow / Milk ) * *

• i i

QF ; 50 kg/ day E-3 U Each; age group E-5 ap kw 5.73 E-07 sec -1 5.3.1.3 F Each element E-1

, m l

SOURCE PSEGODCM 3.0-48 Rev. O, 85/4/2

l Table 3.2-5 PARAMETERS USED IN DOSE FACTOR CALCULATIONS Page 3 of 4 Origin of Value Table in Section of Parameter _

Value R.G. 1.109 NUREG-0133 r Each element type E-15 tg 5.18 E+06 see E-15 j H 8.1 gm/m 3 *** Note 1***

DFL Each age group, organ, E-13 and i

and nuclide E-14 Y

p 0.44 kg/m2 *** Note 2***

Y, 2.0 kg/m E-15 tg 1.73 E+05 sec E-15 f 1.0 5.3.1.2 p

f, 1.0 5.3.1.2 I

• • • For R (G ras s/ Cow / Meat ) * *

• i l *** Note 3*** l l

l Op 50 kg/ day E-3 l U Each age group E-5 ap F Each element E-1 f

r Each element type E-15 tg 5.18 E+06 sec E-15 I H 8.1 gm/m 3 *** Note 1***

DFL Each age group, organ, E-13 and I i

and nuclide E-14 '

Y p 0.44 kg/m *** Note 2***

SOULCE PSEGODCM 3.0-49 Rev. O, 85/4/2

s. .

.. -__-___ )

Table 3.2-5 PARAMETERS USED IN DOSE FACTOR CALCULATIONS Page 4 of 4 Origin of Value Table in Section of Parameter Value R.G. 1.109 NUREG-0133 Y, 2.0 kg/m2 E-15 t 1.73'E+05 sec E-15 f

f 1.0 5.3.1.2 p

f, 1.0 5.3.1.2 l w 5.73 E-07 sec-1 -

5.3.1.3 l Notes

1. Site-specific annual average absolute humidity, from Ref.

3, Section 2.1.3.4.

2. Site specific areal productivity of pasture feed grass, from Ref. 3, Section 2.1.3.4.

3. No evidence was found in any land use or demographic information that animals are kept for meat within 5 miles of the Station.

These values are included for reference only, should the need for them arise.

4. The " Total Body" dose factors from the referenced table were applied to all organs.

i-SOURCE:PSEGODCM 3.0-50 Rev. O, 85/4/2

3.3 METEOROLOGICAL MODEL The dose calculation methods for gaseous effluents described in Section 3.2 require the use of annual average relative dispersion (X/Q) and relative deposition (D/0) parameters.

When new or revised values of these parameters must be computed, the method detailed in Section 2.3.5 of the FSAR (Ref. 2) will be used. All release points are treated as ground level.

The referenced method may be described generally as a ground-level, sector-averaged, straight-line Gaussian model, with wake correction (using an area of 3819 m2). It is based on Regulatory Guide 1.111, Revision 1 (Ref. 5).

i SOURCE:PSEGODCM 3.0-51 Rev. O, 85/4/2 l

1

3.4 DEFINITIONS OF GASEOUS EFFLUENTS TERMS Section of I Term Definition Initial Use ay = the administrative allocation factor (3.1.1) for vent v [unitiess], which is the fraction of the station site boundary dose rate limit which is assigned to vent v.

D b

= the site boundary air dose due to beta (3.2.2) emissions from noble gas radionuclides

[ mrad]. ,

D g

= the site boundary air dose due to gamma (3.2.2) emissions from noble gas radionuclides

[ mrad].

D mp~= dose to organ o of a Member of the (3.2.3)

Public, from radioiodines, tritium, and radionuclides in particulate form with half-lives greater than 8 days [ mrem].

D/O' = the annual average relative deposition (3.2.3) at the location of the Maximum Exposed l Individual [m-23, Fy = the expected flow rate in vent v (3.1.1)

[cc/sec].

K = total body dose factor for gamma (3.1.1) i emissions from noble gas radionuclide i

[ mrem /yr per uCi/m3 ], from Table 3.1-1.

SOURCE PSEGODCM 3.0-52 Rev. O, 85/4/2

Section of Term Definition Initial Use L

t.

= skin dose factor for beta emissions (3 .1.1 )

from noble gas radionuclide i

[ mrem /yr per uCi/m3 ], from Table 3.1-1.

M i

= air dose factor for gamma emissions (3.1.1) from noble gas radionuclide i

[ mrad /yr per uCi/m3], from Table 3.1-1.

N i

= air dose factor for beta emissions from (3.2.2) noble gas radionuclide i

[ mrad /yr per uCi/m 3], from Table 3.,1-1.

P io

= dose parameter for radionuclide i and (3.2.1.b) organ o, for inhalation, from Table 3.2-1 [ mrem /yr per uCi/m3 3, bi = 'the release rate of noble gas (3.2.1.a) radionuclide i as determined from the concentration measured in the analysis of the appropriate sample required by the Technical Specification Table 4.11-2 [uCi/sec].

b'=

i the release rate of non-noble gas (3.2.1.b) radionuclide i as determined from the l concentration measured in the analysis I of'the appropriate sample required by the Technical Specification Table 4.11-2 [uci/sec].

c

_ SOURCE:PSEGODCM 3.0-53 Rev. O, 85/4/2 l l

Section of Term Definition Initial Use i

= cumulative release of noble gas (3.2.2) radionuclide i over the period of interest [uCi].

b'=

i cumulative release of non-noble gas (3.2.3) radionuclide i over the period of interest [uci].

i l

R ijo = dose factor for organ o due to (3.2.3) radionuclide i and pathway j, fr'om Table 3.2-2 [ mrem /yr per uCi/m3 , o r, m2 - mrem /yr per uCi/sec].

Sy = the normal radiation monitor setpoint (3.1.1) for vent v [uci/cc].

Sy' = the conservative radiation monitor (3 .1. 2 )

setpoint for vent v, assuming all noble gas is Kr-89 [uci/cc].

S, y = the normal candidate setpoint for vent (3.1.1) v, based upon the skin dose rate limit of 3000 mrem /yr [uci/cc].

Sy ,' = the conservative candidate setpoint for (3.1.2) vent v, based upon the skin dose rate limit of 3000 mrem /yr, and assuming all noble gas is Kr-89 [uci/cc].

S vt

= the normal candidate setpoint for vent (3.1.1) v, based upon the total body dose rate limit of 500 mrem /yr [uci/cc].

SOURCE PSEGODCM 3.0-54 Rev. O, 85/4/2

- . , _ _ . . _ _ . - - -. - - 2. . - - - . . -

Section of Term Definition Initial Use Sy '

= the conservative candida te setpoint for (3.1.2) vent v, based upon the total body dose rate limit of 500 mrem /yr, and assuming all noble gas is Kr-89 [uci/cc].

SF = the safety factor; a conservative factor (3.1.1) used to compensa te for sta tistical fluctuations and errors of measurements.

W = rela tive. concentra tion or rela tive (3.2.3) ij' deposition for the Maximum Exposed Individual, as appropriate for exposure pathway j and radionuclide i. Its value is X/Q' or D/Q' , as appropria te.

X iy = the measured concentration of noble gas (3.1.1) radionuclide i in the last grab sample analyzed for vent v [uci/cc].

X/O = the' highest annual average rela tive (3.1.1) concentra tion at the site boundary in any sector [sec/m 3]. For post-release calculations, the actual site boundary X/Q in the af fected sector f or the ,

period of the release may be substituted.

X/Q' = the annual average relative (3.2.3) concentra tion a t the loca tion of the Maximum Exposed Individual [sec/m 33, SOURCE:PSEGODCM 3.0-55 Rev. O, 85/4/2

c.

l 2

Section 4.0 l SPECIAL DOSE CALCULATIONS Sections 2.0 and 3.0 described calculations which are made in i connection with each effluent release. In addition to these calculations, the Technical Specifications (Reference 1) require or' imply that certain other types of dose calculations shall be specified in the ODCM. These special dose calculations are described in the present section. i 4.1 ' NECESSITY OF OPERATING EFFLUENT TREATMENT SYSTEMS 4.1.1 Liquid Radwaste Treatment System Technical Specification 3.ll.l.3 reads:

The LIQUID RADWASTE TREATMENT SYSTEM shall be used to reduce the radioactive materials in liquid wastes

, prior to their discharge when the projected doses due to the liquid effluent, from each reactor unit, to UNRESTRICTED AREAS'would exceed 0.06 mrem to the total body or 0.2 mrem to any organ in a 31 day period.

4.

The surveillance requirement for this Specification, which is Technical Specification 4.11.1.3, reads:

Doses due to liquid releases from each reactor unit to UNRESTRICTED AREAft shall be projected at least  !

once per 31 days in accordance with the methodology

.and parameters in the CDCM.

The Liquid Radwaste Treatment System to which this

' decision process applies consists of the filters and demineralizers shown schematically in Figure 4.1-1.

Prior to rendering the system inoperable, and at least once each 31 days while the system remains inoperable, doses due to liquid effluents shall be projected according to the following guidance .

SOURCE:PSEGODCM 4.0-1 Rev. O, 85/4/2 i

.l. Doses f rom all liquid ef fluents f rom all liquid radioactive waste management components s ha ll be included. For the Hope Creek Genera ting S ta tion this shall include releases from the Wa ste Sample Tanks, Floor Drain Sample Tanks, De tergent Drain Tanks, Condensa te Storage Tank, and any. radioactivity in the Cooling Tower Blowdown Line.

2. The projected release rates used in the dose calculation shall be appropriate to the projected modes of operation of all the 1,iquid radwa ste streams. Tha t is, release ra tes f rom liquid ef fluent streams which are projected not to be trea ted must be based on the analysis of pre trea tme ns t samples, and not of samples ta ke n from those streams when the treatment systems are in operation.

3. Doses due to radioactive ma terials in liquid ef fluents shall be computed according to the methods of Section 2.2.

4. The projected dose from Step 3 shall be compared to the Technical Specification limits above (0.06 mrem to the total body or O.2 mrem to any organ). If the projected dose does not exceed the limit, the systems may be ope ra ted as assumed in the projection. If the projected dose does exceed the limit, one of two alternative courses must be implemented: a) the treatment systems on some of the streams must be brought into ope ra tion until the projected dose does not exceed the limits; or b) all of the Liquid Radwaste Trea tmen t System at the Hope Creek Station must be brought into ope ra tion .

1 SOURCE:PSEGODCM 4.0-2 Rev. O, 85/4/2

4.1.2 Ventila tion Exhaust Trea tment System Technical Specifica tion 3.11.2.5 reads:

The VENTILATION EXHAUST TREATMENT SYSTEM shall be used to reduce radioactive ma te rials in gaseous waste prior to their discharge when the projected doses due to gaseous effluent releases, from each reactor unit, to areas at and beyond the SITE BOUNDARY would exceed 0.3 mrem to any organ in a 31 day period.

The surveillance requirement for this Specification, which is Technical Specification 4.11.2.5.1, reads:

Doses due to gaseous releases from the site shall be projected a t least once per 31 days in accordance with the ODCM, when the VENTILATION EXHAUST TREATMENT SYSTEM is not in use.

The Ventilation Exhaust Treatment System to which this decision process applies consists of the charcoal and pa r ticula te filters shown schema tically in Figure 4.1-2. Prior to rendering the system inoperable (other than for routine maintenance), and at least once each 31 days while the system remains inopera ble , doses due to gaseous effluents will be projected according to the following guidance:

1. All gaseous effluent pa thways f rom the Hope Creek S ta tion must be included (including those from the Gaseous Radwaste Treatment System).

2. The projected release ra tes used in the calculation shall be a ppropria te to the projected modes of ope ra tion of all the ventilation exhaust and gaseous radwaste treatment systems a t both Sta tions.

T ha t is, Jelease rates from effluent streams which are projected not to be trea ted must be based on the analysis of pretreatment samples, and not of samples taken from those streams when SOURCE:PSEGODCM 4.0-3 Rev. O, 85/4/2

__-._9 .

- _ - , . _ . _ _ v __ y- . -

the treatment systems are in operation.

3. Dose ra tes a t the Site Boundary shall be computed according to the methods of Section 3.2.1, and multiplied by (31/365 = ) 0.0849 to convert them to a projected cumulative dose for 31 days. Doses to the Maximum Exposed Individual shall be computed according to the methods of Section 3.2.3.

4. The projected dose f rom Step 3 shall be compared to the Tech Spec limit above (0.3 mrem). If the projected dose does not exceed the limit, the systems may be opera ted a s assumed in the projection. If the projected dose does exceed the limit, one of two alterna tive courses must be implemented: a)the treatment systems on some of the streams must be brought i nto ope ra tion until the projected dose does not exceed the limit; or b)all of the Ventila tion Exhaust Trea tment System a t the Hope Creek Station must be brought into opera tion.

4.1.3 Gaseous Radwaste Trea tment System Technical Specifica tion 3.11.2.4 reads:

The GASEOUS RADWASTE TREATMENT SYSTEM shall be in ope ra tion.

The APPLICABILITY of this Specifica tion is "Whenever the main condenser air ejector system is in opera tion. "

The Gaseous'Radwaste Treatment System is shown in Figure 4.1-3. No dose projections are required prior to rendering this system i n o pe ra ble , but this shall not be done unless the main condenser air ejector -

system is rendered inoperable at the same time.

SOURCE:PSEGODCM 4.0-4 Rev. O, 85/4/2 d

Figure 4.1-1 LIQUID RADWASTE TREATMENT SYSTEM 3 -

3 2E a i,

)

=

lb I

.6

= .::

4 :;

_ =

o n

$" 3$

3 : . I 2 2 m a S, t; t; Lj. *

[4- g2 - 2 2 e

i. i, -i  : i: i -

2, m 8

3 $

~

..~

[1

8 : :

3 5 ,8 7 : 2 [ .

.& a 5 o

& 8 8 n y ,

u

=

3 .

{ $ $

g:

O

5 O

g ::

O il il

t

~~

I l 5 , - - .  :

4;  : "

. .  ! .~

&1 a

. 1 3 2 1A g :o 1 2 I

• 3 at" 2

u .

} { _

d, .

n n

i, 8

2  :

2

.

2

• 8 l$ *

$ ** j I$

3g a o 3 I. .:$

• A 3 3 1 :.

SOURCE:PSEGODCM 4.0-5 Rev. O, 85/4/2

Figure 4.1-2 VENTILATION EXHAUST TREATMENT SYSTEM Gaseous Radwaste Trea tment System To North Plant Vent Untrea ted ventila tion m Air Sources Radwaste Decon. _

Eva pora tor Reactor Building -

R H '

Purge Air (Typ. of 3)

Auxiliary Building Radweste Area R H Ventilation Air '

_ To South g 3)

Plant Vent p,

Condensa te Domineralizer Room Air Pipe Chase Air R H C H r Feedwater Heater Room Air Untreated Ventilation _

Air Sources Reactor - To FRVS N N " '

Building Air System Vent (Typ. of 6) (Typ. of 2)

Legend R = Roughing Filter C = Charcoal Filter H = HEPA Filter

' SOURCE:PSEGODCM 4.0-6 Rev. O, 85/4/2

Figure 4.1-3 GASEOUS RADWASTE TREATMENT SYSTEM Main or Auxiliary Steam SJAE Offgas ~ g- - - - - - - - - - - - - -

g I

Preheater Recombiner C er Condense L offgas l_ _ _ _ __T ical of 2 Recombiner Packges_l Holdup Pipes c i 1

- Cooler Guard Reheater -

Condenser

~

g Bed g i 1 To North l HEPA Adsorber m

• I Plant Vent 'g Filter Train I i l _ _ _ _ @ ig t gar _ coal y stem I I

. SOURCE:PSEGODCM 4.0-7 Rev. O, 85/4/2 i

l 4.2 TOTAL FUEL CYCLE DOSE Technical Specification 3.11.4 reads in part:

The annual dose or dose commitment to any MEMBER OF THE PUBLIC due to releases of radioactivity and to radiation from uranium fuel cycle sources shall be limited to less than or equal to 25 mrems to the total body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrems.

The total annual dose or dose commitment to a Member of the Public will be computed as the sum of the doses due to three components: doses due to radioactivity released in effluents from the Hope Creek Station, doses due to effluents from othe uranium fuel ~ cycle sources, and doses due to direct radiation from fuel cycle sources. ,

When it is necessary to perform an evaluation of the total fuel cycle dose (see Technical Specification 3.11.4.a), it shall 4

be performed according to the following guidance:

1. D o s e s due to liquid effluents from the Hope Creek Station shall be calculated according to the methods of Section 2.2 of this ODCM, using total releases for the year from all release pathways at the Station.

2. Doses due to gaseous effluents from the Hope Creek Station shall be calculated according to the methods of Section 3.2 of this ODCM, using total releases for the year from all release pathways at the Station.

3. Effluent doses from the Hope Creek Station shall be summed with those from the Salem Station to determine the total dose due to effluents from the uranium fuel cycle.

4. Direct radiation doses from the fuel cycle will be inferred from the evaluation of readings from environmental monitoring devices (see Section 5.1).

. SOURCE PSEGODCM 4.0-8 Rev. O, 85/4/2

4.3 INITIAL EVALUATION OF UNPLANNED GASEOUS RELEASES For the purpose of initial assessments of the impact of unplanned gaseous releases, dose calculations for the critical receptor in each affected sector may be performd as follows.

For each location, X/Q' and D/Q' will be calculated according to the methods of Section 3.3 of the ODCM, using the measured meteorological parameters for the period of the unplanned release. The location of the critical receptors and the pathways j which should be analyzed for each critical receptor are shown in Table 3.2-3. (For very rough calculations the annual average X/Q and D/O for each receptor are shown

'in Table 3.2-4.) The R ij for the approphiate exposure pathways and age groups will be selected from Tables 4.3-1 and 4.3-2.

SOURCE PSEGODCM 4.0-9 Rev. O, 85/4/2

Table 4.3-1

• INFANT PATHWAY DOSE FACTORS FOR SECTION 4.3 (R )

Page 1 of 3: Dose Factors for Composite Worst Organ I ISOTOPEI INHfLATION I GROU@ PLANEl GRS/COMilLKI GRS/COWlEATI UEGETATION I lH.3 1 6.468E+02 1 0.000E+00 1 2.353E+03 1 0.000E+00 1 0.000E*00 I IC-14 1 2.646E+04 1 0.000E*00 1 3.722E+09 1 0.000E+00 1 0.000E*00 I INA-24 1 1.056E*04 1 1.385E+07 1 2.453E*07 I 0.000E+00 1 0.000E+00 I

[ 5 52 I"5Ih50kIhE~I"U$00bEb5"i"55E9k55"i"0.000E+iG I"U$50bE bh"I ICR-51 1 1.284E+04 1 5.506E+06 1 7.478E+06 1 0.000E+00 1 0.000E+00 I IfN-54 1 9.996E*05 1 1.625E+09 I 6.205E+07 I 0.000E+00 I 0.000E+00 I Ifw-56 1 7.168E+04 1 1.068E+06 1 4.554E*00 1 0.000E*00 1 0.000E+00 I IFE-55 1 8.694E+04 1 0.000E+00 1 2.150E*08 I 0.000E+00 1 0.000E+00 I IFE-59 1 1.015E*06 1 3.204E+08 1 6.234E+08 1 0.000E+00 1 0.000E+00 I 1C0-58 1 7.770E*05 1 4.464E+08 1 9.634E*07 1 0.000E+00 1 0.000E*00 I 100-60 1 4.500E+06 1 2.532E+10 1 3.337E*00 1 0.000E+00 1 0.000E*00 I INI.63 1 3.388E+05 l 0.000E+00 1 5.558E*10 1 0.000E+00 l 0.000E*00 i INI.65 1 5.012E+04 1 3.451E+05 I 4.005E+01 1 0.000E+00 1 0.000E*00 I 100-64 1 1.490E+04 1 6.876E+05 1 6.056E+06 1 0.000E+00 1 0.000E+00 I 12N.65 1 6.468E*05 1 8.583E*00 1 3.029E+10 1 0.000E+00 1 0.000E*00 I 12N-69 1 1.322E*04 1 0.000E+00 1 6.133E-09 I 0.000E*00 1 0.000E+00 I IBR-83 I 3.800E*02 l 7.079E+03 1 1.486E*00 1 0.000E+00 1 0.000E+00 I.

IBP-84 1 4.004E+02 1 2.363E+05 1 1.998E-22 1 0.000E+00 1 0.000E+00 I 18R-85 1 2.044E+01 1 0.000E+00 1 0.000E*00 1 0.000E+00 1 0.000E*00 I IRB-86 1 1.904E+05 l 1.027E+07 1 3.540E+10 1 0.000E+00 1 0.000E+00 I 1118-88 1 5.572E*02 1 3.779E+04 1 2.982E-44 1 0.000E+00 1 0.000E*00 I 198-89 1 3.206E+02 1 1.476E*05 I 5.431E-52 1 0.000E+00 1 0.000E+00 I ISR-89 1 2.030E+06 1 2.509E+04 1 2.002E*10 1 0.000E+00 1 0.000E*00 1 ISR.90 1 4.088E+07 1 0.000E+00 1 1.934E+11 1 0.000E*00 1 0.000E*00 I ISR 91 1 7.336E*04 I 2.511E*06 1 5.115E+05 1 0.000E+00 1 0.000E+00 I

• -- See Note, page 4.0-16 Units: Inhalation - mrem /yr per uCi/m 3

-m 2 mrem /yr per uCi/sec Others SOURCE:PSEGODCM 4.0-10 Rev. O, 85/4/2

Table 4.3-1

• INFANT PATHWAY DOSE FACTORS FOR SECTION 4.3 (Rf3)

Page 2 of 3: Dose Factors for Composite Worst Organ I ISOTOPEI INNALAil0N I GROUND PLANEl E#S/C0wnlu(I GPS / COW /11EATI VEGETATION I 158-92 1 1.400E*05 1 0.631E*05 I 7.962E+01 1 0.000E*00 I 0.000E*00 I lY-90 1 2.689E+05 1 5.300E*03 1 1.496E+06 1 0.000E+00 1 0.000E+00 I lY.91M 1 2.796E+03 1 1.161E+05 I 2.985E-15 1 0.000E*00 I 0.000E+00 I lY-91 1 2.450E+06 I 1.207E+06 I 8.354E*06 1 0.000E+00 I 0.000E+00 1 IY-92 1 1.266E+05 1 2.142E*05 1 1.633E+01 I 0.000E*00 1 0.000E+00 I

.lY-93 1 1.666E+05 I 2.534E+05 1 2.926E+04 1 0.000E+00 1 0.000E+00 I IN-95 l 1.750E*06 1 2.937E+08 l 1.314E+06 1 0.000E+00 1 0.000E+00 I 12#-97 1 1.400E+05 I 3.445E+06 1 7.073E+04 1 0.000E+00 1 0.000E*00 I 1 4 -95 1 4.78aE+05 I 1.657E+00 1 3.314E+00 1 0.000E*00 I 0.000E*00 I .

INO-99 1 1.340E*05 1 4.626E+06 I 4.944E+08 1 0.000E+00 1 0.000E+00 I lic.99M I 2.030E+03 1 2.109E+05 1 2.618E+04 1 0.000E+00 1 0.000E+00 I ITC-101 1 8.442E+02 1 2.260E+04 1 7.771E-57 1 0.000E<0fl 1 0.000E+00 I Im).103 1 5.516E+05 l 1.265E+06 1 1.67BE*05 1 0.000E*00 1 0.000E+00 I 190-105 1 4.844E+04 4 7.212E*05 1 5.096E+00 1 0.000E*00 1 0.000E+00 I im)-106 1 1.156E+07 I 5.049E+08 1 2.299E*06 1 0.000E+00 l 0.000E+00 I IAG-110M i 3.668E+06 1 4.019E+09 1 2.324E*10 1 0.000E*00 1 0.000E+00 I ITE-125M i 4.466E+05 1 2.120E+06 I 2.399E+09 I 0.000E+00 1 0.000E+00 I ITE-127M i 1.312E+06 1 1.063E*05 1 1.649E*09 I 0.000E+00 1 0.000E*00 I ITE-127 1 2.436E+04 1 3.293E+03 I 2.162E+05 1 0.000E+00 1 0.000E+00 I ITE-129M i 1.690E+06 1 2.305E+07 1 2.214E+09 I 0.000E*00 1 0.000E*00 l ITE-129 1 2.632E+04 I 3.076E*04 1 2.670E-07 1 0.000E*00 1 0.000E*00 1 ITE-131M i 1.999E*05 I 9.459E+06 1 3.640E*07 I 0.000E+00 1 0.000E+00 l ITE-131 1 8.210E*03 1 3.450E*07 I 2.202E-30 1 0.000E+00 1 0.000E+00 I ITE-132 1 3.402E*05 1 4.960E*06 I 1.036E+00 l 0.000E+00 1 0.000E*00 I 11 130 1 1.596E+06 I 6.692E*06 I 1.393E*09 1 0.000E*00 1 0.000E*00 I

• -- See Note, page 4.0-16 Units: Inhalation - mrem /yr per uCi/m 3

-m 2 mrem /yr per uCi/sec Others SOURCE:PSEGODCM 4.0-11 Rev. O, 85/4/2

Table 4.3-1 ,

INFANT PATHWAY DOSE FACTORS FOR SECTION 4.3 (Rg)

Page 3 of 3: Dose Factors for Composite Worst Organ AGE GROUP ( IW#fT ) ( N.A. ) ( IWANT ) ( IW ANT ) ( IWANT )

I ISOTOPEl INHALATION I GROU@ PLANEl GRS/COMtILi(I GRS/C0iuffATI VEGETATION I

.......................... .......= _= ......... .........................11-131 1 1.484E+07 1 2.089E+07 1 1.675E+12 1 0.000E+00 1 0.000E*00 I 11-132 1 1.694E+05 l 1.465E*06 1 2.170E+02 1 0.000E*00 1 0.000E*00 I 11 133 I.3.556E*06 1 2.981E+06 1 1.527E+10 1 0.000E+00 1 0.000E*00 I 11 134 1 4.452E*04 1 5.305E*05 1 1.337E-09 1 0.000E+00 1 0.000E+00 I 11 135 1 6.958E+05 1 2.947E+06 1 3.185E+07 1 0.000E+00 1 0.000E+00 1 -

105-134 1 7.028E+35 I 8.007E+09 1 1.082E+11 1 0.000E+00 1 0.000E+00 i ICS-136 1 1.345E+05 1 1.702E*00 1 9.219E+09 1 0.000E+00 1 0.000E+00 1 =

105-137 1 6.118E+05 l 1.201E*10 I 9.583E+10 1 0.000E*00 l 0.000E+00 I

.....................................................................s..........

1C5-138 I 8.764E+02 l 4.102E+05 1 3.468E-22 1 0.000E+00 1 0.000E*00 I IBA-139 I 5.096E+04 1 1.194E*05 1 4.572E-05 1 0.000E*00 1 0.000E+00 I 194-140 1 1.596E+06 1 2.346E+07 1 3.835E+08 1 0.000E+00 1 0.000E+00 I

............................... ................ ................_=- =- - ===

IBA-ill I 4.74fE+03 1 4.754E+04 I 8.075E-44 1 0.000E+00 l 0.000E+00 I 104-142 I t.554E+03 I 5.064E*04 1 0.000E+00 1 0.000E+00 1 0.000E*00 I ILA-140 l 1.600E+05 I 2.180E+07 I 2.991E+05 1 0.000E*00 1 0.000E*00 I ILA-142 1 5.950E+04 1 9.122E+05 l 1.716E.05 l 0.000E+00 1 0.000E*00 I ICE-141 1 5.166E* 05 l 1.540E+07 1 2.174E+07 1 0.000E+00 1 0.000E+00 I ICE.143 1 1.162E+05 1 2.627E+06 1 2.444E+06 1 0.000E+00 1 0.000E+00 I ICE-144 1 9.842E+06 I B.032E*07 1 2.123E*08 1 0.000E*00 1 0.000E*00 I IPR-143 1 4.326E+05 1 0.000E+00 1 1.248E+06 1 0.000E*00 1 0.000E*00 I IPR-144 1 4.204E+03 1 2.112E43 l 1.863E.48 1 0.000E+00 1 0.000E+00 I IND-147 1 3.220E+05 1 1.009E*07 I 9.137E+05 1 0.000E+00 1 0.000E+00 I tie-187 I 3.96?E*04 1 2.740E*06 1 3.979E+06 1 0.000E+00 1 0.000E*00 I 18-239 I 5.950E+04 1 1.976E*06 1 1.496E*05 1 0.000E*00 1 0.000E+00 I

• -- See Note, page 4.0-16 Units: Inhalation - mrem /yr per uCi/m 3 Others -

m 2 mrem /yr per uCi/sec SOURCE PSEGODCM 4.0-12 Rev. O, 85/4/2

h Table 4.3-2

• CHILD PATHWAY DOSE FACTORS FOR SECTION 4.3 (R.i) l Page 1 of 3: Dose Factors for Composite Worst Organ I IS010PEI INHALATI(M i GR0lMD PLANEl 60S/C0wMILKI GRS/COWlEATI VEGETATI(N I lH-3 1 1.12SE*03 1 0.000E+00 1 1.551E+03 1 2.312E*02 I 3.959E+03 I 1C-14 1 3.589E+04 1 0.000E*00 1 1.901E+09 I 6.100E+08 I 8.094E*06 I INA-24 1 1.610E*04 1 1.385E*07 1 1.408E*07 1 2.744E-03 1 3.729E+05 1 IP-32 1 2.605E*06 1 0.030E+00 l 1.237E*11 1 1.179E*10 1 3.366E*09 I ICR-51 1 1.698E+04 I 5.506E+06 I 8.588E*06 I 7.415E+05 1 6.213E+06 I I % 54 1 1.576E*06 1 1.625E*09 1 3.336E+07 l 1.275E+07 I 6.648E+08 i 1 % 56 1 1.232E+05 1 1.(68E*06 I 2.966E*00 l 3.877E-51 1 2.723E+03 i

, IFE-55 1 1.110E+05 1 0.000E*00 1 1.778E+08 1 7.273E+08 I 8.012E+08 1

, IFE 59 1 1.269E+06 1 3.204E+08 I 3.221E*00 1 1.000E*09 I 6.693E+08 i 100-59 1 1.106E*06 1 4.464E+08 l 1.126E+08 I 1.527E+08 1 3.771E+08 i 1C0-64 1 7.067E+06 1 2.532E+10 1 3.005E+08 1 6.105E+08 1 2.095E+09 I lHI-61 1 8.214E+05 1 0.000E+00 1 4.716E+10 1 4.633E+10 1 3.949E+10 I INl.65 l 8.399E+04 1 3.451E*05 1 3.037E*01 1 6.460E-51 1 1.211E+03 I ICU-64 1 3.670E*04 i 6.876E+0i I 5.572E+06 1 2.216E-05 l 5.159E*05 I 12M-65 I 9.953E+05 1 8.583E*08 l 1.752E+10 1 1.591E*09 1 2.164E+09 I 12N-69 I 1.018E*04 1 0.000E+00 1 1.786E-09 I 0.000E+00 1 9.893E-04 I IBD-81 1 4.736E+02 1 7.079E*03 1 6.999E-01 1 1.514E-56 I 5.369E+00 I 100-84 I 5.476E+02 I 2.363E*05 1 1.035E-22 1 0.000E+00 l 3.822E-11 I IPR-85 1 2.531E+01 1 0.000E*00 1 0.000E+00 1 0.000E+00 1 0.000E*00 l 199-86 i 1.983E+05 1 1.027E*07 1 1.395E+10 1 9.171E+08 1 4.520E+08 I 1P9-88 1 5.624E*02 1 3.779E+04 1 1.138E-44 1 0.000E+00 1 4.374E-22 I 100-89 1 3.452E+02 1 1.476E*05 1 2.222E-52 I 9.000E*00 1 4.695E.26 I 158-89 1 2.157E*06 1 2.509E*04 1 1.053E*10 1 7.661E*00 l 3.593E+10 I 150-90 1 1.010E+08 1 0.000E*00 1 1.777E+11 1 1.654E+10 1 1.243E*12 I 158 01 1 1.739E+05 1 2.511E*06 1 4.579E*05 1 8.419E-10 1 1.157E+06 I

• -- See Note, page 4.0-16 Units: Inhalation - mrem /yr per uCi/m 3 Others -

m 2 mrem /yr per uCi/sec SOURCE PSEGODCM 4.0-13 Rev. O, 85/4/2

1-Table 4.3-2 ,

CHILD PATHWAY DOSE FACTORS FOR SECTION 4.3 (Ri p Page 2 of 3: Dose Factors for Composite Worst Organ I ISOTOPEI Int. Ail 0N I GR0l#0 PLANEl GRS/COWNILKI GRS/COWTOTI UEGETATION I ISR-92 1 2.424E+05 I 8.631E+05 1 6.577E*01 1 5. W E.48 I 1.378E*04 I lY-90 I 2.679E*05 1 5.300E+03 1 1.459E+06 1 7.762E+05 I 6.569E+07 I lY-91M i 2.812E*03 1 1.161E+05 I 8.269E-16 1 0.000E+00 1 1.737E-05 I lY-91 1 2.627E*06 1 1.207E*06 I 8.272E+06 1 3.818E+08 I 2.484E+09 I lY-92 1 2.390E+05 1 2.142E+05 1 1.163E+01 1 1.107E.34 I 4.576E+04 I IY-93 1 3.085E+05 1 2.534E*05 1 2.502E+04 1 2.461E-07 1 4.482E+06 I 12R-95 1 2.231E*06 1 2.037E+08 1 1.390E+06 I 9.715E+08 I 8.843E*08 1 12R-97 I 3.511E*05 1 3.445E+06 I 6.600E*04 1 1.116E+00 1. 1.248E+07 I 19 45 I 6.142E+05 1 1.657E*00 1 3.67?E+C8 1 3.621E+09 I 3.070E+08 i IM0 99 1 1.354E+05 I 4.626E+06 1 2.764E*08 1 3.907E+05 1 1.647E*07 I ITC-99M i 4.810E*03 1 2.109E*05 1 2.345E+04 1 1.100E-17 1 5.255E+03 1 ITC-101 1 5.846E+02 1 2.260E+04 1 3.054E-58 1 0.000E+00 1 2.414E-29 I 1 6 103 1 6.623E*05 1 1.265E+08 1 1.762E+05 1 6.378E+09 1 3.971E+08 1 IRU-105 I 9.953E+04 1 7.212E+05 1 3.966E+00 1 9.362E-25 I 5.981E+04 I IRU-106 1 1.432E+07 I 5.049E+08 1 2.286E+06 1 1.090E+11 1 1.159E*10 I IAG-110N I 5.476E+06 I 4.019E+09 I 2.669E+10 1 1.073E*09 1 2.581E*09 I ITE-125N I 4.773E*05 1 2.128E*06 1 1.174E+08 1 9.052E+08 I 3.506E*00 l ITE-127M i 1.400E*06 1 1.083E*05 I 9.437E+08 I 8.050E+09 I ).769E+09 I ITE-127 I 7.624E*04 1 3.293E+03 1 1.895E+05 1 2.557E-08 1 3.903E+05 I ITE-129M i 1.761E+06 1 2.305E*07 l 1.266E+09 1 0.345E*09 I 2.460E*09 I ITE-129 1 2.549E*04 1 3.076E*04 1 9.809E-08 I 0.000E+00 1 7.204E-02 I ITE-131M i 3.078E*05 I 9.459E*06 1 3.570E*07 1 1.562E*04 I 2.le3E*07 I ITE-131 1 2.054E*03 I 3.45nE+07 l 1.350E-31 1 0.000E+00 l 1.349E-14 I ITE-132 1 3.774E*05 1 4.968E+06 1 7.240E+07 I 1.484E*07 1 3.111E*07 I 11 130 1 1.846E*06 I 6.692E*66 1 6.117E+08 1 1.075E-03 1 1.370E.n8 i

• -- See Note, page 4.0-16 Units: Inhalation - mrem /yr per uCi/m 3 Others -m 2 mrem /yr per uCi/sec SOURCE PSEGODCM 4.0-14 Rev. O, 85/4/2

c-Table 4.3-2

• CHILD PATHWAY DOSE FACTORS FOR SECTION 4.3 (Rg)

Page 3 of 3: Dose' Factors for Composite Worst Organ I ISOTOPEI INHotATION l GROIDO PLNEl GPS / COW /filtJI GPS / COW /I1EATI UEGETATION l 11-131 1 1.624E*07 1 2.099E*07 I 6.894E+11 1 8.755E+09 I 4.754E+10 I 11-132 1 1.935E+05 1 1.46cE*06 I 9.368E+01 1 1.421E.56 1 7.869E+03 I 11 133 1 3.84AE*06 I 2.981E+06 I 6.276E+09 1 2.074E+02 1 0.113E+06 I 11 134 1 5.060E*04 1 5.305E*06 I 5.766E-10 1 0.000E+00 I 6.622E-03 I II.135 I 7.918E+05 1 2.947E+04 1 1.369E+07 1 1.653E.14 I 9.973E+06 I 105-134 1 1.014E+06 I 8.007E+09 I 5.910E+10 I 2.407E*09 1 2.631E+10 I IES-136 1 1.709E*05 1 1.702E+06 1 4.412E*09 I 7.041E+07 1 2.247E+08 1 1C5-137 I 9.065E+05 l 1.201E+10 1 5.129E+10 1 2.122E+09 I 2.392E*10 i 104-138 I 8.399E*02 1 4.10"E*05 1 0.794E-23 1 0.000E+00 l 9.133E.11 I Ik-139 I 5.772E*04 1 1.194E*05 l 1.958E-05 I 0.000E+00 1 2.950E+00 I 1%.140 1 1.743E*06 1 2.!46E*07 1 1.963E+08 I 6.975E+07 1 2.767E+08 i IM-141 1 2.919E+03 1 4.754E+04 1 3.112E-45 1 0.000E+00 1 2.042E-21 I Ik-142 1 1.643E+03 1 5.064E+04 1 0.000E+00 1 0.000E+00 1 4.105E-39 i

..ILA-140 1 2.257E*05 1 2.180E+07 I 3.012E+05 1 8.737E+02 1 3.166E+07 I ILA.142 1 7.585E+04 I 9.122E+05 I.8.278E-06 1 0.000E*00 1 2.141E*01 I IEE.141 1 5.439E*05 1 1.540E+07 I 2.165E+07 1 2.198E*07 1 4.002E+09 I ICE-143 1 1.273E+05 1 2.627E+06 I 2.360E*06 1 4.00!E+02 1 1.364E*07 i ICE.144 1 1.195E*07 I 8.032E*07 1 2.110E+08 I 3.011E*09 I 1.039E+10 I IPp.143 1 4.329E+05 1 0.000E*00 1 1.234E+06 I 5.742E+07 1 1.575E+08 I IPs.144 1 1.565E+03 1 2.112E*03 1 3.246E-50 I 0.000E+00 1 3.829E-23 I

% .147 1 3.282E*05 l 1.009E*07 I 9.087E+05 1 2.394E*07 I 9.197E+07 I IW-107 I 9.102E+04 1 2.740E*06 1 3.850E+06 I 4.430E+00 1 5.380E*06 I INA.239 I 6.401E*04 1 1.976E*f6 1 1.454E*05 1 3.551E+03 1 1.357E*07 I

• -- See Note, page 4.0-16 Units: Inhalation - mrem /yr per uCi/m3 Others -m 2 mrem /yr per uci/sec SOURCE:PSEGODCM 4.0-15 Rev. O, 85/4/2

e NOTE: The Rij values of Tables 4.3-1 and 4.3-2 were calculated according to the methods of Reference 6, Section 5.3.

The values used for the various parameters and the origins of those values are given above in Table 3.2-5, with the following exceptions:

1) Rather than being organ-specific, the ingestion and inhalation dose conversion factors (DFL and DFA) were chosen for a composite worst organ.

That is, for each age group and radionuclide, the dose conversion factor used was the highest of any for that age group and radionuclide.

2) The ground plane dose factors (DFG) used were the higher of those given for the total body and the skin in the referenced table of Reg. Guide 1.109.

These R i values are therefore conservative and are most appropriate for initial or rapid assessments.

SOURCE:PSEGODCM 4.0-16 Rev. O, 85/4/2 u_

L-i 4.4 DOSE TO A MEMBER OF THE PUBLIC DUE TO ACTIVITIES INSIDE

THE SITE BOUNDARY i l

(LATER). Proposed wording for the elimination of this re-quirement has been included in the RETS submittal. If the proposed wording is not allowed, this requirement will be addressed and included in this section.

SOURCE:PSEGODCM 4.0-17 Rev. O, 85/4/2

. . . _ . . _. . _ .- . . . _ . _ .m. - _ _ - .

l' l

l l 4.5 INTEGRATED POPULATION DOSE l

l' (LATER). Proposed wording for the elimina tion of this re-quirement has been included in the RETS s u bmi t ta l . If l the proposed wording is not allowed, this requirement will l

i be addressed and included in this section, i

i

l.

• l l

l P

! SOURCE t PSEGODCl4 4.0-18 Rev. O, 85/4/2

_ _ . _ _ . _ _ . _ _ , _ _ . . - . _ . . . .__.__.2_.._,

Section 5.0  ;

RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM  !

)

Technicsl Specification 3.12.1 states, in part: .

I The radiological environmental monitoring program shall be conducted as specified in (RETS) Table 3.12-1.

A description of the Radiological Environmental Monitoring Program thus specified is presented in this section.

5.1 _ SAMPLING PROGRAM The radiological environmental monitoring program will be conducted in accordance with Table 5.1-1 at the locations specified in Figures 5.1-1 and 5.1-2.

NOTE: For the purpose of implementing Technical Specifi-cation 3.12.2, sampling locations will be modified as required to reflect the findings of the Land Use Census.

SOURCE:PSEGODCM 5.0-1 Rev. 3, 85/4/2

li > i

<Il1J( il l

8hH - *H1r 3

hU Or O[ MZ<H %h Z E 3OZHdOM Z 't %OO M>

s[8 r O"3 o

• t h

c n a o o e t e g o' n s n i o n n r s y

oio s d lpT h .l e Y t at C

N s

y i s mad ni as c po E s s na y US QE E S lan 'e al ly r a e n c a i p o m R Y p n t R e oc F L a m af a r d t oy A t a e D N e s - or sl u N A b B .f e i r l A y r t e a F sl sh w h e t v E O s k s o g mr P

Y oe r e o4 r2 l l u a

mau a n o

T G w G > ad G q i t

~

a t

s l

o r

t n

o c

f r o M e A d t n R r el a G i t i e O a cf m R e P el h y ml t l G D u oi r N O l c w a l

H o v e g e

y T

m E w

l p

n o

T M e.

I o ml i N N l a a t O O S M I s k s T u e e L C o . e m A E u r w i T L n e y g e t N L i l E O t p r n n M

N C n m e a o a v h t e

_ O C s ec R s

. l d

_ v e N e E c x

L n e A o C I t a I t n t G t t t a e e O n n n t v b L y e e t e S O v v n v f s I e f o s D N f f v f o o A O o o o k r g

R I f E i _

_ T W E o E M N

_ A S N N f C S N N N l l I _

O m m

_ L l l l l d a m a a 0 1 e 8 7 1

m 9 4 1 4 r 3 0 S 8 f o

r

,D E e p

O C e b

N 1 2 1 2 s l O 0 5 F F 5 E t I 0 2 1 2 H 6 f T 1 3 1 a A h T s S

y r

t n e o m i o t r a t t c E S e N p R l s U P ^RT i CU L A T E $ o 0 r e E 9 t m R Y R ) n m U A8 S

I A

a o e I ( C G O H PT X A . # e E P l mOhOM . ]t n OO 3  ;

m* N %m< G, DwNbNM

(

l!ilI\l

l l Il 1ll'I Il l Q'O[ MIw yU 08 g O:P' C g5m Zh y>F 3OsHOhZg , MOO g QO M O'O @

t e

r a

s Y e C s N y E

U S lakly QE n e E S a e R Y w F L 1 A 3 d D N 1 e N A m A er E O F n fo P id r Y

T loep ed l t e a

o5 c 1 lat u e c

r cl a eil h gt o -

c d r c i a d r p s D et i O t r r H a aid T n c a n E g a M eh o r gt r N p u e O

I mo rd e lp I

T h t m C A t c a y E

L D e s l L w n k L T o n r e O l oie C A f c a w

~

t t n n t _

t t e e n _

_ n n v v w _

e e w

_ v v f f _

N o o f f f o 0 o o E E _

_ 1 N N t 1 W W N N re A S P C S N l t i

( a a m L l l m m 7 4 0 1

9 1 8 0 1 3 4 E

D

_ O C

_ N 1 l

_ O 0 E 2 2 5 I 0 6 F 5 1 T 1 1  ; 2 3 A

T S

n i

o

_ t a

t E S N

R l O

U I Dl N E o E B r t

RY R ) n t A I b o SW A (

C O H PTA E P l nOC%O9 9 MOOO i E m* c lO< o. mNbNN

L1 O

C w

O

.C.U 9

Cn PATHWAY STATION COf4 LOCATION COLLECTION NETHCO ANALYSES O

O C II. S0lt h-C O H 3 O 1001 3.9 al SSW of vent F 8

16El 4.1 al NMt of vent 10 soll plugs to a depth of 6" over an area of 25 ft2 are 3#

3G1 # 16.6 m!!es NE of vent .composited and sealed In a plastic bag at eam location'*

3H3 p 110 ml NE of station A sample all t be collected M

from each location once every m pq 1F1 S.8 at N of vent 3 years W j @$

2 2W e

[

2F2 8.7 el NNE of vent Gamme spectrometry performed on w $"

4 501 3.5 al E of vent collection O >

l N &M

! 8 2FI

@ 2H l $ at NNE of vent Sr-90 analyses on one sample from l ead location on collection Q

s

! 2E1 4.4 mi NNE of vest

=

252 0.4 al NNE of vent $

O 9

x g **Soll samples are taken In general with procedures outlined in HASL-300 (Rev. S/73), if a suitable sample cannot be obtaIned at a 8 O location, a sample shall te obtained from a new location. The M4C shall be notlfled In writing of the new sample location.

g # Control Station I i

N b

N M'

ts)

O C

W O

M.

9 PATHWAY STAT 10N CODE LOCATION COttECTION METHOD AftALY$ES 8 Ill. DIRECT o 9 g

C O H 3 252 0.4 al NNE of vent O r

~ %1 1.0 mi E of vent 6S2 0.2 al ESE of vent 8 M

751 0.12 al SE of vent 1051 0.14 al S$w of vent h U

1151 0.09 el SW of vent trl

$01 3.5 ml E of vent 1001 3.9 ml SSW of went 2 TLD's will to collected r - dose quarterly k

H 1401 3.4 at WW of vent g from each location quarterly > 0m m 2El 4.4 ml NNE of vent

• 3E1 4.1 al NE of vent , y%

G D2 m 1 13E 1 4.2 al NE of vent b Z

• 16El 4.1 al NW of vent am

• j IF1 5.8 al N of vent 1 l 2F2 8.7 al NNE of vent SFl 8.0 ml E of vent Z '

0F 1 6.4 m) E$f o f ant H 8

1. / 9.I el SE or von O 11F1 5.2 al SW of vent M M

13F1 9.8 al W of vent . Z Q

i 3G1 s 16.6 al NE of vent l y all # 34 al NNE of vent M 3841 # 32 mi NE of vent

• y 36t3 s 110 ml NE of vent b

G m

)

s

1. Control Station N

Table 5.1-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Page 5 OF 9 W

)6 1

4 W r g  % -

- t G 8 2

u 8 7 t

2 8_

. . . . . . . E i 3

- E 5 e t

- -  % 7 %" ! ! I 2 .  ! : g i  ! .  ! -

o  !

o o .* . o o " " 4 - 3 -

5 w a = w 3

5 m o , IT T S= =3 =o =a 21 I 23 { - *

• g . . . . . .  :

i i $$$$$$$$$$$$iii e- n o , , - e e , e o e . -

d' ,

a ,* n* A i A & J & J J d : *  ;

5 m

e

• : ~

0 ~

c n m Q{QC2 2yU

- - -  : - e gnsa ~

< n Oi

-8

~

-n

>. .- 3 a

1 S t 5 fE 8 g o -

2 i SOURCE:PSEGODCM 5.0-6 Rev. O, 85/4/2

to O

C W

G M.

. PATHWAY STAT lON CODE LDCATlON m COLLECT lON METH00 ANALYSES in M V. AQUATIC O

8 8 7E l I al W of Mad Horse Creek; o 3 E 4.5 ml SE of vent y N

r T 12C1 # 2.5 at WSW of vent A benthos sample consisting Gensne Isotopic analysis -

h M

H of benthic organisms and samlannually; y 0 associated sediment is taken U S

samlannually Sr-90 samlannually on sediment M 11A1 Outf all area; 650' SW of M went T Md W OW

• t.Q Z C7 VI. INGESTION O 3H n G l

(a) M 8m 15F 1 5.2 al NW of vent Four gallon grab sample of Gemme Isotopic analysts i fresh milk Is collected k [*g I

L 2F4 6.3 ml HE of vent from each farm samlmonthly.

K 1-131 ame;usos sem1 monthly h Z

H 5F2 7.0 ml E of vont 8 O

W 14F1 5. 5 ml WW of vent M Z

O 3G1 # 10.6 miles HE of vent t

W h (b) F Outf all area; 650' SW 8

11A1 Two key samples of fish Gessne Isotopic analysts of edible y

[ l of vent are sealed in plastic portionon collection 3 S 12C1 # 2.5 ml WSW of vent bag or Jar and frozen

[ H samlannually or when in season w

N b

N # Control Station to

tn O

C M

O D.3 T PATHWAY Cn STATION CODE LOCATION COLLECTION METHOD ANALYSES M

@ l y. WATER C

h 11A1 ApproxImately 650 ft H O,

SW of vent e O

O (al S H Two gallon sample to be collected Gesuna Isotopic analysis monthly U 12C1 s 2. 5 al WSW of vent monthly providIng winter Icing Q R t' conditions allow sample collectlon H-3 on quarterly composites F g A 16F1 6.9 ml HMi of vent C H C&D canal

+

E [

C

$h Z O' 7El 1 al W of Nad Horse i Creek; 4.5 ml SE of vent hh

• 4

%g (b) G O >*

R 253 on site 7 0

@ 3H Two gallon grab sample Is collected Gamma Isotopic analysis on 0 ~

Z monthly.

N X1 # 4.1 ml NE of vont quarterly composite y D H-3 analysis are done monthly. O H

Z (cf D O R 2F3 (rawl Salem Water Co. ; 50 ml aliquot is taken daily Gross beta monthly 1 8 ml NNE of vent and composited to a monthly $

y f4 sample of two gallons Gcanne Isotopic analyls on Q

K quarterly composite g

i 3 i+-3 on quarterly composlie

,G N G

CD U1 4

% # Control Station M

(13 O

C W

Q

.M.

9 PATHWAY STATION CODE LOCATION COLLECTION NETH00 (n ANALYSES M

.$ VI. INGESTION O h O U H

g '(c) C 11A1 Outf all area; 650' SW Two keys samples of crab Gemme isotopic analysts of edible O R of vent are sealed In a plastic portion on collection A bag or Jar and frozen g

B samlannually or when O In season h

12C1 # West. Bank opposite M Z

Artificial Island <

H T Wd 2.5 at SWS of vent

$# 0h 3H e M (D 3

e Q) Z 8 Ln (d) FRUITS IG1 # 10.2 miles N of vent Samples are collected O >.

M (R during the normal harvest Radiolodine determination of e Uf 3w VE E TA- 2E 1 4.4 ml N E of vert green leafy vegetables on T10N season, sealed in plastic, and frozen If perishable. collection k

2F 1 5.0 ml NNE of vent Sufficient sample Is col- ]

O lected to yield 500 grams Genum Isotopic analysis on W g

of dry weight collection Z O

T W

H y

3

.m U1 N

(m ,# Control Statton

(/)

O-C W

G M.

y PATHWAY STATION C0(1 LOCATION COLLECTION ETH00 ANALYSES O

, h VI. INGESTION h O s O

(e) G XXX Station vicinity east Muskrats are skinned P- Isotopic analists on edible A side of estuary and frozen sealannaually portion only on collection N , g O

E XXX # west side of mstuary, >

3-5 mi from vent ta M

XXX Within 10 ml of Station Beef portion of cow is***

s sampled and frozen samlannually y yj W @ Ze

+

@ ZH G M@

I @ Z H 8 tn G O >-

% C* H I

@ ZH O

Z H

d O

W H

Z XXX = location given at t in.o O of collection T

W g 888

= This sample Is subject to availability of slaughtered cow n

4

1. Control Station

.G i

Ln N

A N

N

Figure 5.1-1 ONSITE SAMPLING LOCATIONS ARTIFICIAL ISLAND y

/

f.

I j -

/

I l ng

~ O

/ I b (

E

/ -

f O." L SER ) ,

s t l[

'e /

j j

\

3 -

I n I

_5 A 'i 1 allow yi p

w

~ s r *3a l1 SS '

Q f . '"g .

~ f; ,,,.

k

,.,451 TR tg 41 ,

P "

3

~* 3 l 13 7

51 2 Y 6

\

11 7 10' 9 8

N N

d f

scata ,, ,,,,

SOURCE:PSEGODCM 5.0-11 Rev. O, 85/4/2

i I

l Figure 5.1-2 OFFSITE SAMPLING LOCATIONS ARTIFICIAL ISLAND 9EN E y l

'*'Q/

N ,.

) ,

>  : . -r .'_-

I

r :\ '

/ ,o. .

t'. ,,,

~

av , t ) f' s =e.

\ - ,'- \

N I *

,i ~[ ( 'l ' \

,, i\.  ?*

(! .r. ,.

A.,',

s'

, I.i . '".! ,. ! i / ,

- s g e

• 'L' e /,\

/ ,N N ,

3 g

's, WL SNI N S O E(,O '

N s , 'Q'U i N f N,

g,. h* '

w' .*'; 's 1 I.s '

/  %

e di. in s _ ,

\ '

N a ~

\  : .

= s '\N*. 1 '

o aa i

, p, . ,

i 'p , Ii of ,y s

s. ss

&~

1 - -

.. s ,,,t ig.- .. ,

^

^

' ^ l

[ l

- ID,,, j - ,

\ l

&i / k \, N,,'

- )

N,

. m. ,

l

. '\

\

~, .

[ '" I

/

f , 'N tA ' o

, ,,i / v' /

\ ,

\

.e ,

E'

/ \ s

,,, * 'N _

l '

N . ,

i i. N l m m 'i. . . ... .

N

,e k i \ i l

l SOURCE:PSEGODCM 5.0-12 Rev. O, 85/4/2

4 5.2 INTERLABORATORY COMPARISON PROGRAM Technical Specification 3.12.3 states, in part:

Analyses shall be performed on radioactive materials supplied as part of an Interlaboratory Comparison Program that has been approved by the Commission.

Participation in an approved Interlaboratory Comparison Program ensures that an independent check on the precision and accuracy of the measurements of radioactive materials in environmental sample matrices is performed. This check is performed as part of the QA program for environmental monitoring in order to demonstrate that the results are valid for the purpose of Section IV.B.2 of Appendix I to 10CFR50.

(

A summary of the Interlaboratory Comparison Program results obtained is required to be included in the Annual Radiological

Environmental Operating Report pursuant to Technical Speci-fication 6.9.1.11.

SOURCE:PSEGODCM 5.0-13 Rev. O, 85/4/2

Table 3.2-2 PATHWAY DOSE FACTORS FOR SECTION 3.2.3 (Rg3g)*

Page 15 of 21: Dose Factors for Kidney

_ .- . /

I ISOTCMI It**l4 TION l 690L90 ft4NEl GPS /E0W/tituf t A II-131 8 5.100E+04 1 1.721E*07 I 5.954E+09 l 11-139 I 3.94GE+03 1 1.245E+06 1 5.169E+00 I Il-131 1 2.240E+04 1 2.451E+06 I 9.076E+07 I II.134 I 2.086E+03 1 4.467E+05 I 6.41dE-11 I 11-135 1 0.47AE+03 1 2.626E+06 1 3.961E+5 I IES.134 1 1.904E+05 1 6.R1E+09 1 2.786E+10 I 105-136 I 5.642E+04 i 1.502E+0 1 3.674E+09 I 10S-137 1 1.722E+05 1 1.030E+10 1 2.572E+10 l IES.138 1 4.10?bO2 1 3.509E*05 1 1.092E-22 I 6%-139 I 5.922E-04 1 1.061E*05 1 2.976E-10 I IM-140 l 1.343E+01 1 2.0!3E*07 l 9.104E+04 I 1%-141 1 6.496E-05 I 4.172E+04 1 2.723E-40 I

~

IM-142 1 1.904E-05 1 4.445E*04 I 0.000E+00 I ILA-140 1 0.000E+00 1 1.923E*07 1 0.00nE+00 I It A-142 1 0.000E+00 1 7.602E*05 1 0.00nE+00 1 LEE-141 1 5.250E+03 6 1.366E+07 1 1.297E+04 I ire-141 1 5.647E+01 1 2.312E*04 1 1.220E*02 l ICE-144 I 5.376E*05 1 6.946d07 I 6.120E+05 I IPO.141 1 1.974E+03 1 0.000E+00 I 3.207E+02 I IP0-144 I 6.720E-03 1 1.037E*03 1 1.451E-53 I 19-147 1 3.150E*03 1 0.400F+06 I 5.559E+02 I tu.107 1 0.000F+00 1 2.I5bE+06 1 0.00nE+00 I IW-299 I 6.622C+01 1 1.706E+06 1 1.032E*01 I

• -- See Note, page_3.0-43 Units: Inhalation - mrem /yr per uCi/m3

.Others -

m2 mrem /yr per uCi/sec SOURCE:PSEGODCM 3.0-36 Rev. O, 85/4/2 u